data_2xy8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2xy8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 CA--C 1.524 -0.03 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 CA--C 1.526 0.056 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HZ1' ' CD ' ' A' ' 94' ' ' GLU . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 56' ' ' ARG . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.987 0.422 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' B' ' 32' ' ' ASN . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' B' ' 30' ' ' ARG . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.957 0.408 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.489 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HZ1' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.176 0.512 . . . . 1.0 110.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' B' ' 59' ' ' HIS . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' B' ' 19' ' ' ASP . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HZ2' ' CD ' ' A' ' 110' ' ' GLU . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HZ1' ' CG ' ' A' ' 75' ' ' ASP . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.989 0.423 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.635 0.255 . . . . 1.0 111.049 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.651 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.182 0.515 . . . . 1.0 110.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.77 -44.85 95.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.647 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -77.75 -9.38 58.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.539 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.7 ttp -68.67 -35.06 76.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -79.02 -40.53 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.24 -46.0 84.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.33 -14.53 32.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.276 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 67.3 mt 64.47 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.724 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.94 -75.89 0.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 62.36 94.66 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.35 -56.26 1.01 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.85 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.352 0.749 0 C-N-CA 121.887 1.725 . . . . 1.0 111.974 179.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.651 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.638 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.107 0.48 . . . . 1.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -22.5 66.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.788 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.93 -29.62 69.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.262 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 49.0 mtt -70.43 -30.34 67.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.5 -39.78 94.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.747 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.19 -47.35 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.48 -26.44 35.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.271 . . . . 1.0 111.733 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt 67.97 -74.37 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.046 0.539 . . . . 1.0 111.388 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.96 -81.18 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.032 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? 48.71 58.92 4.77 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.557 0.536 . . . . 1.0 111.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.81 -56.81 5.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.607 -0.724 . . . . 1.0 112.572 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--N 1.352 0.729 0 C-N-CA 122.186 1.924 . . . . 1.0 111.999 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HZ1' ' CD ' ' A' ' 94' ' ' GLU . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.684 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.655 0.264 . . . . 1.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -39.53 83.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -91.94 -24.2 19.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.508 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 47.9 ttp -63.71 -42.93 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.986 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.75 -46.5 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.04 -35.27 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -100.03 -28.99 12.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.674 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 79.0 mt 68.9 -71.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.331 0.652 . . . . 1.0 111.785 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 t -130.35 -87.98 0.5 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 54.97 54.98 8.25 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 1.0 111.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.39 -55.97 22.06 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.35 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--N 1.354 0.866 0 C-N-CA 121.74 1.626 . . . . 1.0 111.83 179.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.684 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.676 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 56' ' ' ARG . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.671 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.031 0.443 . . . . 1.0 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -67.1 -18.5 65.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.204 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.45 -47.66 72.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.889 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.2 mmt -75.36 -24.22 57.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.121 0.486 . . . . 1.0 109.712 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.31 -45.89 82.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.525 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' B' ' 32' ' ' ASN . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' B' ' 30' ' ' ARG . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p -79.06 -25.57 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.79 37.85 4.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.152 0.501 . . . . 1.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.7 tp -86.08 -46.97 9.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.467 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.1 m -90.21 93.9 9.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.978 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -119.99 -167.95 1.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.432 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 28.5 tp -73.06 -56.88 3.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 111.787 0.292 . . . . 1.0 111.787 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--N 1.354 0.867 0 C-N-CA 122.157 1.905 . . . . 1.0 111.929 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.676 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.682 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -46.39 90.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.105 0.479 . . . . 1.0 110.507 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.47 -30.26 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.815 -0.629 . . . . 1.0 111.164 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -61.68 -40.77 96.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.633 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.79 -38.01 64.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.982 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.25 -25.9 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.47 41.67 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 1.0 111.678 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.08 -28.69 69.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.705 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -80.27 63.56 4.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 1.0 110.887 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 17.65 19.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.291 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 mt -113.43 127.86 26.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.995 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.643 2.229 . . . . 1.0 112.091 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.682 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.489 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HZ1' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.668 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.028 0.442 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -41.71 82.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.167 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -78.44 -9.92 59.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.967 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -66.57 -33.99 76.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.067 0.46 . . . . 1.0 109.768 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.22 -40.78 58.8 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.28 -43.3 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -83.17 -29.27 28.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt 70.27 -52.14 0.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.2 m -152.2 -54.32 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.558 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.96 44.05 29.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.729 0.643 . . . . 1.0 112.416 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.5 -55.08 49.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.771 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.782 0 C-N-CA 122.212 1.941 . . . . 1.0 111.549 178.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.668 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' CG ' ' HE ' ' B' ' 68' ' ' ARG . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.165 0.507 . . . . 1.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -67.47 -20.5 65.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -67.45 -47.57 69.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.051 0.453 . . . . 1.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.75 -24.71 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.084 0.469 . . . . 1.0 109.753 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -28.65 70.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.298 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' B' ' 59' ' ' HIS . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' B' ' 19' ' ' ASP . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.41 3.39 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -131.39 36.68 3.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 69.6 mt -71.51 -79.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.263 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.6 m 68.44 -76.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.534 0.568 . . . . 1.0 112.534 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 62.74 90.24 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.81 117.04 66.95 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.524 -0.762 . . . . 1.0 109.359 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.931 2.421 . . . . 1.0 112.294 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.68 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HZ2' ' CD ' ' A' ' 110' ' ' GLU . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.197 0.522 . . . . 1.0 110.129 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -35.37 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 1.0 111.512 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -36.87 85.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 1.0 110.658 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.8 mmm -66.43 -30.87 71.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.275 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.2 -43.22 24.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.26 -27.82 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -88.4 24.56 1.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 1.0 112.101 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.52 -24.14 66.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 32.3 0.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.711 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -21.06 64.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.0 110.889 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tp -91.96 116.23 66.09 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--O 1.237 0.46 0 C-N-CA 122.504 2.136 . . . . 1.0 112.295 -179.832 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.677 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HZ1' ' CG ' ' A' ' 75' ' ' ASP . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.681 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.816 0.341 . . . . 1.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.41 -35.71 73.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.825 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.31 -29.77 70.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.739 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 18.4 mmm -65.51 -38.52 89.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.465 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -66.28 -42.23 88.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.04 -19.73 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.17 59.22 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.085 0.469 . . . . 1.0 110.696 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -28.32 66.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.175 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -82.77 65.37 7.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -74.81 -22.51 58.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.38 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 mt -126.01 125.97 24.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.825 2.35 . . . . 1.0 111.551 179.64 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.681 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.657 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.938 0.399 . . . . 1.0 110.279 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -64.26 -15.03 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.243 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.73 -33.93 73.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.402 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 22.2 mmt -71.05 -40.53 71.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.578 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.54 -37.5 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.049 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.6 -9.97 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.36 57.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.295 0.48 . . . . 1.0 112.295 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -81.73 -37.7 26.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.073 0.463 . . . . 1.0 109.899 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.35 119.79 30.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -127.96 -92.69 0.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 46.4 tp -136.5 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 111.763 0.283 . . . . 1.0 111.763 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 121.739 1.626 . . . . 1.0 111.508 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . 0.657 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 90' ' ' ILE . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 30' ' ' ILE . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.432 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HE2' ' OD2' ' A' ' 55' ' ' ASP . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.763 ' HA ' HG22 ' A' ' 15' ' ' THR . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 HG21 ' A' ' 68' ' ' ILE . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.69 ' HE2' HG22 ' A' ' 78' ' ' THR . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 29' ' ' LYS . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 16' ' ' THR . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 61' ' ' GLU . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD21 ' B' ' 20' ' ' LEU . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 74' ' ' LEU . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' B' ' 20' ' ' LEU . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.626 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 71' ' ' GLU . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' HD21 ' A' ' 95' ' ' LEU . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' MET . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 90' ' ' ILE . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 127' ' ' VAL . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 28' ' ' HIS . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.489 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.423 ' HG3' HD12 ' A' ' 30' ' ' ILE . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 104' ' ' ILE . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' CYS . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 165' ' ' LEU . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.76 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 161' ' ' LEU . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 170' ' ' ILE . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 166' ' ' LEU . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.516 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.0 t70 . . . . . 0 CA--C 1.524 -0.03 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' B' ' 15' ' ' LYS . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' HIS . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG22 HD22 ' B' ' 48' ' ' LEU . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.524 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' B' ' 38' ' ' GLU . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.627 HG23 ' HB1' ' B' ' 21' ' ' ALA . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' B' ' 45' ' ' PRO . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.647 ' HB3' HD11 ' B' ' 48' ' ' LEU . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.765 ' HD2' HD21 ' B' ' 48' ' ' LEU . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.765 HD21 ' HD2' ' B' ' 45' ' ' PRO . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.792 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' B' ' 57' ' ' ILE . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 54' ' ' GLU . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 74' ' ' LEU . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' SER . . . . . 0.653 ' HB3' ' HB1' ' B' ' 26' ' ' ALA . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 36' ' ' VAL . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 30' ' ' ILE . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.574 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.867 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.678 ' HA ' HG22 ' A' ' 15' ' ' THR . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 14' ' ' GLU . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 10' ' ' VAL . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 43' ' ' LEU . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 38' ' ' VAL . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 33' ' ' ILE . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.604 ' HB3' HG22 ' A' ' 78' ' ' THR . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 16' ' ' THR . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 65' ' ' VAL . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' GLU . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' OD1' HG23 ' A' ' 58' ' ' VAL . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 76' ' ' LYS . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 53' ' ' LYS . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' MET . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.712 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 103' ' ' ASP . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' ILE . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HG3' HD12 ' A' ' 30' ' ' ILE . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.712 ' HD3' ' HG3' ' A' ' 94' ' ' GLU . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HE ' ' A' ' 135' ' ' ARG . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HE ' ' HG ' ' A' ' 131' ' ' LEU . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 167' ' ' ASP . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' HG11 ' A' ' 174' ' ' VAL . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 170' ' ' ILE . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 170' ' ' ILE . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HB2' HD13 ' A' ' 145' ' ' LEU . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.543 HG21 ' SG ' ' A' ' 149' ' ' CYS . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 148' ' ' LEU . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.557 ' O ' HG23 ' B' ' 18' ' ' VAL . 34.6 t70 . . . . . 0 CA--C 1.526 0.056 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 14' ' ' ASP . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 39' ' ' ALA . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.62 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 36' ' ' ILE . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 37' ' ' ALA . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.87 ' HB3' HD11 ' B' ' 48' ' ' LEU . 75.1 mm-40 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.53 ' HD2' HD21 ' B' ' 48' ' ' LEU . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.919 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.87 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.919 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 57' ' ' ILE . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 60' ' ' ARG . 59.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 34' ' ' GLY . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.75 HG22 ' HA ' ' A' ' 30' ' ' ILE . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.75 ' HA ' HG22 ' A' ' 15' ' ' THR . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 10' ' ' VAL . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 82' ' ' VAL . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' THR . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' HG3' ' B' ' 33' ' ' MET . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.627 HD11 HD21 ' A' ' 73' ' ' LEU . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.627 HD21 HD11 ' A' ' 68' ' ' ILE . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 72' ' ' PHE . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 52' ' ' LEU . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 104' ' ' ILE . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 103' ' ' ASP . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 102' ' ' PHE . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 97' ' ' ILE . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 HD13 ' A' ' 95' ' ' LEU . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 15' ' ' THR . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 104' ' ' ILE . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HB3' HG11 ' A' ' 174' ' ' VAL . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 49' ' ' HIS . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 148' ' ' LEU . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.5 t70 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 14' ' ' ASP . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.628 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.548 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.633 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' B' ' 28' ' ' LYS . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' B' ' 38' ' ' GLU . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' HG3' ' B' ' 28' ' ' LYS . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.456 ' HG2' HG22 ' B' ' 36' ' ' ILE . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.548 HG23 ' HB1' ' B' ' 21' ' ' ALA . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.814 ' HB3' HD11 ' B' ' 48' ' ' LEU . 28.9 mm-40 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' B' ' 48' ' ' LEU . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' B' ' 44' ' ' GLN . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' B' ' 49' ' ' ARG . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' OD2' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.746 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HB ' HG22 ' A' ' 36' ' ' VAL . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.577 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 30' ' ' ILE . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 15' ' ' THR . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 66' ' ' HIS . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 10' ' ' VAL . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 8' ' ' GLN . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 44' ' ' THR . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 HH22 ' HA2' ' A' ' 180' ' ' GLY . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 39' ' ' VAL . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HD22 ' A' ' 165' ' ' LEU . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HE2' HG22 ' A' ' 78' ' ' THR . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 16' ' ' THR . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.578 ' HE1' HD11 ' A' ' 31' ' ' ILE . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.442 ' O ' HG12 ' A' ' 90' ' ' ILE . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 86' ' ' PHE . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' MET . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 90' ' ' ILE . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 107' ' ' MET . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB3' HD11 ' A' ' 30' ' ' ILE . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 104' ' ' ILE . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.509 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 148' ' ' LEU . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.557 HD13 HG11 ' A' ' 174' ' ' VAL . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.487 HH21 HD23 ' A' ' 148' ' ' LEU . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.577 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 49' ' ' HIS . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 170' ' ' ILE . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.445 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 36' ' ' VAL . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.557 HG11 HD13 ' A' ' 148' ' ' LEU . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.52 ' HA2' HH22 ' A' ' 41' ' ' ARG . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.987 0.422 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.509 ' OD2' ' HD2' ' B' ' 55' ' ' ARG . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.687 HG21 HD21 ' B' ' 56' ' ' LEU . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' B' ' 35' ' ' VAL . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' B' ' 34' ' ' PRO . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 33' ' ' MET . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' B' ' 28' ' ' LYS . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' B' ' 44' ' ' GLN . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' B' ' 42' ' ' ARG . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 40' ' ' VAL . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.509 ' HD2' ' OD2' ' B' ' 19' ' ' ASP . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 90' ' ' ILE . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' HD23 ' A' ' 11' ' ' LEU . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 30' ' ' ILE . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.478 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.854 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.854 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 15' ' ' THR . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 16' ' ' THR . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HG2' HG23 ' A' ' 39' ' ' VAL . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 37' ' ' GLU . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD1' ' HE2' ' A' ' 72' ' ' PHE . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' THR . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.814 HG12 HD11 ' B' ' 20' ' ' LEU . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.591 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' LYS . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 52' ' ' LEU . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.565 ' HB ' HD21 ' A' ' 95' ' ' LEU . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' MET . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 90' ' ' ILE . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 103' ' ' ASP . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.478 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.498 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 170' ' ' ILE . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 159' ' ' ARG . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 156' ' ' ASN . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.552 HG21 ' SG ' ' A' ' 149' ' ' CYS . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.957 0.408 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.814 HD11 HG12 ' A' ' 68' ' ' ILE . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' B' ' 40' ' ' VAL . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' HIS . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.496 ' HA ' HG21 ' B' ' 35' ' ' VAL . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' B' ' 28' ' ' LYS . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.513 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ALA . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 26' ' ' ALA . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' SER . . . . . 0.445 ' OG ' ' HB1' ' B' ' 26' ' ' ALA . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 37' ' ' GLU . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 97' ' ' ILE . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.751 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 106' ' ' PHE . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' HE1' ' A' ' 66' ' ' HIS . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 52' ' ' LEU . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 9' ' ' ILE . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 33' ' ' ILE . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.721 ' HB3' HG22 ' A' ' 78' ' ' THR . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 16' ' ' THR . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HE1' HD11 ' A' ' 31' ' ' ILE . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 HD21 ' B' ' 20' ' ' LEU . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 53' ' ' LYS . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' HD22 ' A' ' 52' ' ' LEU . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.652 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' MET . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 90' ' ' ILE . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 100' ' ' ALA . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 118' ' ' ILE . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.959 ' HB3' HG11 ' A' ' 174' ' ' VAL . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 178' ' ' MET . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 174' ' ' VAL . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 170' ' ' ILE . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 166' ' ' LEU . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.959 HG11 ' HB3' ' A' ' 148' ' ' LEU . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 t70 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' ASP . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.646 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.556 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' PHE . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 28' ' ' LYS . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.902 ' HD2' ' HB2' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' B' ' 38' ' ' GLU . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.902 ' HB2' ' HD2' ' B' ' 28' ' ' LYS . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.572 ' HG2' HG22 ' B' ' 36' ' ' ILE . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 37' ' ' ALA . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 41' ' ' GLU . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 1.003 ' HB3' HD11 ' B' ' 48' ' ' LEU . 84.0 mm-40 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.83 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 1.003 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.83 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' B' ' 56' ' ' LEU . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.432 HD22 ' NH2' ' B' ' 53' ' ' ARG . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' GLU . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 30' ' ' ILE . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.675 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 15' ' ' THR . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.437 HG21 HG23 ' A' ' 16' ' ' THR . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.71 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 16' ' ' THR . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HA2' ' B' ' 24' ' ' GLY . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.787 HG12 HD11 ' B' ' 20' ' ' LEU . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 53' ' ' LYS . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HE2' ' HE3' ' A' ' 107' ' ' MET . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.454 ' HE3' ' HE2' ' A' ' 86' ' ' PHE . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' A' ' 109' ' ' TYR . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 166' ' ' LEU . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 166' ' ' LEU . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 49' ' ' HIS . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.476 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.497 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 27.0 t70 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.176 0.512 . . . . 1.0 110.298 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' ASP . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 68' ' ' ILE . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HZ ' ' A' ' 63' ' ' PHE . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' B' ' 30' ' ' ARG . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.484 ' HG2' ' CE2' ' B' ' 52' ' ' PHE . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 42' ' ' ARG . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HG2' ' OE1' ' B' ' 44' ' ' GLN . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HG2' ' B' ' 41' ' ' GLU . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 54' ' ' GLU . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.631 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 52' ' ' PHE . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.422 ' HE2' ' CG ' ' B' ' 19' ' ' ASP . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.5 ' HA ' ' OG ' ' B' ' 63' ' ' SER . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' B' ' 60' ' ' ARG . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 30' ' ' ILE . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.618 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 15' ' ' THR . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 78' ' ' THR . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 16' ' ' THR . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.436 HG23 HD21 ' B' ' 20' ' ' LEU . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 73' ' ' LEU . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 53' ' ' LYS . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 95' ' ' LEU . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 91' ' ' ARG . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 90' ' ' ILE . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 127' ' ' VAL . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 15' ' ' THR . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 104' ' ' ILE . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 138' ' ' PHE . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 147' ' ' ALA . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 174' ' ' VAL . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.637 ' SG ' HG21 ' A' ' 170' ' ' ILE . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.624 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.637 HG21 ' SG ' ' A' ' 149' ' ' CYS . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 148' ' ' LEU . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.634 HG11 HD13 ' B' ' 48' ' ' LEU . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.447 ' CG ' ' HD3' ' B' ' 55' ' ' ARG . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 68' ' ' ILE . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.411 HG22 ' H ' ' B' ' 39' ' ' ALA . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.51 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.411 ' H ' HG22 ' B' ' 36' ' ' ILE . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' B' ' 37' ' ' ALA . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.487 ' HD2' HD11 ' B' ' 48' ' ' LEU . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 49' ' ' ARG . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.634 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' B' ' 46' ' ' GLU . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.447 ' HD3' ' CG ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' B' ' 60' ' ' ARG . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' B' ' 60' ' ' ARG . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.788 HG22 ' HA ' ' A' ' 30' ' ' ILE . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.709 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HG22 ' A' ' 15' ' ' THR . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 72' ' ' PHE . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 79' ' ' PHE . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 16' ' ' THR . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 65' ' ' VAL . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 61' ' ' GLU . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 53' ' ' LYS . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 52' ' ' LEU . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' MET . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 124' ' ' PHE . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 121' ' ' THR . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.488 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 142' ' ' ARG . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 145' ' ' LEU . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 156' ' ' ASN . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 149' ' ' CYS . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 159' ' ' ARG . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.473 ' HB3' ' SG ' ' A' ' 149' ' ' CYS . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 155' ' ' ASP . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.406 ' ND1' HD12 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 170' ' ' ILE . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 166' ' ' LEU . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 178' ' ' MET . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 174' ' ' VAL . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.45 ' O ' HG23 ' B' ' 18' ' ' VAL . 4.6 t70 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.989 0.423 . . . . 1.0 110.26 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 15' ' ' LYS . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 14' ' ' ASP . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 72' ' ' PHE . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' B' ' 40' ' ' VAL . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.58 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' B' ' 25' ' ' VAL . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.707 ' HD2' HD11 ' B' ' 48' ' ' LEU . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.707 HD11 ' HD2' ' B' ' 45' ' ' PRO . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' B' ' 55' ' ' ARG . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' B' ' 51' ' ' TRP . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.495 HD13 HG11 ' B' ' 25' ' ' VAL . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 60' ' ' ARG . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 37' ' ' GLU . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 30' ' ' ILE . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 18' ' ' MET . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' HA ' HG22 ' A' ' 15' ' ' THR . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 39' ' ' VAL . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 37' ' ' GLU . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB2' HD13 ' A' ' 165' ' ' LEU . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 33' ' ' ILE . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 16' ' ' THR . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.434 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.74 ' HG2' ' HA ' ' B' ' 63' ' ' SER . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 53' ' ' LYS . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 91' ' ' ARG . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' LYS . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 90' ' ' ILE . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 128' ' ' THR . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.414 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.414 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 141' ' ' LYS . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.828 ' HB3' HG11 ' A' ' 174' ' ' VAL . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 174' ' ' VAL . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 49' ' ' HIS . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 174' ' ' VAL . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 148' ' ' LEU . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.408 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.635 0.255 . . . . 1.0 111.049 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' B' ' 15' ' ' LYS . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 14' ' ' ASP . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 56' ' ' LEU . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.53 ' HE1' ' HG3' ' B' ' 33' ' ' MET . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.794 ' HA ' HG11 ' B' ' 35' ' ' VAL . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' MET . . . . . 0.53 ' HG3' ' HE1' ' B' ' 27' ' ' PHE . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.794 HG11 ' HA ' ' B' ' 28' ' ' LYS . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' B' ' 45' ' ' PRO . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PRO . . . . . 0.464 ' HD2' HD21 ' B' ' 48' ' ' LEU . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.464 HD21 ' HD2' ' B' ' 45' ' ' PRO . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.628 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.421 ' HG ' HH21 ' B' ' 53' ' ' ARG . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.407 ' O ' HG12 ' B' ' 64' ' ' VAL . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' SER . . . . . 0.74 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.407 HG12 ' O ' ' B' ' 61' ' ' LEU . 3.5 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 90' ' ' ILE . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 30' ' ' ILE . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.432 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HE2' ' OD2' ' A' ' 55' ' ' ASP . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.763 ' HA ' HG22 ' A' ' 15' ' ' THR . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 HG21 ' A' ' 68' ' ' ILE . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.69 ' HE2' HG22 ' A' ' 78' ' ' THR . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 29' ' ' LYS . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 16' ' ' THR . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 61' ' ' GLU . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD21 ' B' ' 20' ' ' LEU . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 74' ' ' LEU . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' B' ' 20' ' ' LEU . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.626 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 71' ' ' GLU . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' HD21 ' A' ' 95' ' ' LEU . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' MET . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 90' ' ' ILE . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 127' ' ' VAL . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 28' ' ' HIS . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.489 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.423 ' HG3' HD12 ' A' ' 30' ' ' ILE . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 104' ' ' ILE . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' CYS . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 165' ' ' LEU . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.76 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 161' ' ' LEU . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 170' ' ' ILE . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 166' ' ' LEU . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.182 0.515 . . . . 1.0 110.442 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.77 -44.85 95.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.647 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' B' ' 15' ' ' LYS . 61.6 mm-40 -77.75 -9.38 58.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.539 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.7 ttp -68.67 -35.06 76.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.516 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.0 t70 -79.02 -40.53 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 12' ' ' GLU . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' HIS . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG22 HD22 ' B' ' 48' ' ' LEU . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.524 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' B' ' 38' ' ' GLU . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.627 HG23 ' HB1' ' B' ' 21' ' ' ALA . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' B' ' 45' ' ' PRO . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.647 ' HB3' HD11 ' B' ' 48' ' ' LEU . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.765 ' HD2' HD21 ' B' ' 48' ' ' LEU . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.765 HD21 ' HD2' ' B' ' 45' ' ' PRO . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.792 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' B' ' 57' ' ' ILE . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 54' ' ' GLU . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 74' ' ' LEU . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.653 ' HB3' ' HB1' ' B' ' 26' ' ' ALA . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.24 -46.0 84.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.33 -14.53 32.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.276 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 67.3 mt 64.47 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.724 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.94 -75.89 0.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 62.36 94.66 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 87.2 mt -78.35 -56.26 1.01 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.85 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 71.6 Cg_endo . . . . . 0 C--N 1.352 0.749 0 C-N-CA 121.887 1.725 . . . . 1.0 111.974 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.651 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 36' ' ' VAL . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.638 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 30' ' ' ILE . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.574 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.867 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.678 ' HA ' HG22 ' A' ' 15' ' ' THR . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 14' ' ' GLU . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 10' ' ' VAL . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 43' ' ' LEU . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 38' ' ' VAL . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 33' ' ' ILE . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HD2' HD22 ' B' ' 69' ' ' LEU . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' B' ' 69' ' ' LEU . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 16' ' ' THR . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 65' ' ' VAL . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' GLU . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' OD1' HG23 ' A' ' 58' ' ' VAL . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 76' ' ' LYS . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 53' ' ' LYS . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' MET . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.712 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 103' ' ' ASP . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' ILE . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HG3' HD12 ' A' ' 30' ' ' ILE . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.712 ' HD3' ' HG3' ' A' ' 94' ' ' GLU . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HE ' ' A' ' 135' ' ' ARG . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HE ' ' HG ' ' A' ' 131' ' ' LEU . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 167' ' ' ASP . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' HG11 ' A' ' 174' ' ' VAL . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 170' ' ' ILE . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 170' ' ' ILE . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HB2' HD13 ' A' ' 145' ' ' LEU . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.543 HG21 ' SG ' ' A' ' 149' ' ' CYS . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 148' ' ' LEU . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.107 0.48 . . . . 1.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -22.5 66.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.788 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.93 -29.62 69.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.262 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.534 ' HA ' HG12 ' B' ' 16' ' ' VAL . 49.0 mtt -70.43 -30.34 67.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.055 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.557 ' O ' HG23 ' B' ' 18' ' ' VAL . 34.6 t70 -62.5 -39.78 94.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.747 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 13' ' ' MET . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 14' ' ' ASP . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 39' ' ' ALA . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.62 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 36' ' ' ILE . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 37' ' ' ALA . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.87 ' HB3' HD11 ' B' ' 48' ' ' LEU . 75.1 mm-40 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.53 ' HD2' HD21 ' B' ' 48' ' ' LEU . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.919 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.87 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.919 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 57' ' ' ILE . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 60' ' ' ARG . 59.9 t -81.19 -47.35 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.48 -26.44 35.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.271 . . . . 1.0 111.733 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt 67.97 -74.37 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.046 0.539 . . . . 1.0 111.388 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.96 -81.18 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.032 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? 48.71 58.92 4.77 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.557 0.536 . . . . 1.0 111.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.741 HD22 ' HD2' ' A' ' 53' ' ' LYS . 5.7 mt -70.81 -56.81 5.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.607 -0.724 . . . . 1.0 112.572 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 12.8 Cg_exo . . . . . 0 C--N 1.352 0.729 0 C-N-CA 122.186 1.924 . . . . 1.0 111.999 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 34' ' ' GLY . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.75 HG22 ' HA ' ' A' ' 30' ' ' ILE . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.75 ' HA ' HG22 ' A' ' 15' ' ' THR . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 10' ' ' VAL . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 82' ' ' VAL . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' THR . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' HG3' ' B' ' 33' ' ' MET . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.627 HD11 HD21 ' A' ' 73' ' ' LEU . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.627 HD21 HD11 ' A' ' 68' ' ' ILE . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 72' ' ' PHE . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 52' ' ' LEU . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 104' ' ' ILE . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 103' ' ' ASP . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 102' ' ' PHE . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 97' ' ' ILE . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 HD13 ' A' ' 95' ' ' LEU . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 15' ' ' THR . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 104' ' ' ILE . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HB3' HG11 ' A' ' 174' ' ' VAL . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 49' ' ' HIS . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.684 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 148' ' ' LEU . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.655 0.264 . . . . 1.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.412 ' HB ' ' OE2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -59.24 -39.53 83.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' B' ' 11' ' ' THR . 11.6 mm-40 -91.94 -24.2 19.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.508 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG12 ' B' ' 16' ' ' VAL . 47.9 ttp -63.71 -42.93 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.986 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.5 t70 -58.75 -46.5 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' B' ' 13' ' ' MET . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 14' ' ' ASP . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.628 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.548 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.633 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' B' ' 28' ' ' LYS . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' B' ' 38' ' ' GLU . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' HG3' ' B' ' 28' ' ' LYS . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.456 ' HG2' HG22 ' B' ' 36' ' ' ILE . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.548 HG23 ' HB1' ' B' ' 21' ' ' ALA . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.814 ' HB3' HD11 ' B' ' 48' ' ' LEU . 28.9 mm-40 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' B' ' 48' ' ' LEU . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' B' ' 44' ' ' GLN . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' B' ' 49' ' ' ARG . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' OD2' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.04 -35.27 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -100.03 -28.99 12.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.674 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 79.0 mt 68.9 -71.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.331 0.652 . . . . 1.0 111.785 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 t -130.35 -87.98 0.5 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 54.97 54.98 8.25 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 1.0 111.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 84.9 mt -65.39 -55.97 22.06 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.35 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 71.5 Cg_endo . . . . . 0 C--N 1.354 0.866 0 C-N-CA 121.74 1.626 . . . . 1.0 111.83 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.684 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.746 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HB ' HG22 ' A' ' 36' ' ' VAL . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.577 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.676 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 30' ' ' ILE . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 15' ' ' THR . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 66' ' ' HIS . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 10' ' ' VAL . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 8' ' ' GLN . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 44' ' ' THR . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 HH22 ' HA2' ' A' ' 180' ' ' GLY . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 39' ' ' VAL . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HD22 ' A' ' 165' ' ' LEU . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HE2' HG22 ' A' ' 78' ' ' THR . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 16' ' ' THR . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.578 ' HE1' HD11 ' A' ' 31' ' ' ILE . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.509 HD23 HD12 ' B' ' 66' ' ' LEU . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.442 ' O ' HG12 ' A' ' 90' ' ' ILE . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 86' ' ' PHE . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' MET . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 90' ' ' ILE . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 107' ' ' MET . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB3' HD11 ' A' ' 30' ' ' ILE . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 104' ' ' ILE . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.509 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 148' ' ' LEU . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.557 HD13 HG11 ' A' ' 174' ' ' VAL . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.487 HH21 HD23 ' A' ' 148' ' ' LEU . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.577 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 49' ' ' HIS . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 170' ' ' ILE . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.671 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 36' ' ' VAL . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.557 HG11 HD13 ' A' ' 148' ' ' LEU . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.52 ' HA2' HH22 ' A' ' 41' ' ' ARG . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.031 0.443 . . . . 1.0 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -67.1 -18.5 65.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.204 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.504 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.5 mm-40 -66.45 -47.66 72.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.889 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.2 mmt -75.36 -24.22 57.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.121 0.486 . . . . 1.0 109.712 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.31 -45.89 82.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.525 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 12' ' ' GLU . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.509 ' OD2' ' HD2' ' B' ' 55' ' ' ARG . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.687 HG21 HD21 ' B' ' 56' ' ' LEU . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' B' ' 35' ' ' VAL . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' B' ' 34' ' ' PRO . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 33' ' ' MET . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' B' ' 28' ' ' LYS . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' B' ' 44' ' ' GLN . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' B' ' 42' ' ' ARG . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 40' ' ' VAL . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.509 ' HD2' ' OD2' ' B' ' 19' ' ' ASP . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p -79.06 -25.57 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' B' ' 68' ' ' ARG . 5.5 p30 -120.79 37.85 4.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.152 0.501 . . . . 1.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 74' ' ' LEU . 19.7 tp -86.08 -46.97 9.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.467 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.1 m -90.21 93.9 9.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.978 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' B' ' 65' ' ' ASN . 3.8 mtp180 -119.99 -167.95 1.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.713 ' HB3' ' HD3' ' B' ' 70' ' ' PRO . 28.5 tp -73.06 -56.88 3.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 111.787 0.292 . . . . 1.0 111.787 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' B' ' 69' ' ' LEU . 4.4 Cg_exo . . . . . 0 C--N 1.354 0.867 0 C-N-CA 122.157 1.905 . . . . 1.0 111.929 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.676 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 90' ' ' ILE . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' HD23 ' A' ' 11' ' ' LEU . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 30' ' ' ILE . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.478 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.854 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.854 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 15' ' ' THR . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 16' ' ' THR . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HG2' HG23 ' A' ' 39' ' ' VAL . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 37' ' ' GLU . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD1' ' HE2' ' A' ' 72' ' ' PHE . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' THR . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.814 HG12 HD11 ' B' ' 20' ' ' LEU . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' LYS . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 52' ' ' LEU . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.565 ' HB ' HD21 ' A' ' 95' ' ' LEU . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' MET . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 90' ' ' ILE . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 103' ' ' ASP . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.478 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.498 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 170' ' ' ILE . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 159' ' ' ARG . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 156' ' ' ASN . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.682 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.552 HG21 ' SG ' ' A' ' 149' ' ' CYS . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -46.39 90.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.105 0.479 . . . . 1.0 110.507 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.47 -30.26 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.815 -0.629 . . . . 1.0 111.164 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -61.68 -40.77 96.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.633 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.79 -38.01 64.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.982 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.814 HD11 HG12 ' A' ' 68' ' ' ILE . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' B' ' 40' ' ' VAL . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' HIS . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.496 ' HA ' HG21 ' B' ' 35' ' ' VAL . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' B' ' 28' ' ' LYS . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.513 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ALA . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 26' ' ' ALA . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.445 ' OG ' ' HB1' ' B' ' 26' ' ' ALA . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.25 -25.9 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.47 41.67 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 1.0 111.678 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.08 -28.69 69.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.705 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -80.27 63.56 4.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 1.0 110.887 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 17.65 19.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.291 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' B' ' 70' ' ' PRO . 52.9 mt -113.43 127.86 26.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 69' ' ' LEU . 28.8 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.643 2.229 . . . . 1.0 112.091 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.682 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 37' ' ' GLU . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 97' ' ' ILE . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.751 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 106' ' ' PHE . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' HE1' ' A' ' 66' ' ' HIS . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 52' ' ' LEU . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 9' ' ' ILE . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 33' ' ' ILE . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.721 ' HB3' HG22 ' A' ' 78' ' ' THR . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 16' ' ' THR . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HE1' HD11 ' A' ' 31' ' ' ILE . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 HD21 ' B' ' 20' ' ' LEU . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 53' ' ' LYS . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' HD22 ' A' ' 52' ' ' LEU . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.652 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' MET . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 90' ' ' ILE . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 100' ' ' ALA . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 118' ' ' ILE . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.959 ' HB3' HG11 ' A' ' 174' ' ' VAL . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 178' ' ' MET . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 174' ' ' VAL . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 170' ' ' ILE . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.668 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 166' ' ' LEU . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.959 HG11 ' HB3' ' A' ' 148' ' ' LEU . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.028 0.442 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -41.71 82.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.167 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -78.44 -9.92 59.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.967 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -66.57 -33.99 76.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.067 0.46 . . . . 1.0 109.768 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 t70 -75.22 -40.78 58.8 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' ASP . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.646 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.556 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' PHE . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 28' ' ' LYS . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.902 ' HD2' ' HB2' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' B' ' 38' ' ' GLU . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.902 ' HB2' ' HD2' ' B' ' 28' ' ' LYS . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.572 ' HG2' HG22 ' B' ' 36' ' ' ILE . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 37' ' ' ALA . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 41' ' ' GLU . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 1.003 ' HB3' HD11 ' B' ' 48' ' ' LEU . 84.0 mm-40 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.83 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 1.003 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.83 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' B' ' 56' ' ' LEU . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.432 HD22 ' NH2' ' B' ' 53' ' ' ARG . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.28 -43.3 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.855 ' HB2' ' HG3' ' B' ' 68' ' ' ARG . 21.2 p-10 -83.17 -29.27 28.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt 70.27 -52.14 0.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.2 m -152.2 -54.32 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.558 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.855 ' HG3' ' HB2' ' B' ' 65' ' ' ASN . 0.1 OUTLIER 53.96 44.05 29.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.729 0.643 . . . . 1.0 112.416 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 34.6 mt -59.5 -55.08 49.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.771 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.782 0 C-N-CA 122.212 1.941 . . . . 1.0 111.549 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.668 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' GLU . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 30' ' ' ILE . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.675 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 15' ' ' THR . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.437 HG21 HG23 ' A' ' 16' ' ' THR . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.71 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' NH2' ' B' ' 68' ' ' ARG . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 16' ' ' THR . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HA2' ' B' ' 24' ' ' GLY . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.787 HG12 HD11 ' B' ' 20' ' ' LEU . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' CG ' ' HE ' ' B' ' 68' ' ' ARG . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 53' ' ' LYS . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HE2' ' HE3' ' A' ' 107' ' ' MET . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.454 ' HE3' ' HE2' ' A' ' 86' ' ' PHE . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' A' ' 109' ' ' TYR . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 166' ' ' LEU . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 166' ' ' LEU . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 49' ' ' HIS . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.476 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.165 0.507 . . . . 1.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -67.47 -20.5 65.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -67.45 -47.57 69.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.051 0.453 . . . . 1.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.75 -24.71 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.084 0.469 . . . . 1.0 109.753 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 27.0 t70 -63.54 -28.65 70.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.298 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' ASP . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 68' ' ' ILE . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HZ ' ' A' ' 63' ' ' PHE . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' B' ' 30' ' ' ARG . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.484 ' HG2' ' CE2' ' B' ' 52' ' ' PHE . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 42' ' ' ARG . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HG2' ' OE1' ' B' ' 44' ' ' GLN . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HG2' ' B' ' 41' ' ' GLU . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 54' ' ' GLU . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.631 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 52' ' ' PHE . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.422 ' HE2' ' CG ' ' B' ' 19' ' ' ASP . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.5 ' HA ' ' OG ' ' B' ' 63' ' ' SER . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' B' ' 60' ' ' ARG . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.41 3.39 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -131.39 36.68 3.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 69.6 mt -71.51 -79.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.263 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.6 m 68.44 -76.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.534 0.568 . . . . 1.0 112.534 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.617 ' NH2' ' HG ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER 62.74 90.24 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.81 117.04 66.95 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.524 -0.762 . . . . 1.0 109.359 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.931 2.421 . . . . 1.0 112.294 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.68 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 30' ' ' ILE . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.618 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 15' ' ' THR . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 78' ' ' THR . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 16' ' ' THR . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.436 HG23 HD21 ' B' ' 20' ' ' LEU . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 73' ' ' LEU . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 53' ' ' LYS . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 95' ' ' LEU . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 91' ' ' ARG . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 90' ' ' ILE . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 127' ' ' VAL . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 15' ' ' THR . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 104' ' ' ILE . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 138' ' ' PHE . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 147' ' ' ALA . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 174' ' ' VAL . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.637 ' SG ' HG21 ' A' ' 170' ' ' ILE . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.624 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.637 HG21 ' SG ' ' A' ' 149' ' ' CYS . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 148' ' ' LEU . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.197 0.522 . . . . 1.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -35.37 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 1.0 111.512 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -36.87 85.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 1.0 110.658 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.8 mmm -66.43 -30.87 71.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.275 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.2 -43.22 24.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.634 HG11 HD13 ' B' ' 48' ' ' LEU . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.447 ' CG ' ' HD3' ' B' ' 55' ' ' ARG . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 68' ' ' ILE . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.411 HG22 ' H ' ' B' ' 39' ' ' ALA . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.51 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.411 ' H ' HG22 ' B' ' 36' ' ' ILE . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' B' ' 37' ' ' ALA . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.487 ' HD2' HD11 ' B' ' 48' ' ' LEU . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 49' ' ' ARG . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.634 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' B' ' 46' ' ' GLU . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.447 ' HD3' ' CG ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' B' ' 60' ' ' ARG . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' B' ' 60' ' ' ARG . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.602 ' HA ' ' OD1' ' B' ' 65' ' ' ASN . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.26 -27.82 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' B' ' 62' ' ' ALA . 25.0 p-10 -88.4 24.56 1.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 1.0 112.101 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.52 -24.14 66.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 32.3 0.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.711 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' B' ' 68' ' ' ARG . 0.0 OUTLIER -68.61 -21.06 64.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.0 110.889 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 53' ' ' LYS . 8.5 tp -91.96 116.23 66.09 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.006 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--O 1.237 0.46 0 C-N-CA 122.504 2.136 . . . . 1.0 112.295 -179.832 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.677 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.788 HG22 ' HA ' ' A' ' 30' ' ' ILE . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.709 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HG22 ' A' ' 15' ' ' THR . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 72' ' ' PHE . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 79' ' ' PHE . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 16' ' ' THR . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 65' ' ' VAL . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 61' ' ' GLU . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 53' ' ' LYS . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 52' ' ' LEU . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' MET . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 124' ' ' PHE . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 121' ' ' THR . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.488 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 142' ' ' ARG . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 145' ' ' LEU . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 156' ' ' ASN . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 149' ' ' CYS . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 159' ' ' ARG . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.473 ' HB3' ' SG ' ' A' ' 149' ' ' CYS . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 155' ' ' ASP . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.406 ' ND1' HD12 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 170' ' ' ILE . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.681 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 166' ' ' LEU . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 178' ' ' MET . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 174' ' ' VAL . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.816 0.341 . . . . 1.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.41 -35.71 73.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.825 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.31 -29.77 70.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.739 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 18.4 mmm -65.51 -38.52 89.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.465 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.45 ' O ' HG23 ' B' ' 18' ' ' VAL . 4.6 t70 -66.28 -42.23 88.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.26 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 15' ' ' LYS . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 14' ' ' ASP . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 72' ' ' PHE . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' B' ' 40' ' ' VAL . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.58 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' B' ' 25' ' ' VAL . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.707 ' HD2' HD11 ' B' ' 48' ' ' LEU . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.707 HD11 ' HD2' ' B' ' 45' ' ' PRO . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' B' ' 55' ' ' ARG . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' B' ' 51' ' ' TRP . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.495 HD13 HG11 ' B' ' 25' ' ' VAL . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 60' ' ' ARG . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.04 -19.73 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.17 59.22 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.085 0.469 . . . . 1.0 110.696 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -28.32 66.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.175 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -82.77 65.37 7.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -74.81 -22.51 58.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.38 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 70' ' ' PRO . 58.6 mt -126.01 125.97 24.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.472 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 69' ' ' LEU . 25.7 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.825 2.35 . . . . 1.0 111.551 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.681 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 37' ' ' GLU . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 30' ' ' ILE . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 18' ' ' MET . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' HA ' HG22 ' A' ' 15' ' ' THR . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 39' ' ' VAL . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 37' ' ' GLU . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB2' HD13 ' A' ' 165' ' ' LEU . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 33' ' ' ILE . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 16' ' ' THR . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.434 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.74 ' HG2' ' HA ' ' B' ' 63' ' ' SER . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' B' ' 66' ' ' LEU . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 53' ' ' LYS . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 91' ' ' ARG . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' LYS . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 90' ' ' ILE . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 128' ' ' THR . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.414 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.414 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 141' ' ' LYS . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.828 ' HB3' HG11 ' A' ' 174' ' ' VAL . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 174' ' ' VAL . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 49' ' ' HIS . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.657 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 174' ' ' VAL . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 148' ' ' LEU . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.938 0.399 . . . . 1.0 110.279 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -64.26 -15.03 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.243 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.73 -33.93 73.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.402 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 22.2 mmt -71.05 -40.53 71.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.578 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.408 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -75.54 -37.5 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.049 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' B' ' 15' ' ' LYS . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 14' ' ' ASP . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 56' ' ' LEU . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.53 ' HE1' ' HG3' ' B' ' 33' ' ' MET . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.794 ' HA ' HG11 ' B' ' 35' ' ' VAL . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' MET . . . . . 0.53 ' HG3' ' HE1' ' B' ' 27' ' ' PHE . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.794 HG11 ' HA ' ' B' ' 28' ' ' LYS . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' B' ' 45' ' ' PRO . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PRO . . . . . 0.464 ' HD2' HD21 ' B' ' 48' ' ' LEU . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.464 HD21 ' HD2' ' B' ' 45' ' ' PRO . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.628 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.421 ' HG ' HH21 ' B' ' 53' ' ' ARG . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.407 ' O ' HG12 ' B' ' 64' ' ' VAL . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.74 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.407 HG12 ' O ' ' B' ' 61' ' ' LEU . 3.5 p -73.6 -9.97 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -146.36 57.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.295 0.48 . . . . 1.0 112.295 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' LEU . . . . . 0.505 ' H ' HD23 ' B' ' 66' ' ' LEU . 2.0 pt? -81.73 -37.7 26.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.073 0.463 . . . . 1.0 109.899 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.35 119.79 30.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -127.96 -92.69 0.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' B' ' 70' ' ' PRO . 46.4 tp -136.5 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 111.763 0.283 . . . . 1.0 111.763 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 69' ' ' LEU . 96.2 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 121.739 1.626 . . . . 1.0 111.508 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . 0.657 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 90' ' ' ILE . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 30' ' ' ILE . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.432 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HE2' ' OD2' ' A' ' 55' ' ' ASP . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.763 ' HA ' HG22 ' A' ' 15' ' ' THR . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 HG21 ' A' ' 68' ' ' ILE . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.69 ' HE2' HG22 ' A' ' 78' ' ' THR . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 29' ' ' LYS . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 16' ' ' THR . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 61' ' ' GLU . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD21 ' B' ' 20' ' ' LEU . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 74' ' ' LEU . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' B' ' 20' ' ' LEU . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.626 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 71' ' ' GLU . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' HD21 ' A' ' 95' ' ' LEU . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' MET . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 90' ' ' ILE . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 127' ' ' VAL . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 28' ' ' HIS . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.489 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.423 ' HG3' HD12 ' A' ' 30' ' ' ILE . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 104' ' ' ILE . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' CYS . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 165' ' ' LEU . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.76 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 161' ' ' LEU . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 170' ' ' ILE . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 166' ' ' LEU . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.516 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.0 t70 . . . . . 0 CA--C 1.524 -0.03 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' B' ' 15' ' ' LYS . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' HIS . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG22 HD22 ' B' ' 48' ' ' LEU . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.524 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' B' ' 38' ' ' GLU . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.627 HG23 ' HB1' ' B' ' 21' ' ' ALA . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' B' ' 45' ' ' PRO . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.647 ' HB3' HD11 ' B' ' 48' ' ' LEU . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.765 ' HD2' HD21 ' B' ' 48' ' ' LEU . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.765 HD21 ' HD2' ' B' ' 45' ' ' PRO . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.792 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' B' ' 57' ' ' ILE . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 54' ' ' GLU . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 74' ' ' LEU . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . 0.653 ' HB3' ' HB1' ' B' ' 26' ' ' ALA . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 36' ' ' VAL . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 30' ' ' ILE . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.574 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.867 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.678 ' HA ' HG22 ' A' ' 15' ' ' THR . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 14' ' ' GLU . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 10' ' ' VAL . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 43' ' ' LEU . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 38' ' ' VAL . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 33' ' ' ILE . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.604 ' HB3' HG22 ' A' ' 78' ' ' THR . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 16' ' ' THR . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 65' ' ' VAL . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' GLU . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' OD1' HG23 ' A' ' 58' ' ' VAL . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 76' ' ' LYS . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 53' ' ' LYS . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' MET . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.712 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 103' ' ' ASP . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' ILE . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HG3' HD12 ' A' ' 30' ' ' ILE . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.712 ' HD3' ' HG3' ' A' ' 94' ' ' GLU . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HE ' ' A' ' 135' ' ' ARG . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HE ' ' HG ' ' A' ' 131' ' ' LEU . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 167' ' ' ASP . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' HG11 ' A' ' 174' ' ' VAL . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 170' ' ' ILE . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 170' ' ' ILE . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HB2' HD13 ' A' ' 145' ' ' LEU . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.543 HG21 ' SG ' ' A' ' 149' ' ' CYS . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 148' ' ' LEU . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.557 ' O ' HG23 ' B' ' 18' ' ' VAL . 34.6 t70 . . . . . 0 CA--C 1.526 0.056 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 14' ' ' ASP . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 39' ' ' ALA . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.62 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 36' ' ' ILE . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 37' ' ' ALA . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.87 ' HB3' HD11 ' B' ' 48' ' ' LEU . 16.3 mm100 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.53 ' HD2' HD21 ' B' ' 48' ' ' LEU . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.919 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.87 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.919 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 57' ' ' ILE . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 60' ' ' ARG . 59.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 34' ' ' GLY . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.75 HG22 ' HA ' ' A' ' 30' ' ' ILE . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.75 ' HA ' HG22 ' A' ' 15' ' ' THR . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 10' ' ' VAL . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 82' ' ' VAL . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' THR . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' HG3' ' B' ' 33' ' ' MET . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.627 HD11 HD21 ' A' ' 73' ' ' LEU . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.627 HD21 HD11 ' A' ' 68' ' ' ILE . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 72' ' ' PHE . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 52' ' ' LEU . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 104' ' ' ILE . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 103' ' ' ASP . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 102' ' ' PHE . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 97' ' ' ILE . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 HD13 ' A' ' 95' ' ' LEU . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 15' ' ' THR . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 104' ' ' ILE . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HB3' HG11 ' A' ' 174' ' ' VAL . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 49' ' ' HIS . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 148' ' ' LEU . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.5 t70 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.727 HG22 HE21 ' B' ' 44' ' ' GLN . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.628 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.548 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.633 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' B' ' 28' ' ' LYS . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' B' ' 38' ' ' GLU . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' HG3' ' B' ' 28' ' ' LYS . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.456 ' HG2' HG22 ' B' ' 36' ' ' ILE . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.548 HG23 ' HB1' ' B' ' 21' ' ' ALA . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.814 ' HB3' HD11 ' B' ' 48' ' ' LEU . 12.2 mm100 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' B' ' 48' ' ' LEU . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' B' ' 44' ' ' GLN . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' B' ' 49' ' ' ARG . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' OD2' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.746 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HB ' HG22 ' A' ' 36' ' ' VAL . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.577 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 30' ' ' ILE . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 15' ' ' THR . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 66' ' ' HIS . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 10' ' ' VAL . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 8' ' ' GLN . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 44' ' ' THR . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 HH22 ' HA2' ' A' ' 180' ' ' GLY . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 39' ' ' VAL . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HD22 ' A' ' 165' ' ' LEU . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HE2' HG22 ' A' ' 78' ' ' THR . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 16' ' ' THR . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.578 ' HE1' HD11 ' A' ' 31' ' ' ILE . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.442 ' O ' HG12 ' A' ' 90' ' ' ILE . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 86' ' ' PHE . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' MET . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 90' ' ' ILE . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 107' ' ' MET . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB3' HD11 ' A' ' 30' ' ' ILE . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 104' ' ' ILE . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.509 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 148' ' ' LEU . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.557 HD13 HG11 ' A' ' 174' ' ' VAL . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.487 HH21 HD23 ' A' ' 148' ' ' LEU . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.577 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 49' ' ' HIS . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 170' ' ' ILE . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.445 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 36' ' ' VAL . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.557 HG11 HD13 ' A' ' 148' ' ' LEU . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.52 ' HA2' HH22 ' A' ' 41' ' ' ARG . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.987 0.422 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.509 ' OD2' ' HD2' ' B' ' 55' ' ' ARG . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.687 HG21 HD21 ' B' ' 56' ' ' LEU . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' B' ' 35' ' ' VAL . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' B' ' 34' ' ' PRO . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 33' ' ' MET . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' B' ' 28' ' ' LYS . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' B' ' 44' ' ' GLN . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' B' ' 42' ' ' ARG . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 40' ' ' VAL . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.509 ' HD2' ' OD2' ' B' ' 19' ' ' ASP . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 90' ' ' ILE . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' HD23 ' A' ' 11' ' ' LEU . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 30' ' ' ILE . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.478 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.854 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.854 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 15' ' ' THR . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 16' ' ' THR . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HG2' HG23 ' A' ' 39' ' ' VAL . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 37' ' ' GLU . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD1' ' HE2' ' A' ' 72' ' ' PHE . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' THR . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.814 HG12 HD11 ' B' ' 20' ' ' LEU . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.591 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' LYS . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 52' ' ' LEU . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.565 ' HB ' HD21 ' A' ' 95' ' ' LEU . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' MET . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 90' ' ' ILE . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 103' ' ' ASP . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.478 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.498 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 170' ' ' ILE . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 159' ' ' ARG . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 156' ' ' ASN . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.552 HG21 ' SG ' ' A' ' 149' ' ' CYS . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.957 0.408 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.814 HD11 HG12 ' A' ' 68' ' ' ILE . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' B' ' 40' ' ' VAL . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' HIS . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.496 ' HA ' HG21 ' B' ' 35' ' ' VAL . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' B' ' 28' ' ' LYS . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.513 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ALA . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 26' ' ' ALA . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . 0.445 ' OG ' ' HB1' ' B' ' 26' ' ' ALA . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 37' ' ' GLU . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 97' ' ' ILE . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.751 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 106' ' ' PHE . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' HE1' ' A' ' 66' ' ' HIS . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 52' ' ' LEU . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 9' ' ' ILE . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 33' ' ' ILE . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.721 ' HB3' HG22 ' A' ' 78' ' ' THR . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 16' ' ' THR . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HE1' HD11 ' A' ' 31' ' ' ILE . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 HD21 ' B' ' 20' ' ' LEU . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 53' ' ' LYS . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' HD22 ' A' ' 52' ' ' LEU . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.652 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' MET . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 90' ' ' ILE . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 100' ' ' ALA . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 118' ' ' ILE . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.959 ' HB3' HG11 ' A' ' 174' ' ' VAL . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 178' ' ' MET . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 174' ' ' VAL . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 170' ' ' ILE . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 166' ' ' LEU . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.959 HG11 ' HB3' ' A' ' 148' ' ' LEU . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 t70 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' ASP . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.646 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.556 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' PHE . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 28' ' ' LYS . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.902 ' HD2' ' HB2' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' B' ' 38' ' ' GLU . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.902 ' HB2' ' HD2' ' B' ' 28' ' ' LYS . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.572 ' HG2' HG22 ' B' ' 36' ' ' ILE . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 37' ' ' ALA . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 41' ' ' GLU . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 1.003 ' HB3' HD11 ' B' ' 48' ' ' LEU . 18.8 mm100 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.83 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 1.003 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.83 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' B' ' 56' ' ' LEU . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.432 HD22 ' NH2' ' B' ' 53' ' ' ARG . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' GLU . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 30' ' ' ILE . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.675 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 15' ' ' THR . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.437 HG21 HG23 ' A' ' 16' ' ' THR . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.71 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 16' ' ' THR . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HA2' ' B' ' 24' ' ' GLY . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.787 HG12 HD11 ' B' ' 20' ' ' LEU . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 53' ' ' LYS . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HE2' ' HE3' ' A' ' 107' ' ' MET . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.454 ' HE3' ' HE2' ' A' ' 86' ' ' PHE . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' A' ' 109' ' ' TYR . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 166' ' ' LEU . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 166' ' ' LEU . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 49' ' ' HIS . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.476 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.497 ' HB2' ' CG ' ' A' ' 12' ' ' ASP . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 27.0 t70 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.176 0.512 . . . . 1.0 110.298 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' ASP . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 68' ' ' ILE . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HZ ' ' A' ' 63' ' ' PHE . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' B' ' 30' ' ' ARG . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.484 ' HG2' ' CE2' ' B' ' 52' ' ' PHE . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 42' ' ' ARG . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HG2' ' OE1' ' B' ' 44' ' ' GLN . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HG2' ' B' ' 41' ' ' GLU . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 54' ' ' GLU . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.631 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 52' ' ' PHE . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.5 ' HA ' ' OG ' ' B' ' 63' ' ' SER . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' B' ' 60' ' ' ARG . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 30' ' ' ILE . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.618 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 15' ' ' THR . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 78' ' ' THR . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 16' ' ' THR . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.436 HG23 HD21 ' B' ' 20' ' ' LEU . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 73' ' ' LEU . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 53' ' ' LYS . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 95' ' ' LEU . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 91' ' ' ARG . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 90' ' ' ILE . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 127' ' ' VAL . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 15' ' ' THR . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 104' ' ' ILE . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 138' ' ' PHE . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 147' ' ' ALA . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 174' ' ' VAL . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.637 ' SG ' HG21 ' A' ' 170' ' ' ILE . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.624 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.637 HG21 ' SG ' ' A' ' 149' ' ' CYS . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 148' ' ' LEU . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.634 HG11 HD13 ' B' ' 48' ' ' LEU . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.447 ' CG ' ' HD3' ' B' ' 55' ' ' ARG . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 68' ' ' ILE . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.411 HG22 ' H ' ' B' ' 39' ' ' ALA . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.51 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.411 ' H ' HG22 ' B' ' 36' ' ' ILE . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' B' ' 37' ' ' ALA . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.487 ' HD2' HD11 ' B' ' 48' ' ' LEU . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 49' ' ' ARG . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.634 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' B' ' 46' ' ' GLU . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.447 ' HD3' ' CG ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' B' ' 60' ' ' ARG . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' B' ' 60' ' ' ARG . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.788 HG22 ' HA ' ' A' ' 30' ' ' ILE . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.709 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HG22 ' A' ' 15' ' ' THR . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 72' ' ' PHE . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 79' ' ' PHE . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 16' ' ' THR . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 65' ' ' VAL . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 61' ' ' GLU . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 53' ' ' LYS . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 52' ' ' LEU . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' MET . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 124' ' ' PHE . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 121' ' ' THR . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.488 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 142' ' ' ARG . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 145' ' ' LEU . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 156' ' ' ASN . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 149' ' ' CYS . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 159' ' ' ARG . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.473 ' HB3' ' SG ' ' A' ' 149' ' ' CYS . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 155' ' ' ASP . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.406 ' ND1' HD12 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 170' ' ' ILE . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 166' ' ' LEU . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 178' ' ' MET . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 174' ' ' VAL . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.45 ' O ' HG23 ' B' ' 18' ' ' VAL . 4.6 t70 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.989 0.423 . . . . 1.0 110.26 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 15' ' ' LYS . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 14' ' ' ASP . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 72' ' ' PHE . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' B' ' 40' ' ' VAL . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.58 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' B' ' 25' ' ' VAL . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.707 ' HD2' HD11 ' B' ' 48' ' ' LEU . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.707 HD11 ' HD2' ' B' ' 45' ' ' PRO . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' B' ' 55' ' ' ARG . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' B' ' 51' ' ' TRP . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.495 HD13 HG11 ' B' ' 25' ' ' VAL . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 60' ' ' ARG . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 37' ' ' GLU . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 30' ' ' ILE . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 18' ' ' MET . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' HA ' HG22 ' A' ' 15' ' ' THR . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.764 HD11 ' HE1' ' A' ' 66' ' ' HIS . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 39' ' ' VAL . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 37' ' ' GLU . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB2' HD13 ' A' ' 165' ' ' LEU . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 33' ' ' ILE . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 16' ' ' THR . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.764 ' HE1' HD11 ' A' ' 31' ' ' ILE . 6.5 p80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.434 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.74 ' HG2' ' HA ' ' B' ' 63' ' ' SER . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 53' ' ' LYS . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 91' ' ' ARG . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' LYS . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 90' ' ' ILE . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 128' ' ' THR . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.414 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.414 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 141' ' ' LYS . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.828 ' HB3' HG11 ' A' ' 174' ' ' VAL . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 174' ' ' VAL . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 49' ' ' HIS . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 174' ' ' VAL . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 148' ' ' LEU . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.408 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.635 0.255 . . . . 1.0 111.049 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' B' ' 15' ' ' LYS . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 14' ' ' ASP . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 56' ' ' LEU . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.53 ' HE1' ' HG3' ' B' ' 33' ' ' MET . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.794 ' HA ' HG11 ' B' ' 35' ' ' VAL . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' MET . . . . . 0.53 ' HG3' ' HE1' ' B' ' 27' ' ' PHE . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.794 HG11 ' HA ' ' B' ' 28' ' ' LYS . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' B' ' 45' ' ' PRO . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PRO . . . . . 0.464 ' HD2' HD21 ' B' ' 48' ' ' LEU . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.464 HD21 ' HD2' ' B' ' 45' ' ' PRO . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.628 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.421 ' HG ' HH21 ' B' ' 53' ' ' ARG . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.407 ' O ' HG12 ' B' ' 64' ' ' VAL . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' SER . . . . . 0.74 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.407 HG12 ' O ' ' B' ' 61' ' ' LEU . 3.5 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.893 0.378 . . . . 1.0 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -101.76 136.49 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.939 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 90' ' ' ILE . 50.5 mm -116.97 121.37 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.469 . . . . 1.0 111.87 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 47.1 t -104.19 129.79 55.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.8 tp -131.36 150.15 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.855 1.057 . . . . 1.0 113.855 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 25.2 t70 -145.66 112.84 6.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 120.59 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 79.6 mm-40 -91.51 130.85 37.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 30' ' ' ILE . 11.1 p -124.63 173.52 8.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 1.0 111.901 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.4 60.11 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.883 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.32 168.49 40.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.67 . . . . 1.0 111.892 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.432 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 19.9 ptm -124.25 157.82 33.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.715 0.293 . . . . 1.0 110.386 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.86 127.31 41.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 1.0 109.71 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -79.69 -28.94 40.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.83 0.347 . . . . 1.0 111.553 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.98 143.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.47 -134.26 35.84 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.327 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.45 115.79 19.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -61.39 -12.63 15.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.9 0.704 . . . . 1.0 112.9 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -107.88 -14.86 14.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 45.7 tt0 -65.6 124.93 23.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 1.0 112.087 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.14 2.46 88.04 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.694 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 89.7 m-70 -117.46 166.07 12.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.859 -0.201 . . . . 1.0 110.633 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HE2' ' OD2' ' A' ' 55' ' ' ASP . 18.7 mmmt -139.13 161.59 37.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.835 0.35 . . . . 1.0 111.376 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.763 ' HA ' HG22 ' A' ' 15' ' ' THR . 66.3 mt -86.5 135.18 25.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 HG21 ' A' ' 68' ' ' ILE . 27.1 pt -113.02 -29.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.837 0.681 . . . . 1.0 112.837 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 58.9 tt0 -144.09 136.31 26.56 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.876 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -119.26 118.14 56.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.944 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.59 114.33 1.99 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.872 -0.68 . . . . 1.0 111.654 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.48 140.76 48.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 1.0 110.685 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.6 m -117.39 146.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.954 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -102.14 130.16 48.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.006 0.432 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.08 116.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.087 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.3 t -124.5 123.69 66.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.971 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 59.37 39.56 22.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.714 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 64.49 20.99 12.35 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.757 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -132.53 151.17 52.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.807 0.337 . . . . 1.0 110.893 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.73 115.95 21.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -76.46 -27.8 56.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.119 0.485 . . . . 1.0 111.133 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.24 57.52 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.29 60.3 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.641 0.734 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -83.99 140.11 32.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.734 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -108.04 103.71 12.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.577 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.16 106.04 9.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.956 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.91 162.4 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.42 149.07 41.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 65.6 mt -121.09 177.35 5.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.108 0.48 . . . . 1.0 111.871 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.69 ' HE2' HG22 ' A' ' 78' ' ' THR . 4.6 tppt? -88.57 133.08 36.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.431 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 53.4 Cg_endo -71.75 -35.5 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.287 1.991 . . . . 1.0 112.135 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 29' ' ' LYS . 33.1 m-20 62.95 7.44 2.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.419 0.628 . . . . 1.0 111.839 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -166.97 -175.13 2.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 96.7 mt -87.87 142.62 27.66 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.312 0.383 . . . . 1.0 111.213 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 16' ' ' THR . 60.0 t -66.6 141.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.952 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.74 137.62 87.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.945 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 76.9 Cg_exo -50.74 -44.43 40.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.288 2.659 . . . . 1.0 113.117 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 40.2 tt0 -64.52 -48.25 75.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.09 70.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.448 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.18 -43.54 97.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.982 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.34 -20.99 80.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.832 -0.699 . . . . 1.0 112.855 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 61' ' ' GLU . 97.7 t -62.97 -54.14 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.25 0.463 . . . . 1.0 112.25 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.4 14.01 1.6 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.24 100.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 115.838 1.095 . . . . 1.0 115.838 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD21 ' B' ' 20' ' ' LEU . 1.9 mt -148.24 126.01 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -109.15 147.41 32.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -59.88 -39.31 84.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.403 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 74' ' ' LEU . 43.5 mp0 -62.11 -15.67 47.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' B' ' 20' ' ' LEU . 26.8 t80 -84.0 -29.39 27.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.015 0.436 . . . . 1.0 110.796 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.626 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 1.8 mt -98.79 20.94 12.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.49 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 71' ' ' GLU . 35.5 mt -79.1 -51.21 9.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.24 -24.37 46.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.0 111.44 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -60.38 148.58 79.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.832 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 58.3 Cg_endo -70.59 165.55 31.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.011 2.474 . . . . 1.0 112.635 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -97.2 179.01 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.261 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -63.12 -25.34 68.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.81 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.842 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.06 -21.58 54.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.606 0.595 . . . . 1.0 112.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.62 20.87 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.33 -58.55 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.619 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.39 -35.59 75.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.723 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.73 -51.75 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -72.07 -34.75 68.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 7.2 ttm -59.49 -50.23 74.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.415 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.58 -30.66 71.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 1.0 111.692 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -66.66 -33.87 76.6 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' HD21 ' A' ' 95' ' ' LEU . 42.3 pt -112.38 -10.37 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' MET . 25.9 ttm105 -61.92 126.82 28.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.407 -0.183 . . . . 1.0 111.467 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.24 43.84 54.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.985 -0.626 . . . . 1.0 112.48 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.34 171.99 14.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.865 0.364 . . . . 1.0 111.257 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -88.09 124.54 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.645 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 90' ' ' ILE . 52.5 mt -103.91 102.45 12.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.99 106.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.516 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.97 159.76 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -99.23 109.67 22.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 72.64 55.54 0.14 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.11 -28.81 1.91 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.082 -1.417 . . . . 1.0 113.801 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.53 -27.14 67.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.018 0.437 . . . . 1.0 110.963 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 82.9 t80 -76.55 -67.56 0.68 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.31 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.37 -56.41 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 1.0 112.885 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 127' ' ' VAL . 33.0 mm -55.89 -38.43 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.82 0.343 . . . . 1.0 111.214 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.45 -39.47 97.34 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.43 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 28' ' ' HIS . 15.0 m-85 -74.27 -39.48 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.0 110.308 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 79.6 mtp -59.45 -54.68 43.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.56 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.46 -34.42 75.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.489 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 67.2 t80 -59.36 -50.55 73.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.97 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.423 ' HG3' HD12 ' A' ' 30' ' ' ILE . 12.1 mm-40 -64.63 -36.83 85.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.677 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.12 -41.7 97.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 p -69.67 -27.85 65.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.603 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 94.4 mt -68.15 -22.62 64.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.0 110.773 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.31 -21.49 59.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.794 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 58.77 39.39 24.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.643 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -107.31 17.12 23.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.884 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 61.98 17.32 8.9 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.06 121.73 73.29 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.703 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.35 167.32 24.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.621 2.214 . . . . 1.0 111.266 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -60.01 142.24 54.26 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.436 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 9.9 m -53.46 -30.74 42.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 1.0 112.398 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -68.01 -8.28 36.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.875 0.694 . . . . 1.0 112.875 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.0 p -89.93 -21.04 22.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 26.8 p90 -123.93 -0.35 8.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 76.0 m -137.72 143.96 41.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.868 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -85.98 100.43 12.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 104' ' ' ILE . 40.3 t -85.25 114.75 25.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.37 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.8 m -126.09 123.62 38.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.174 0.512 . . . . 1.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.25 132.1 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.467 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 p -81.76 -21.31 37.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.006 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.07 -36.03 77.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 1.0 109.76 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.83 98.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.804 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -65.98 -47.84 83.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.691 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.15 83.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.143 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -65.68 -32.43 73.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.954 0.407 . . . . 1.0 110.972 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -77.2 -35.65 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.107 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.7 mtp -74.92 -46.62 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.323 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.43 84.8 42.13 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.179 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.1 120.72 6.15 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.07 2.513 . . . . 1.0 112.648 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.38 82.59 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.795 -0.639 . . . . 1.0 113.227 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -108.43 154.83 21.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -65.68 117.0 7.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -115.63 35.42 4.43 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.38 167.23 21.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' CYS . 18.8 tp -61.11 -45.42 94.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.333 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.67 -31.67 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 1.0 110.687 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.79 65.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.224 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.93 -36.33 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.734 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 1.7 t -56.38 -53.76 53.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.904 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.78 82.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.803 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -61.79 -45.58 93.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.927 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.13 13.44 20.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 1.0 111.712 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.18 51.65 9.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.56 -0.745 . . . . 1.0 112.862 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.02 133.57 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.76 123.77 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.004 0.43 . . . . 1.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.34 13.22 13.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.13 0.49 . . . . 1.0 110.097 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -38.92 6.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.102 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -98.5 43.67 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 1.0 111.437 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -109.55 135.8 49.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.1 m -66.88 -35.74 80.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.057 0.456 . . . . 1.0 110.814 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 165' ' ' LEU . 57.3 mt -63.82 118.1 7.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 0.5 OUTLIER -113.14 140.7 47.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 102.54 -154.35 18.42 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.549 -0.834 . . . . 1.0 113.23 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.76 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -59.8 -35.05 73.88 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.827 0.451 . . . . 1.0 111.975 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 161' ' ' LEU . 18.2 tp -60.95 -30.71 70.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.706 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 170' ' ' ILE . 20.4 tp -66.7 -50.83 61.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 68.8 m-20 -63.44 -43.0 98.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.744 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.45 79.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.741 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -60.13 -47.73 84.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 166' ' ' LEU . 45.5 mm -61.82 -46.03 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.01 -36.37 77.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.956 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.22 91.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.864 0.364 . . . . 1.0 110.345 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.74 -43.16 97.31 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.817 -0.628 . . . . 1.0 110.529 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.15 -45.22 97.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.15 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -57.22 -48.56 78.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.39 -32.34 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.535 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.5 80.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.79 0.328 . . . . 1.0 111.471 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.1 mtm -72.61 -34.28 67.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.26 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.7 p -97.9 19.43 13.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 1.0 110.552 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.12 -37.01 5.78 Favored Glycine 0 C--O 1.247 0.907 0 CA-C-O 118.547 -1.141 . . . . 1.0 112.035 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.261 0 CA-C-N 118.511 1.156 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.182 0.515 . . . . 1.0 110.442 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.77 -44.85 95.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.647 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' B' ' 15' ' ' LYS . 61.6 mm-40 -77.75 -9.38 58.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.539 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.7 ttp -68.67 -35.06 76.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.516 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.0 t70 -79.02 -40.53 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 12' ' ' GLU . 4.3 mmmm -60.18 -44.66 94.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 112.185 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.93 -29.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.973 0.416 . . . . 1.0 111.744 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' HIS . 0.3 OUTLIER -73.42 -28.01 61.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.52 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG22 HD22 ' B' ' 48' ' ' LEU . 79.1 t -64.6 -40.44 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.833 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.156 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -65.74 -53.24 43.45 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.332 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -65.91 -39.47 90.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.635 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -18.07 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.156 0.428 . . . . 1.0 112.156 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.27 -19.16 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.332 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.76 -21.42 65.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.097 -0.573 . . . . 1.0 113.326 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -71.14 -21.58 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.982 0.42 . . . . 1.0 111.05 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -77.35 -28.55 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 1.0 111.05 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.26 -9.62 34.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -64.17 -26.79 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.779 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -4.85 37.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.164 0.507 . . . . 1.0 110.526 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -141.53 56.16 1.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.41 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.21 54.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.193 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -99.46 -8.63 24.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 41.3 mmm -131.02 153.85 81.88 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.122 -0.944 . . . . 1.0 108.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.89 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.795 2.33 . . . . 1.0 112.788 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.42 106.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.183 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.59 97.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.969 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.524 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -68.54 -20.94 64.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.0 112.103 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' B' ' 38' ' ' GLU . 1.7 pt-20 -87.86 -9.72 52.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.733 0.301 . . . . 1.0 111.143 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.72 72.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 1.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.627 HG23 ' HB1' ' B' ' 21' ' ' ALA . 11.5 p -67.49 -27.45 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.298 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -67.72 -23.95 65.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.795 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -96.32 -34.38 11.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' B' ' 45' ' ' PRO . 3.6 tp10 -71.0 -29.69 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.647 ' HB3' HD11 ' B' ' 48' ' ' LEU . 2.7 mm100 -98.76 101.83 13.17 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.765 ' HD2' HD21 ' B' ' 48' ' ' LEU . 23.4 Cg_exo -65.85 168.67 14.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.177 2.584 . . . . 1.0 112.908 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 2.6 mm-40 -66.93 -22.65 65.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.791 -0.64 . . . . 1.0 112.191 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -62.1 -14.41 36.32 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.765 HD21 ' HD2' ' B' ' 45' ' ' PRO . 2.0 pp -127.02 20.04 6.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.792 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 2.7 mmt180 -63.53 -33.58 75.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -40.53 94.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.497 . . . . 1.0 110.105 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -75.08 -38.83 61.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.147 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.75 -36.1 83.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -56.2 -48.72 75.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.117 0.484 . . . . 1.0 110.657 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' B' ' 57' ' ' ILE . 15.8 tt0 -72.93 -34.66 66.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -37.03 71.73 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.331 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -64.86 -44.07 90.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.511 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 54' ' ' GLU . 27.5 mt -62.99 -46.17 96.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.07 73.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.903 -0.589 . . . . 1.0 111.915 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -84.72 -35.9 22.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -66.29 -27.67 68.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.998 0.428 . . . . 1.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.21 -21.84 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 1.0 110.008 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 74' ' ' LEU . . . -76.63 -36.88 57.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.526 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.653 ' HB3' ' HB1' ' B' ' 26' ' ' ALA . 11.5 p -66.92 -21.19 66.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.063 0.459 . . . . 1.0 111.041 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.24 -46.0 84.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.24 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.33 -14.53 32.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.276 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 67.3 mt 64.47 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.724 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.94 -75.89 0.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 62.36 94.66 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 87.2 mt -78.35 -56.26 1.01 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.85 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 71.6 Cg_endo . . . . . 0 C--N 1.352 0.749 0 C-N-CA 121.887 1.725 . . . . 1.0 111.974 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.651 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -88.07 133.78 33.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.509 -0.314 . . . . 1.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.33 103.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 36' ' ' VAL . 40.7 t -81.18 120.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 tp -129.62 146.31 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.638 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 34.9 t70 -139.42 124.96 19.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.594 -1.632 . . . . 1.0 106.594 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -115.78 106.38 13.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.2 mm-40 -75.51 130.6 39.14 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 30' ' ' ILE . 13.3 p -122.87 -175.05 3.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.114 0.483 . . . . 1.0 112.257 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.6 -23.55 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.519 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.95 -173.31 35.21 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.574 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.5 ptm -146.97 158.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.208 0.504 . . . . 1.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 89.3 m-20 -94.41 166.3 12.13 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -95.09 -49.64 5.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.838 0.351 . . . . 1.0 111.242 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.73 164.14 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.324 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.13 -128.68 31.34 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.864 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.43 103.59 16.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.867 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 15.5 p-80 -63.39 -6.09 4.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -111.01 -7.98 14.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.891 0.33 . . . . 1.0 111.891 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 tp10 -69.87 130.81 43.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 1.0 111.094 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.3 82.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.705 -0.76 . . . . 1.0 112.343 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.89 163.92 26.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 22.2 mmmt -143.33 161.03 39.4 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.816 0.341 . . . . 1.0 111.136 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.678 ' HA ' HG22 ' A' ' 15' ' ' THR . 95.4 mt -81.67 140.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.74 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 14' ' ' GLU . 35.3 pt -109.97 -34.52 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.7 141.64 27.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 1.0 111.258 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 66.1 mt -116.56 119.5 62.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.849 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -127.88 116.43 2.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.032 -0.604 . . . . 1.0 111.797 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 148.3 43.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.686 0.279 . . . . 1.0 110.993 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 10' ' ' VAL . 28.8 m -124.2 148.87 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.285 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.46 120.27 38.6 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 111.865 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 43' ' ' LEU . 22.5 t -116.8 107.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.871 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.0 t -119.31 127.33 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.076 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.8 36.01 19.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.252 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 mtp85 67.81 14.05 9.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.782 -0.645 . . . . 1.0 112.712 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -125.58 146.49 49.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.748 0.309 . . . . 1.0 110.639 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 38' ' ' VAL . 49.9 mt -81.56 119.59 23.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 p -72.78 -27.31 61.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.999 0.428 . . . . 1.0 111.393 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.62 -27.74 15.63 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -74.73 111.37 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -123.26 -179.74 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.868 0.366 . . . . 1.0 111.794 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -131.14 130.69 43.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 1.0 109.721 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 19.2 t-80 -153.78 108.3 3.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.608 0.242 . . . . 1.0 111.501 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.38 159.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.89 150.24 35.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.024 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 33' ' ' ILE . 27.2 mt -131.58 159.12 39.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 1.0 111.191 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HD2' HD22 ' B' ' 69' ' ' LEU . 26.5 ttpp -86.47 120.47 72.09 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.701 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.45 -17.57 16.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.596 2.197 . . . . 1.0 113.193 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' B' ' 69' ' ' LEU . 0.7 OUTLIER 63.67 14.36 8.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.18 -174.22 4.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.18 145.3 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 16' ' ' THR . 93.6 t -67.12 138.94 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.264 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 139.25 97.66 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.95 -43.73 29.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.497 2.798 . . . . 1.0 113.148 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 65' ' ' VAL . 28.9 tt0 -68.04 -44.46 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.21 -33.87 75.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.95 0.405 . . . . 1.0 110.803 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.69 -43.97 97.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.519 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.9 82.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.91 -0.662 . . . . 1.0 113.053 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' GLU . 89.3 t -87.91 -53.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.657 0.243 . . . . 1.0 111.657 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -105.9 -14.21 15.28 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.121 1.156 . . . . 1.0 114.121 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.62 62.32 5.66 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.646 -0.788 . . . . 1.0 113.384 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -141.41 132.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -105.19 154.26 20.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.295 0.372 . . . . 1.0 111.159 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' OD1' HG23 ' A' ' 58' ' ' VAL . 11.8 m-20 -69.61 -28.42 65.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.323 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.37 -5.33 2.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 51.7 t80 -103.65 -16.63 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 1.0 110.664 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.16 26.11 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.151 0.501 . . . . 1.0 111.402 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.44 -30.34 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.085 -0.507 . . . . 1.0 112.28 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -31.5 17.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 1.0 111.66 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 39.2 mmtm -67.62 151.85 96.8 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.207 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 76' ' ' LYS . 10.3 Cg_exo -73.26 -170.0 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.277 2.651 . . . . 1.0 113.144 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 53' ' ' LYS . 33.0 p -113.13 -174.78 2.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -75.19 -17.53 60.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.69 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.426 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -79.75 -59.76 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 1.0 112.043 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 m -82.28 20.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -53.25 60.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 1.0 110.811 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.02 -34.49 76.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 1.0 111.155 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -59.92 -47.63 84.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -70.48 -39.6 74.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.483 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 21.6 ttm -60.4 -48.18 82.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 1.0 111.337 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.21 -30.37 71.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.952 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -72.85 -46.53 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.0 pt -92.45 -2.84 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' MET . 36.3 ttm105 -61.68 122.92 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.407 . . . . 1.0 111.934 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.71 48.59 60.92 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.631 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.65 163.58 30.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.002 0.43 . . . . 1.0 111.515 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.712 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 82.8 tt0 -93.05 104.45 16.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.5 mt -76.39 116.31 16.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.203 -0.453 . . . . 1.0 112.123 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 38.6 t -108.54 101.42 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 103' ' ' ASP . 19.4 mt -126.38 158.71 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.784 0.326 . . . . 1.0 111.281 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -98.38 113.31 25.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.1 t30 69.88 55.93 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.39 -30.97 3.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.238 -1.346 . . . . 1.0 113.752 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.14 -22.82 63.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.0 111.463 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.9 t80 -84.97 -65.06 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.486 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' ILE . 3.6 m-20 -57.95 -51.0 71.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mm -59.41 -40.22 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.821 0.344 . . . . 1.0 110.809 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.36 91.65 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.56 -40.05 61.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.151 -0.314 . . . . 1.0 110.151 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 80.4 mtp -58.21 -55.32 36.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.291 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.16 -36.32 79.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.593 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -60.74 -52.45 65.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HG3' HD12 ' A' ' 30' ' ' ILE . 8.7 mm-40 -60.26 -42.39 95.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.747 -0.66 . . . . 1.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -61.94 -35.92 79.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 1.0 111.143 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -72.14 -31.15 65.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.552 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.52 -24.41 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 1.0 111.238 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.9 mt -71.29 -24.97 62.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.741 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 59.01 33.97 23.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.302 0.572 . . . . 1.0 111.646 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -97.29 19.13 13.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.819 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 56.15 42.2 28.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.706 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.37 124.29 63.28 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.31 167.19 27.59 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.282 1.988 . . . . 1.0 111.244 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -58.17 140.91 52.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.485 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 3.9 m -53.46 -31.94 47.81 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -68.44 -7.34 30.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.2 p -87.77 -5.62 58.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.188 0.44 . . . . 1.0 112.188 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 10.9 p90 -138.39 -16.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.05 140.51 52.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 1.0 111.174 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.712 ' HD3' ' HG3' ' A' ' 94' ' ' GLU . 76.0 tttt -75.7 122.02 23.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.73 107.63 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.2 m -111.95 121.01 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -94.91 123.7 38.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.47 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 p -78.39 -17.44 56.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HE ' ' A' ' 135' ' ' ARG . 47.9 tp -69.51 -39.86 77.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.71 98.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.742 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.16 -51.35 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.516 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.46 80.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.01 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HE ' ' HG ' ' A' ' 131' ' ' LEU . 36.2 mtm180 -62.44 -28.32 69.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.52 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -91.91 -30.55 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.013 0.435 . . . . 1.0 111.242 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.9 mtp -81.12 -35.46 31.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.103 0.478 . . . . 1.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -129.01 79.04 75.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.04 120.21 7.0 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.341 2.694 . . . . 1.0 113.071 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.32 0.25 88.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.214 -0.517 . . . . 1.0 113.402 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.33 165.38 12.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.803 0.302 . . . . 1.0 110.508 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -67.43 108.34 2.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -99.79 30.06 3.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.7 m -78.39 162.96 26.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 167' ' ' ASP . 0.3 OUTLIER -61.67 -50.95 70.44 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.439 -0.163 . . . . 1.0 111.315 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.97 -27.98 69.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.969 0.414 . . . . 1.0 111.433 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.49 -41.64 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.222 0.534 . . . . 1.0 109.747 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' HG11 ' A' ' 174' ' ' VAL . 87.8 mt -65.49 -34.73 78.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.04 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 170' ' ' ILE . 21.4 m -62.23 -54.13 45.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.04 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.68 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -65.75 -34.67 78.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.301 -0.408 . . . . 1.0 111.594 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -103.7 10.4 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.487 0.551 . . . . 1.0 112.487 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 63.92 29.25 14.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.454 0.538 . . . . 1.0 112.454 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.22 113.59 32.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.25 126.16 28.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -118.93 7.65 11.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.035 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.649 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -96.96 58.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 1.0 111.291 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -114.37 137.27 52.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.471 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -37.21 83.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.842 0.353 . . . . 1.0 111.452 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 141.52 58.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -138.11 138.02 38.28 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.65 -145.12 16.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.195 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -78.34 -33.02 49.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.112 0.482 . . . . 1.0 110.619 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.25 -17.44 64.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 170' ' ' ILE . 19.2 tp -69.42 -62.36 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HB2' HD13 ' A' ' 145' ' ' LEU . 8.4 p-10 -75.47 -20.59 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.201 0.815 . . . . 1.0 113.201 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.03 95.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.371 0.605 . . . . 1.0 109.49 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -66.94 -40.68 87.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.731 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.543 HG21 ' SG ' ' A' ' 149' ' ' CYS . 17.5 mm -63.73 -41.5 92.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.178 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.85 -36.92 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.393 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -46.57 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.001 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -59.73 -41.08 90.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.788 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 148' ' ' LEU . 72.0 t -72.21 -45.97 59.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.433 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -57.59 -40.0 78.08 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.69 -37.38 81.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.886 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.13 64.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.908 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 69.0 mtm -69.13 -36.77 77.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.196 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.5 p -103.82 30.35 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.67 36.6 0.39 Allowed Glycine 0 C--O 1.249 1.066 0 CA-C-O 118.662 -1.077 . . . . 1.0 111.611 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.253 0 CA-C-N 118.531 1.165 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.107 0.48 . . . . 1.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -22.5 66.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.788 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.93 -29.62 69.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.262 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.534 ' HA ' HG12 ' B' ' 16' ' ' VAL . 49.0 mtt -70.43 -30.34 67.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.055 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.557 ' O ' HG23 ' B' ' 18' ' ' VAL . 34.6 t70 -62.5 -39.78 94.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.747 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -72.84 -46.36 53.45 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.581 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 13' ' ' MET . 9.8 p -64.22 -29.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.108 0.48 . . . . 1.0 111.296 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -69.42 -35.01 75.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.975 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 14' ' ' ASP . 61.5 t -58.87 -41.8 83.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.99 0.424 . . . . 1.0 110.427 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.56 -42.01 95.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.914 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -45.18 88.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.431 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.85 -31.43 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.309 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.71 -7.65 41.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.987 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.07 -26.41 56.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.922 0.391 . . . . 1.0 110.427 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.68 -24.49 71.23 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.0 112.188 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.37 -33.46 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 1.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.24 -45.75 46.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.046 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.39 -19.32 65.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.55 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.14 -21.26 46.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.044 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.44 -26.57 68.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.039 0.447 . . . . 1.0 110.728 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -96.49 83.24 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.506 -0.554 . . . . 1.0 109.506 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 60.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -127.69 -8.16 5.62 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -123.06 155.5 64.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.156 -0.929 . . . . 1.0 108.789 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.94 85.76 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.457 2.105 . . . . 1.0 111.727 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.06 141.22 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 39' ' ' ALA . 3.5 pt -131.61 135.1 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.62 ' O ' HG12 ' B' ' 40' ' ' VAL . . . -75.81 -34.71 60.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 1.0 111.706 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.74 -22.32 65.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 1.0 112.044 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 36' ' ' ILE . . . -58.8 -36.28 74.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.766 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 37' ' ' ALA . 8.6 p -69.91 -35.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.31 . . . . 1.0 111.435 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -72.36 -28.74 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.334 0.588 . . . . 1.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -76.88 -34.34 57.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.462 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.47 -42.9 16.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.854 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.87 ' HB3' HD11 ' B' ' 48' ' ' LEU . 16.3 mm100 -83.77 113.14 45.45 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.53 ' HD2' HD21 ' B' ' 48' ' ' LEU . 21.4 Cg_exo -67.67 -179.37 1.98 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.548 2.832 . . . . 1.0 113.501 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.919 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 43.8 mt-10 -79.98 -18.5 50.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.14 -3.29 2.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.87 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.0 pp -136.82 23.09 3.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.919 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 3.3 mmt180 -64.79 -24.83 67.68 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -39.38 65.21 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -70.58 -41.54 72.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.118 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.61 -35.23 77.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.449 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.92 67.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.27 -37.23 86.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.326 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -38.96 90.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.601 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.24 -48.24 79.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 32.0 mt -60.67 -47.86 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.68 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.68 93.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.002 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -72.06 -35.36 69.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.686 0.624 . . . . 1.0 112.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 9.5 ptm180 -63.58 -30.48 71.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.186 0.517 . . . . 1.0 110.054 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 57' ' ' ILE . 80.3 mt -69.05 -43.32 74.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 1.0 109.448 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.4 70.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.252 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 8.3 m -69.99 -21.08 63.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.758 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 60' ' ' ARG . 59.9 t -81.19 -47.35 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.026 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.48 -26.44 35.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.271 . . . . 1.0 111.733 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt 67.97 -74.37 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.046 0.539 . . . . 1.0 111.388 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.96 -81.18 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.032 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? 48.71 58.92 4.77 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.557 0.536 . . . . 1.0 111.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.741 HD22 ' HD2' ' A' ' 53' ' ' LYS . 5.7 mt -70.81 -56.81 5.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.607 -0.724 . . . . 1.0 112.572 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 12.8 Cg_exo . . . . . 0 C--N 1.352 0.729 0 C-N-CA 122.186 1.924 . . . . 1.0 111.999 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.803 0.335 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -109.93 129.03 55.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.48 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.07 112.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.036 0.446 . . . . 1.0 110.272 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 35.6 t -93.38 125.81 45.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 34' ' ' GLY . 12.0 tp -130.67 151.96 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.102 0.778 . . . . 1.0 113.102 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 12.4 t70 -136.49 104.0 5.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -86.19 107.46 17.9 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.7 mm-40 -97.56 125.65 42.39 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.75 HG22 ' HA ' ' A' ' 30' ' ' ILE . 35.5 p -117.91 -168.98 1.6 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.571 0.224 . . . . 1.0 111.396 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -73.88 -32.64 63.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.147 0.499 . . . . 1.0 109.656 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.49 179.05 42.3 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 24.6 ptm -135.56 143.76 45.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.052 0.426 . . . . 1.0 111.383 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.91 143.62 26.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.796 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.35 -6.61 23.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.0 111.1 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -116.96 113.96 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 1.0 111.192 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.3 -122.64 5.76 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.863 -0.684 . . . . 1.0 111.899 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -85.31 119.75 26.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.915 0.388 . . . . 1.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -64.28 -17.2 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.045 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -104.76 6.36 34.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.586 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -57.08 107.07 0.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.021 0.439 . . . . 1.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.7 18.97 79.02 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.955 -0.566 . . . . 1.0 113.167 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -116.15 154.2 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.644 -0.327 . . . . 1.0 110.746 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 1.7 mmmp? -133.8 163.8 28.66 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 111.437 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.75 ' HA ' HG22 ' A' ' 15' ' ' THR . 78.9 mt -87.08 133.64 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.444 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.3 pt -124.38 -19.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.675 0.62 . . . . 1.0 112.675 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.1 mt-10 -132.06 122.81 26.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.794 0.33 . . . . 1.0 111.542 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 63.1 mt -113.65 111.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.605 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -127.25 110.08 1.16 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.835 -0.698 . . . . 1.0 111.608 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -136.15 138.89 42.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 1.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 10' ' ' VAL . 30.6 m -114.49 141.67 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.985 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -97.2 122.75 40.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.0 111.646 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.29 109.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.183 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.93 122.2 67.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.828 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.52 41.17 26.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.429 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 45.6 mtp85 68.08 10.5 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -129.1 146.38 51.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.877 0.37 . . . . 1.0 111.487 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.39 116.52 20.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.637 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -16.18 60.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.528 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.75 -11.39 57.73 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.558 -0.829 . . . . 1.0 111.265 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.71 96.4 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.66 143.13 47.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.811 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -108.93 118.78 37.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.185 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.3 t-80 -147.45 99.96 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.831 0.348 . . . . 1.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.37 163.3 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -111.66 149.28 31.78 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 82' ' ' VAL . 44.3 mt -130.07 165.13 22.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 1.0 112.187 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -70.78 131.16 87.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.325 -0.852 . . . . 1.0 109.328 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 63.6 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.32 2.013 . . . . 1.0 113.217 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 64.23 7.89 3.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.071 0.463 . . . . 1.0 111.331 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -167.48 -166.34 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.534 -0.913 . . . . 1.0 108.534 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.67 141.13 28.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.715 0.293 . . . . 1.0 111.016 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 95.9 t -68.48 132.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.155 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' THR . 7.6 m-20 -71.57 129.74 88.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.737 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' HG3' ' B' ' 33' ' ' MET . 50.7 Cg_exo -55.46 -27.51 59.34 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.094 2.529 . . . . 1.0 112.267 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.86 -26.71 67.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.28 -5.46 27.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.281 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.17 -49.09 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.931 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.3 3.86 79.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.699 -0.762 . . . . 1.0 112.808 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.98 -54.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 1.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -126.12 5.39 7.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.6 84.46 0.05 OUTLIER Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.249 -0.501 . . . . 1.0 113.177 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.627 HD11 HD21 ' A' ' 73' ' ' LEU . 4.9 tt -145.73 155.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 O-C-N 122.591 -0.358 . . . . 1.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -140.03 160.57 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.523 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 16.8 m-20 -63.82 -38.29 90.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.057 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -66.58 -1.2 3.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.331 -0.849 . . . . 1.0 112.639 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 61.2 t80 -106.78 -23.82 12.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 1.0 110.769 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.627 HD21 HD11 ' A' ' 68' ' ' ILE . 6.9 mt -104.23 21.02 17.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 1.0 111.095 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 33.1 mt -79.22 -47.93 15.1 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.929 0.715 . . . . 1.0 112.929 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.44 -32.91 37.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 72' ' ' PHE . 8.9 mmtm -51.67 146.84 12.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.668 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.51 174.8 7.84 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.018 2.478 . . . . 1.0 113.025 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.1 p -94.27 164.04 13.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.698 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.69 -35.74 78.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.86 -27.6 68.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.86 -38.3 46.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 52' ' ' LEU . 34.5 m -95.52 7.66 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.836 0.35 . . . . 1.0 111.291 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.24 84.82 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.2 -46.05 78.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -63.81 -42.89 97.58 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.954 -0.388 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -63.1 -43.8 97.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.997 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtm -64.3 -45.69 86.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.552 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.2 -32.78 74.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 1.0 110.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.62 -44.51 96.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.797 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.6 pt -99.66 4.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 113.08 0.771 . . . . 1.0 113.08 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -62.58 111.74 2.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.688 0.28 . . . . 1.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.55 48.51 50.18 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.527 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.48 158.67 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.718 -0.283 . . . . 1.0 110.752 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -77.4 122.19 24.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 104' ' ' ILE . 59.7 mt -91.37 99.86 12.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.816 0.341 . . . . 1.0 111.423 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.85 102.77 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 103' ' ' ASP . 13.1 pt -127.87 179.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.566 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -120.09 98.9 6.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 102' ' ' PHE . 59.0 t30 87.5 76.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.498 1.123 . . . . 1.0 109.285 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 97' ' ' ILE . . . -48.05 -36.06 12.3 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.23 71.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.926 0.393 . . . . 1.0 111.407 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 59.0 t80 -78.77 -69.08 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.848 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.8 m-20 -52.08 -62.32 1.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.669 0.606 . . . . 1.0 112.543 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 HD13 ' A' ' 95' ' ' LEU . 43.8 mm -57.53 -38.41 63.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.674 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.68 -39.24 94.94 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.359 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 15' ' ' THR . 6.0 m-85 -77.14 -42.68 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 1.0 110.98 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 83.5 mtp -57.14 -50.8 71.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -37.07 86.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.113 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.76 -51.33 69.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.783 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 17.2 mm-40 -61.07 -38.81 87.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 1.0 111.374 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -58.79 -45.69 89.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.896 0.379 . . . . 1.0 111.204 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -28.97 68.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.817 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.95 -23.39 61.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 1.0 111.237 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 43.2 mt -73.72 -23.33 59.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.0 110.594 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 58.41 38.05 25.73 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.249 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.83 22.21 14.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.491 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.6 t70 54.38 42.38 31.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.059 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.01 127.58 63.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.209 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.0 171.12 15.32 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.788 2.325 . . . . 1.0 111.822 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.74 142.29 58.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 m -58.64 -27.17 64.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.146 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -78.46 7.16 7.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.168 0.803 . . . . 1.0 113.168 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -90.67 -52.36 4.92 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.105 -0.372 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -98.64 2.88 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 59.4 m -136.09 143.8 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -95.88 116.82 29.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 104' ' ' ILE . 21.6 t -92.53 128.24 44.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.9 m -132.92 127.98 35.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.211 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -97.85 125.25 42.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 1.0 111.485 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.3 p -72.15 -27.5 62.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.462 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.07 -31.64 71.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.784 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.55 67.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.978 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.22 -46.6 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.573 . . . . 1.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.16 -42.38 85.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -62.46 -25.0 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.717 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -85.28 -17.83 35.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.938 0.399 . . . . 1.0 110.499 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.3 mtp -93.18 -33.81 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.02 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.96 75.84 65.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.179 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.95 128.03 11.98 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.754 2.302 . . . . 1.0 112.03 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.72 84.0 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.996 -0.621 . . . . 1.0 112.265 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -110.56 178.89 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 21.4 ttp85 -83.26 109.27 17.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -108.1 30.13 6.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.148 0.499 . . . . 1.0 112.178 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.7 p -78.65 169.47 18.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.17 -49.53 77.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.0 110.909 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.9 -37.4 82.1 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . . . -62.78 -41.21 99.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.782 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HB3' HG11 ' A' ' 174' ' ' VAL . 97.2 mt -65.62 -35.28 80.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 45.6 m -63.17 -55.96 20.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.603 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.15 97.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 1.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -57.76 -41.21 81.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.737 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -98.0 10.18 40.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.01 26.75 16.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.096 -0.502 . . . . 1.0 112.131 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 62.6 mt -89.0 121.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.747 0.308 . . . . 1.0 110.172 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 0.8 OUTLIER -67.01 126.84 30.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.218 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -125.32 19.72 8.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 1.0 109.641 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.66 -35.3 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.563 -0.744 . . . . 1.0 112.235 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -93.94 20.56 7.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.9 0.381 . . . . 1.0 111.605 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 16.6 mmm-85 -83.43 116.33 22.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.1 m -62.95 -31.48 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.999 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -73.72 110.65 8.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.541 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -100.41 162.22 13.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.47 -155.03 29.1 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.749 -0.739 . . . . 1.0 113.617 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -60.83 -26.38 67.29 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.096 0.559 . . . . 1.0 112.356 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 49' ' ' HIS . 21.6 tp -65.77 -27.68 68.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.972 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.2 tp -65.97 -59.41 3.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.956 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.684 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 5.5 m-20 -60.78 -37.96 83.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.827 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.55 -48.52 81.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.227 0.537 . . . . 1.0 110.118 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.7 -45.53 89.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.158 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.12 -51.43 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.704 -0.68 . . . . 1.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.98 -36.22 74.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.536 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 -47.54 83.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.906 0.384 . . . . 1.0 110.305 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.98 -41.93 97.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 148' ' ' LEU . 84.9 t -68.45 -46.22 80.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.278 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.13 -46.42 88.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.503 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.02 -29.6 70.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.53 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.14 64.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.86 -25.16 58.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.457 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 p -105.77 15.6 26.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 1.0 111.209 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -121.88 -97.82 1.47 Allowed Glycine 0 C--O 1.244 0.755 0 CA-C-O 118.687 -1.063 . . . . 1.0 111.788 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.445 0 CA-C-N 118.728 1.264 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.655 0.264 . . . . 1.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.412 ' HB ' ' OE2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -59.24 -39.53 83.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.545 0.572 . . . . 1.0 112.545 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' B' ' 11' ' ' THR . 11.6 mm-40 -91.94 -24.2 19.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.508 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG12 ' B' ' 16' ' ' VAL . 47.9 ttp -63.71 -42.93 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.986 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 18' ' ' VAL . 28.5 t70 -58.75 -46.5 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.139 0.495 . . . . 1.0 109.932 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.73 -39.37 80.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.6 -0.727 . . . . 1.0 112.023 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' B' ' 13' ' ' MET . 2.1 p -68.85 -24.02 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.257 0.551 . . . . 1.0 111.022 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.41 -23.69 50.61 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.055 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.727 HG22 HE21 ' B' ' 44' ' ' GLN . 46.6 t -68.25 -39.53 81.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.628 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.514 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -61.88 -48.74 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.815 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.548 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -66.14 -32.25 73.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.324 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.63 -16.37 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -76.25 -24.62 54.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.158 0.504 . . . . 1.0 110.453 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -25.08 70.46 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.652 -0.704 . . . . 1.0 112.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -66.89 -31.04 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.568 . . . . 1.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.1 -45.78 22.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.166 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -61.39 -19.79 62.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.052 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.633 ' HG3' ' HB2' ' B' ' 37' ' ' ALA . 14.7 tmtt? -60.04 -25.74 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.41 -24.89 64.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.195 0.521 . . . . 1.0 109.816 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -93.57 72.68 4.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.9 40.04 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.22 -16.85 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 1.0 109.798 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 95.6 mmm -128.06 155.68 77.49 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.524 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.43 109.49 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.647 2.231 . . . . 1.0 112.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' B' ' 28' ' ' LYS . 7.7 p -129.41 129.79 67.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.466 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' B' ' 38' ' ' GLU . 1.7 mt -110.03 97.31 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.058 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' HG3' ' B' ' 28' ' ' LYS . . . -72.94 -20.23 61.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.915 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.456 ' HG2' HG22 ' B' ' 36' ' ' ILE . 3.9 pt-20 -85.66 -10.57 55.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 1.0 111.057 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.73 -33.44 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.962 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.548 HG23 ' HB1' ' B' ' 21' ' ' ALA . 7.7 p -60.5 -44.33 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.386 0.513 . . . . 1.0 112.386 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.75 -19.58 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.553 0.216 . . . . 1.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -87.61 -46.9 9.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.49 -45.25 69.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.814 ' HB3' HD11 ' B' ' 48' ' ' LEU . 12.2 mm100 -85.54 117.64 69.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.761 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' B' ' 48' ' ' LEU . 38.5 Cg_exo -61.66 166.16 12.31 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.32 2.68 . . . . 1.0 113.574 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 0.1 OUTLIER -68.33 -11.38 59.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.355 -0.839 . . . . 1.0 112.594 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.08 -4.36 9.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' B' ' 44' ' ' GLN . 1.0 OUTLIER -128.55 28.51 5.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.351 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' B' ' 49' ' ' ARG . 2.5 mmp_? -59.87 -43.57 94.63 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.791 0.329 . . . . 1.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -62.09 -54.75 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.761 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -57.21 -46.66 82.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.294 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -60.02 -48.38 81.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -66.76 -36.3 82.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.789 0.328 . . . . 1.0 111.277 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.56 -42.1 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' OD2' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -77.6 -17.35 57.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.123 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.8 -39.19 93.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.452 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 mt -57.83 -48.6 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.59 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.256 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -74.29 -44.36 53.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.185 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -28.39 69.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.843 0.354 . . . . 1.0 111.039 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 mt -77.34 -32.65 55.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 1.0 109.834 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.5 87.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.349 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -7.21 30.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.99 0.424 . . . . 1.0 111.581 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.04 -35.27 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.003 0.43 . . . . 1.0 109.929 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -100.03 -28.99 12.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.674 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 79.0 mt 68.9 -71.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.331 0.652 . . . . 1.0 111.785 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 t -130.35 -87.98 0.5 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 54.97 54.98 8.25 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 1.0 111.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 84.9 mt -65.39 -55.97 22.06 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.35 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 71.5 Cg_endo . . . . . 0 C--N 1.354 0.866 0 C-N-CA 121.74 1.626 . . . . 1.0 111.83 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.684 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.914 0.387 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.746 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.8 mt-30 -92.57 138.42 31.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.61 114.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.775 0.322 . . . . 1.0 110.291 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HB ' HG22 ' A' ' 36' ' ' VAL . 97.1 t -91.09 136.98 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 12.9 tp -135.21 154.02 51.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.577 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.2 t70 -147.94 107.65 3.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.754 -1.573 . . . . 1.0 106.754 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -93.87 112.51 24.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.281 0.845 . . . . 1.0 113.281 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.676 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 74.3 mm-40 -90.26 124.65 35.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 30' ' ' ILE . 23.3 p -121.15 -171.37 2.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.501 0.556 . . . . 1.0 112.501 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.23 3.77 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.968 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.01 175.73 14.13 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.964 -0.636 . . . . 1.0 111.544 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 27.4 ptm -136.46 161.4 35.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.069 0.435 . . . . 1.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.92 150.84 23.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.801 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -92.16 -28.47 17.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.96 0.409 . . . . 1.0 111.0 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 pt -110.72 144.44 18.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.864 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.07 -138.38 39.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.29 -0.481 . . . . 1.0 112.491 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -76.91 120.56 22.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.784 0.326 . . . . 1.0 110.125 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.86 -15.53 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.983 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -106.72 5.49 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.068 0.396 . . . . 1.0 112.068 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.2 tp10 -66.78 122.54 17.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 1.0 110.934 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.22 25.06 76.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.934 -0.65 . . . . 1.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.85 161.8 28.99 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.647 -0.326 . . . . 1.0 110.958 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 19.3 mmmt -142.13 157.85 44.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.328 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 15' ' ' THR . 72.0 mt -83.04 138.14 19.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 66' ' ' HIS . 41.1 pt -113.53 -25.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.693 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.94 121.86 67.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.926 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.48 118.34 2.47 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.76 148.43 45.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.719 0.295 . . . . 1.0 111.025 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 10' ' ' VAL . 31.6 m -125.51 145.04 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.062 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -98.59 124.32 43.3 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.355 0.502 . . . . 1.0 112.355 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 8' ' ' GLN . 10.1 t -113.84 107.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.94 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 44' ' ' THR . 70.5 t -116.79 121.46 67.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 63.83 36.32 10.47 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.474 0.484 . . . . 1.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 HH22 ' HA2' ' A' ' 180' ' ' GLY . 21.9 mtp180 70.74 11.27 7.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.487 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -126.87 149.67 49.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.731 0.3 . . . . 1.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.47 116.76 21.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 39' ' ' VAL . 1.3 p -71.15 -27.27 63.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.503 . . . . 1.0 110.557 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.34 -3.58 50.86 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.44 61.68 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.19 0.519 . . . . 1.0 109.64 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -81.6 149.66 28.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -114.41 118.61 34.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.463 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HD22 ' A' ' 165' ' ' LEU . 10.3 t-160 -135.94 96.52 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.839 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.89 150.94 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -107.69 144.95 34.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 49.7 mt -121.98 161.35 23.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 1.0 111.486 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HE2' HG22 ' A' ' 78' ' ' THR . 2.2 tppt? -71.49 129.88 88.17 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HD3' ' HB2' ' A' ' 73' ' ' LEU . 61.6 Cg_endo -74.46 -21.17 17.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.325 2.017 . . . . 1.0 112.209 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.66 -41.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.731 0.645 . . . . 1.0 111.636 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 54' ' ' PRO . 6.9 ptm180 -123.55 -171.18 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 73.7 mt -89.32 146.87 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.086 0.47 . . . . 1.0 112.065 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 16' ' ' THR . 61.8 t -72.18 137.8 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.19 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -71.47 144.05 88.51 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.009 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.1 -44.22 28.78 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.568 2.845 . . . . 1.0 113.43 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.7 tt0 -64.36 -43.84 93.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.162 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -34.97 75.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.905 0.383 . . . . 1.0 110.779 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -67.02 -34.18 77.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.522 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.33 -1.42 86.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.849 -0.691 . . . . 1.0 112.801 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 75.6 t -101.42 -57.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.675 -0.309 . . . . 1.0 111.385 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.578 ' HE1' HD11 ' A' ' 31' ' ' ILE . 3.9 p80 -109.59 -2.95 17.21 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.763 1.023 . . . . 1.0 113.763 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.53 74.38 0.32 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 114.244 0.457 . . . . 1.0 114.244 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.3 mt -139.54 123.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.14 154.76 17.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.431 0.457 . . . . 1.0 111.437 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 2.7 m-20 -63.37 -36.74 84.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.59 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -64.14 -4.89 3.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -96.47 -27.78 14.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 1.0 110.673 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 5.4 mt -100.39 17.8 20.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.509 HD23 HD12 ' B' ' 66' ' ' LEU . 1.9 tm? -73.88 -51.61 15.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.654 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.77 -31.26 40.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.502 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.3 145.62 45.92 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.41 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 40.2 Cg_endo -67.24 163.46 34.26 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 122.917 2.412 . . . . 1.0 113.165 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 53' ' ' LYS . 1.8 p -88.35 -179.22 6.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.208 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -65.22 -31.16 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.619 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -26.11 66.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.7 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -29.37 61.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -114.57 15.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.39 -57.77 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.85 -41.95 91.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.38 -50.43 72.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.137 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.442 ' O ' HG12 ' A' ' 90' ' ' ILE . 34.9 t80 -69.45 -39.59 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.748 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 10.5 ttm -61.69 -46.71 88.53 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -30.94 71.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.655 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -69.19 -35.89 76.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 86' ' ' PHE . 38.3 pt -101.44 -15.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' MET . 31.7 ttm105 -61.11 126.2 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.453 0.538 . . . . 1.0 112.453 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.35 36.13 40.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.034 -0.603 . . . . 1.0 113.27 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.53 167.02 22.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.716 0.293 . . . . 1.0 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.33 115.91 24.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 90' ' ' ILE . 51.8 mt -93.06 105.09 17.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 1.0 111.471 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 20.8 t -100.13 99.23 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.93 164.03 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.044 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -103.48 105.22 15.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.09 60.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.75 -28.83 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.177 -1.374 . . . . 1.0 113.705 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.45 71.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.016 0.436 . . . . 1.0 110.686 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 88.6 t80 -74.4 -60.62 2.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.891 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.35 -56.28 23.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.433 -0.803 . . . . 1.0 113.106 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 107' ' ' MET . 35.3 mm -57.74 -35.44 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.897 0.38 . . . . 1.0 111.123 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -29.21 68.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.856 -0.688 . . . . 1.0 111.857 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB3' HD11 ' A' ' 30' ' ' ILE . 4.3 m-85 -86.37 -40.58 15.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 104' ' ' ILE . 88.0 mtp -58.26 -53.92 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.286 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -61.21 -34.23 74.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.357 0.599 . . . . 1.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -63.8 -52.59 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.405 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.9 mm-40 -59.2 -41.35 88.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.164 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -63.74 -34.98 79.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.067 0.461 . . . . 1.0 110.919 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.0 m -71.47 -32.94 68.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.053 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.81 -19.01 65.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.554 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 mt -79.0 -22.66 45.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.084 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 60.35 25.59 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.827 -0.624 . . . . 1.0 112.088 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -89.57 12.69 15.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.782 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.71 25.76 14.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.23 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.03 127.84 93.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.34 156.24 67.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.143 1.895 . . . . 1.0 110.66 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -57.99 146.99 30.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.297 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 m -54.05 -29.4 43.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -74.49 3.54 7.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.137 0.791 . . . . 1.0 113.137 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.9 p -102.87 -23.59 13.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -120.83 -0.27 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 70.8 m -140.74 144.31 35.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.251 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -86.49 108.13 18.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.9 120.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 1.0 111.818 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.1 m -127.76 128.08 44.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.277 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.16 124.02 40.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.044 0.449 . . . . 1.0 112.009 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 p -74.87 -23.82 58.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.689 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.509 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 57.8 tp -69.17 -37.49 78.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.976 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.9 90.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 1.0 109.792 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.4 t -63.65 -47.66 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.91 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -42.76 92.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.018 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 78.3 mtm180 -62.27 -37.63 86.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.58 -21.89 47.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.313 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.6 mtp -87.36 -30.85 20.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.779 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -132.5 86.91 43.73 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.782 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.14 131.98 18.84 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.156 2.57 . . . . 1.0 113.026 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.28 37.67 94.82 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.473 -0.785 . . . . 1.0 113.206 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -134.17 155.67 49.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -63.17 120.9 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.471 -1.307 . . . . 1.0 107.471 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -115.96 19.36 15.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.147 0.795 . . . . 1.0 113.147 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.06 166.66 17.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 148' ' ' LEU . 24.0 tp -56.02 -46.26 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.0 110.69 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.3 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.93 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.13 82.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.479 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.557 HD13 HG11 ' A' ' 174' ' ' VAL . 68.1 mt -67.18 -37.39 83.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 38.6 m -61.79 -47.75 83.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.68 -27.57 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.822 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.487 HH21 HD23 ' A' ' 148' ' ' LEU . 4.8 ttm-85 -74.51 -38.05 62.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.587 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.08 9.66 38.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 57.26 44.59 21.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.279 0.562 . . . . 1.0 111.98 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 94.4 mt -104.19 118.63 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.625 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 159' ' ' ARG . 2.8 t70 -66.23 129.69 40.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.0 111.39 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.41 15.81 8.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.509 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -44.16 3.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 1.0 112.208 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -90.22 33.96 0.88 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.131 0.491 . . . . 1.0 110.712 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 155' ' ' ASP . 29.6 mmm-85 -95.29 127.58 41.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.457 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.91 57.13 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.073 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.39 146.84 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.243 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -138.19 116.69 12.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 166' ' ' LEU . . . 115.97 -159.96 13.59 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.304 -0.951 . . . . 1.0 113.872 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.577 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -53.95 -40.83 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.674 0.79 . . . . 1.0 112.865 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 49' ' ' HIS . 20.5 tp -62.28 -24.62 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.349 . . . . 1.0 111.76 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 170' ' ' ILE . 43.0 tp -67.54 -52.6 36.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.0 109.98 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.671 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 71.8 m-20 -65.36 -38.33 89.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.721 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.39 -45.4 88.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.344 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -63.88 -44.55 92.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.063 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.2 mm -63.03 -47.4 92.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.592 . . . . 1.0 111.008 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.98 -37.82 80.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 36' ' ' VAL . . . -61.64 -49.91 74.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.236 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.499 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.557 HG11 HD13 ' A' ' 148' ' ' LEU . 39.8 t -63.52 -49.21 83.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 1.0 111.292 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.03 -39.2 91.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.511 -0.313 . . . . 1.0 111.275 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.9 mt -64.94 -27.78 69.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 1.0 111.035 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.12 -37.11 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 43.5 ttm -63.84 -43.25 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.436 -0.802 . . . . 1.0 111.338 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.6 p -99.28 25.9 6.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.732 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.52 ' HA2' HH22 ' A' ' 41' ' ' ARG . . . -89.7 143.58 17.26 Favored Glycine 0 C--O 1.25 1.116 0 CA-C-O 118.363 -1.243 . . . . 1.0 111.738 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.309 0 CA-C-N 118.798 1.299 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.031 0.443 . . . . 1.0 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -67.1 -18.5 65.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.204 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.504 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.5 mm-40 -66.45 -47.66 72.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.889 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.2 mmt -75.36 -24.22 57.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.121 0.486 . . . . 1.0 109.712 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.31 -45.89 82.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.525 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 38.1 mmtm -70.69 -24.15 62.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 12' ' ' GLU . 55.4 t -60.59 -39.18 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.129 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -63.45 -43.11 98.33 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.989 0.424 . . . . 1.0 110.706 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.34 -41.24 92.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.509 ' OD2' ' HD2' ' B' ' 55' ' ' ARG . 13.5 t0 -65.47 -42.51 92.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.163 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -45.01 96.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.16 77.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.057 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.89 -18.76 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.151 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.93 -24.87 52.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.421 . . . . 1.0 109.963 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.19 -23.18 71.37 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.687 HG21 HD21 ' B' ' 56' ' ' LEU . 11.9 t -71.47 -25.67 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.807 0.337 . . . . 1.0 110.143 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.83 -40.66 39.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.3 -21.57 64.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.101 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.509 ' HA ' HG21 ' B' ' 35' ' ' VAL . 0.7 OUTLIER -59.91 -19.23 50.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.683 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.41 -28.06 66.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -94.04 81.39 4.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.27 24.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -88.13 -3.04 58.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' B' ' 34' ' ' PRO . 67.2 mtp -132.78 162.57 56.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.09 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 33' ' ' MET . 57.6 Cg_endo -71.49 73.76 2.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.6 2.2 . . . . 1.0 112.261 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' B' ' 28' ' ' LYS . 0.8 OUTLIER -92.95 96.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.638 . . . . 1.0 111.531 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -101.31 116.42 44.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.39 65.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.973 0.416 . . . . 1.0 110.26 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.43 -31.1 72.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.298 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.51 86.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' B' ' 44' ' ' GLN . 32.6 m -84.82 -33.29 8.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.076 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -69.24 -32.59 71.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' B' ' 42' ' ' ARG . 22.5 ptt85 -77.88 -13.19 59.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.257 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.64 -43.76 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.321 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 40' ' ' VAL . 36.5 mm-40 -74.79 123.38 88.97 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.038 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.03 154.5 73.11 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.752 2.301 . . . . 1.0 113.225 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.28 -18.3 65.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.22 -24.62 67.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.657 -0.701 . . . . 1.0 112.036 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 43.3 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 1.0 111.915 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -60.14 -37.48 80.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -44.92 96.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.672 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -59.63 -45.21 92.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 1.0 110.341 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.25 -42.67 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.461 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.12 -48.29 76.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.553 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -46.02 79.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.728 0.299 . . . . 1.0 111.583 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.509 ' HD2' ' OD2' ' B' ' 19' ' ' ASP . 0.4 OUTLIER -62.5 -31.97 72.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.301 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -60.14 -48.93 79.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.065 179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -65.1 -43.87 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.15 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.299 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -70.21 -32.22 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.338 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -68.97 -21.77 64.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.433 0.635 . . . . 1.0 109.566 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.08 6.57 45.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.416 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.49 -35.09 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.604 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.7 p -68.31 -20.01 64.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p -79.06 -25.57 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.932 0.396 . . . . 1.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' B' ' 68' ' ' ARG . 5.5 p30 -120.79 37.85 4.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.152 0.501 . . . . 1.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 74' ' ' LEU . 19.7 tp -86.08 -46.97 9.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.467 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.1 m -90.21 93.9 9.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.978 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' B' ' 65' ' ' ASN . 3.8 mtp180 -119.99 -167.95 1.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.713 ' HB3' ' HD3' ' B' ' 70' ' ' PRO . 28.5 tp -73.06 -56.88 3.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 111.787 0.292 . . . . 1.0 111.787 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' B' ' 69' ' ' LEU . 4.4 Cg_exo . . . . . 0 C--N 1.354 0.867 0 C-N-CA 122.157 1.905 . . . . 1.0 111.929 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.676 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.87 0.367 . . . . 1.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.5 mt-30 -109.07 146.14 34.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 90' ' ' ILE . 32.7 mm -125.11 113.87 37.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 1.0 110.625 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.35 121.0 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -121.91 160.07 25.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.055 0.761 . . . . 1.0 113.055 -177.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' HD23 ' A' ' 11' ' ' LEU . 36.0 t70 -151.36 108.7 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 m -87.61 118.85 27.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 79.8 mm-40 -106.72 115.19 29.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 30' ' ' ILE . 82.7 p -110.73 -168.06 1.26 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.333 0.587 . . . . 1.0 112.431 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -82.5 -18.59 41.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.608 179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 160.44 -174.0 37.09 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.478 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 26.0 ptm -146.61 155.11 42.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.012 0.406 . . . . 1.0 111.292 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.854 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 92.4 m-20 -96.01 147.39 23.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.153 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -87.92 -26.17 22.84 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.928 0.394 . . . . 1.0 110.754 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.91 150.73 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.966 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.88 -141.67 38.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.189 -0.529 . . . . 1.0 111.78 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -78.68 114.14 17.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.854 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 5.1 p-80 -66.23 -9.32 31.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -106.21 -6.43 18.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.6 tp10 -63.83 115.5 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.603 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 17.09 71.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.721 -0.752 . . . . 1.0 112.85 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -127.9 166.93 17.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.5 156.38 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.0 111.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 15' ' ' THR . 67.7 mt -80.49 134.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 16' ' ' THR . 32.3 pt -119.28 -27.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 48.4 tt0 -137.71 129.44 28.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.975 0.417 . . . . 1.0 111.384 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 78.5 mt -117.7 120.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.831 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.09 115.34 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . . . -140.01 141.45 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.621 0.248 . . . . 1.0 111.186 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.35 141.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.747 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HG2' HG23 ' A' ' 39' ' ' VAL . 38.6 tt0 -90.59 122.02 33.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.098 0.475 . . . . 1.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -114.84 104.23 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.612 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 37' ' ' GLU . 48.5 t -113.62 122.43 67.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.324 -0.398 . . . . 1.0 109.941 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.96 39.31 20.25 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 61.65 24.77 14.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.304 -0.862 . . . . 1.0 112.231 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -132.74 147.99 52.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.502 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.04 121.07 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -82.59 -30.58 29.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.03 0.443 . . . . 1.0 111.582 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.55 -6.73 31.74 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.733 -0.947 . . . . 1.0 110.733 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -79.9 91.9 5.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -107.63 149.8 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.186 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -121.85 111.94 17.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.513 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.1 t-160 -138.4 89.34 2.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 164.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.108 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD1' ' HE2' ' A' ' 72' ' ' PHE . 82.9 m-85 -125.09 141.89 51.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.253 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 16.0 mt -129.42 145.24 51.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.347 0.499 . . . . 1.0 112.347 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.5 ttpp -74.01 123.29 89.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.753 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.3 -22.71 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.878 2.386 . . . . 1.0 113.283 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.96 11.79 7.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.266 0.555 . . . . 1.0 111.462 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -151.65 140.21 20.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.456 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 8.8 mp -54.3 135.41 44.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' THR . 35.8 t -66.76 137.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.941 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 65.8 m-20 -67.33 134.94 93.23 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.395 -0.595 . . . . 1.0 109.395 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.61 -33.87 50.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.113 2.542 . . . . 1.0 112.277 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.5 -44.3 82.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.989 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.53 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.882 0.372 . . . . 1.0 110.647 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.58 -41.14 94.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.176 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.7 -0.19 83.79 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.93 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -88.12 -50.92 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.697 0.249 . . . . 1.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -126.84 6.34 6.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.36 63.43 5.25 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 114.955 0.742 . . . . 1.0 114.955 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.814 HG12 HD11 ' B' ' 20' ' ' LEU . 5.6 mt -130.86 127.11 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.196 0.498 . . . . 1.0 110.876 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.67 162.51 14.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.149 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 1.9 m-20 -65.1 -35.13 80.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.826 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -61.06 -8.7 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 52.7 t80 -102.04 -31.06 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.82 -3.56 58.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 58.6 mt -68.02 -36.32 79.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.547 0.573 . . . . 1.0 112.547 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.69 33.79 3.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.389 0.614 . . . . 1.0 111.828 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 45.4 mmtm -125.02 159.8 57.42 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.016 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 55.3 Cg_endo -70.97 172.11 14.45 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.63 2.22 . . . . 1.0 111.873 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' LYS . 44.0 p -110.39 175.01 5.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.585 -0.28 . . . . 1.0 110.596 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.05 -31.85 73.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 1.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -20.46 65.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.861 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.34 -23.03 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.0 112.41 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 52' ' ' LEU . 33.4 m -114.25 10.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -51.92 65.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 1.0 112.074 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.11 -40.7 96.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.235 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -62.86 -53.4 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.366 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.67 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.263 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 35.0 ttm -58.74 -49.89 75.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.01 -35.84 78.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 1.0 111.41 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.33 -42.61 70.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.0 112.953 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.565 ' HB ' HD21 ' A' ' 95' ' ' LEU . 47.6 pt -113.7 6.92 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' MET . 16.3 ttm105 -69.69 128.1 35.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 31.27 61.33 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.57 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -127.37 172.3 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.351 . . . . 1.0 111.164 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 1.1 tt0 -94.23 113.38 25.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 90' ' ' ILE . 85.2 mt -90.68 118.2 29.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 1.0 111.577 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.24 107.72 23.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 103' ' ' ASP . 2.8 pt -128.78 -179.16 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.429 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 4.9 t60 -120.94 106.76 11.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 45.3 t30 76.28 71.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.03 -28.23 3.85 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.542 -1.208 . . . . 1.0 113.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.57 -27.23 69.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.923 0.392 . . . . 1.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.478 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 54.0 t80 -82.54 -65.58 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.402 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 97' ' ' ILE . 8.3 m-20 -52.65 -63.25 1.21 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.521 0.513 . . . . 1.0 112.347 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.19 -38.22 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.148 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.32 -37.72 93.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.294 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.4 -40.49 26.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.791 0.329 . . . . 1.0 110.824 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 70.8 mtp -58.85 -55.35 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.24 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.52 -35.06 76.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.0 110.45 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 6.1 t80 -62.54 -48.14 80.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.747 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.59 -38.2 90.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 1.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.1 -42.16 99.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.968 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -66.4 -25.12 66.62 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.125 0.417 . . . . 1.0 112.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 88.5 mt -72.99 -25.75 61.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.887 0.375 . . . . 1.0 110.836 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.3 mt -70.33 -26.81 63.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.2 mttt 55.26 37.5 28.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.513 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -102.12 26.26 7.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.451 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.3 43.16 23.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.333 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 127.5 35.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.053 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.64 178.74 7.24 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.89 2.393 . . . . 1.0 112.292 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.96 145.83 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.984 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 m -62.98 -21.0 65.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.981 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -72.98 -3.85 28.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.5 p -93.05 -38.04 11.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 1.0 111.744 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -107.8 4.13 25.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 79.5 m -140.98 149.31 41.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.697 0.284 . . . . 1.0 110.825 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -86.12 119.91 26.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.896 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.2 t -94.95 114.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.304 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -128.49 123.97 34.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.846 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -97.53 126.56 42.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.904 0.383 . . . . 1.0 111.547 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -76.52 -24.77 53.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 1.0 111.006 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 64.7 tp -67.5 -35.56 79.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.124 0.488 . . . . 1.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.14 84.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.739 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.17 -46.92 83.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.024 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.19 93.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.65 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.498 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 70.4 mtm180 -64.76 -28.44 69.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.049 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.64 -36.8 43.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -73.36 -44.66 58.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.729 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.89 88.63 36.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.554 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.65 131.42 17.27 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.488 2.792 . . . . 1.0 113.357 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.1 20.04 74.46 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.475 -0.784 . . . . 1.0 113.286 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -117.09 158.22 24.57 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -70.46 124.28 23.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -121.96 32.62 5.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.449 0.537 . . . . 1.0 112.449 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 171.17 15.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.2 -51.16 67.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.707 0.289 . . . . 1.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.69 -37.35 70.75 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.187 0.518 . . . . 1.0 111.535 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.35 -43.25 77.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.722 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.06 -40.59 94.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 170' ' ' ILE . 69.6 m -58.82 -46.75 86.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.88 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.56 70.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.749 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -66.34 -40.15 89.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.431 0.53 . . . . 1.0 112.431 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -97.96 0.65 46.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.988 0.423 . . . . 1.0 111.597 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 61.2 50.51 4.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.4 109.13 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.195 -0.668 . . . . 1.0 109.195 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.89 120.19 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 1.0 111.997 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 159' ' ' ARG . 22.1 p-10 -119.35 6.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.599 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -42.96 11.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.027 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -93.12 41.21 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 1.0 110.401 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 156' ' ' ASN . 21.8 mmm-85 -108.12 139.24 43.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 1.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -11.52 59.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.967 0.413 . . . . 1.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.09 126.57 30.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.083 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -112.89 136.83 52.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.08 -157.04 38.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.052 -0.594 . . . . 1.0 113.661 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -56.55 -21.92 29.67 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.43 0.692 . . . . 1.0 112.771 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.19 -32.77 71.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 1.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.44 -47.4 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.273 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.682 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 48.3 m-20 -60.17 -43.81 95.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.504 -0.771 . . . . 1.0 111.55 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.4 88.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.074 0.464 . . . . 1.0 110.526 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 46.3 tp60 -64.27 -50.58 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.316 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.552 HG21 ' SG ' ' A' ' 149' ' ' CYS . 45.0 mm -61.53 -46.35 96.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.526 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.29 -38.27 79.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.564 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.22 80.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.164 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 27.4 mt-10 -59.16 -47.46 85.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.645 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.37 -40.82 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.966 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.49 -47.96 80.5 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.149 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.98 -37.5 87.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.844 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.22 -35.15 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.538 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 72.6 mtm -72.92 -22.7 60.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.009 0.433 . . . . 1.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.1 p -109.75 22.88 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.961 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.01 -87.24 0.62 Allowed Glycine 0 C--O 1.247 0.947 0 CA-C-O 118.747 -1.03 . . . . 1.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.248 -4.35 0 CA-C-N 118.57 1.185 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -46.39 90.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.105 0.479 . . . . 1.0 110.507 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.47 -30.26 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.815 -0.629 . . . . 1.0 111.164 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -61.68 -40.77 96.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.633 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.79 -38.01 64.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.982 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' B' ' 15' ' ' LYS . 21.0 mmtt -64.62 -45.74 85.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.272 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.07 -27.74 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.874 -0.331 . . . . 1.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -63.03 -35.41 80.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.099 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.69 -39.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.492 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.58 -32.11 70.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.814 HD11 HG12 ' A' ' 68' ' ' ILE . 52.1 tp -66.88 -51.73 51.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.998 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.92 81.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.82 61.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.701 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.19 -19.69 39.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.392 . . . . 1.0 110.113 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.94 74.11 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' B' ' 40' ' ' VAL . 1.6 t -72.17 -24.76 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.456 . . . . 1.0 110.224 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' HIS . . . -76.79 -41.07 45.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' B' ' 30' ' ' ARG . 2.0 t80 -70.44 -7.13 40.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.783 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.496 ' HA ' HG21 ' B' ' 35' ' ' VAL . 7.9 ttpp -69.75 -7.02 35.92 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 1.0 109.995 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.43 -34.38 76.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -92.79 67.46 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.298 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.81 -7.69 2.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.571 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.521 0.677 . . . . 1.0 109.634 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.3 163.7 19.28 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.579 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.93 73.26 1.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.779 2.32 . . . . 1.0 112.466 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' B' ' 28' ' ' LYS . 7.4 p -99.33 124.5 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.259 0.552 . . . . 1.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -90.43 105.89 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.513 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -70.64 -30.52 67.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.0 110.451 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.74 -25.08 65.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.858 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.15 73.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.083 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ALA . 1.8 m -68.62 -20.56 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 1.0 111.259 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.95 -9.19 23.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.361 0.6 . . . . 1.0 109.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -97.67 -37.56 9.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.247 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.73 21.71 2.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 1.0 112.015 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -117.93 89.01 32.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.134 0.492 . . . . 1.0 111.686 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 145.66 98.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.76 2.307 . . . . 1.0 111.622 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -27.43 67.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -61.59 -19.19 61.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.659 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.3 36.56 1.22 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.123 0.487 . . . . 1.0 110.202 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -61.02 -40.12 92.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.418 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -34.94 78.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.028 0.442 . . . . 1.0 110.423 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.78 -42.53 90.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.039 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -64.73 -37.77 88.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.872 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.03 -38.96 89.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.217 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -65.06 -44.33 89.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -29.25 70.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 44.9 tp -64.96 -47.91 75.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.977 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 57.1 mt -63.21 -46.36 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.448 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.75 81.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 1.0 112.344 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 26' ' ' ALA . 12.2 m170 -76.57 -28.41 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.539 0.57 . . . . 1.0 112.539 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -69.34 -21.67 63.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.244 0.545 . . . . 1.0 110.39 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.89 0.27 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.874 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.46 -52.52 4.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.056 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.445 ' OG ' ' HB1' ' B' ' 26' ' ' ALA . 2.5 m -60.84 -25.7 66.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.152 0.426 . . . . 1.0 112.152 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.25 -25.9 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.47 41.67 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 1.0 111.678 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.08 -28.69 69.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.705 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -80.27 63.56 4.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 1.0 110.887 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 17.65 19.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.291 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' B' ' 70' ' ' PRO . 52.9 mt -113.43 127.86 26.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 69' ' ' LEU . 28.8 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.643 2.229 . . . . 1.0 112.091 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.682 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.901 0.381 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 41.9 mt-30 -110.4 143.4 40.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 37' ' ' GLU . 31.9 mm -124.35 120.88 60.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.78 0.324 . . . . 1.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 91.3 t -90.83 134.33 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 97' ' ' ILE . 21.9 tp -132.71 154.3 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' ' HB1' ' A' ' 164' ' ' ALA . 20.7 t70 -157.98 117.54 3.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.1 p -113.44 130.15 56.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 77.0 mm-40 -94.25 127.0 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 p -106.55 177.53 4.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.232 0.456 . . . . 1.0 112.232 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.751 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -80.99 -5.95 58.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.878 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' OD2' ' A' ' 59' ' ' ASP . . . 150.43 178.67 25.54 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -141.92 150.16 41.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.877 0.339 . . . . 1.0 111.037 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.59 139.45 30.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.014 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.18 -17.66 28.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.819 0.342 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.57 147.6 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.82 -127.15 8.81 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.73 34.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.52 -14.29 28.21 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.99 9.83 24.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 1.0 111.722 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -54.82 102.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.57 24.29 76.98 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-N 116.061 -0.518 . . . . 1.0 113.911 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -113.44 167.89 10.21 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.369 -0.489 . . . . 1.0 110.126 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -144.49 158.87 43.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 1.0 111.223 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 106' ' ' PHE . 61.6 mt -87.73 136.22 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.285 -1.006 . . . . 1.0 108.285 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' HE1' ' A' ' 66' ' ' HIS . 30.5 pt -116.32 -27.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.608 0.966 . . . . 1.0 113.608 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 49.0 tt0 -136.59 127.8 28.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 52' ' ' LEU . 71.9 mt -113.86 116.05 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.858 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.35 123.39 5.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.889 -0.884 . . . . 1.0 110.889 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -143.32 152.33 41.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 1.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 16.7 m -131.25 145.68 34.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.797 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 9' ' ' ILE . 41.5 tt0 -97.62 126.28 42.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.083 0.468 . . . . 1.0 111.97 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.88 110.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.595 -0.73 . . . . 1.0 110.003 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.41 132.78 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.595 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 58.69 31.4 21.11 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 70.05 24.27 5.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.609 -0.723 . . . . 1.0 112.104 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -142.03 159.64 41.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.697 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.4 mt -84.43 128.14 34.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 p -90.06 -6.39 55.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.772 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.74 -6.57 82.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.713 -0.756 . . . . 1.0 111.463 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -76.37 83.99 3.12 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.176 0.512 . . . . 1.0 109.771 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -97.51 147.43 24.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.72 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.2 t80 -116.86 130.72 56.89 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.0 t-80 -153.83 97.85 2.13 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.387 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -125.64 158.56 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 1.0 110.841 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -118.06 141.76 48.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.26 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 33' ' ' ILE . 10.2 mt -122.85 132.34 54.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.81 0.338 . . . . 1.0 111.561 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.721 ' HB3' HG22 ' A' ' 78' ' ' THR . 21.5 ttpp -73.58 116.94 56.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 -18.91 8.52 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.728 2.285 . . . . 1.0 112.785 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.66 24.96 14.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.619 0.723 . . . . 1.0 111.115 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -150.75 159.08 44.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.032 -0.985 . . . . 1.0 108.98 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 95.1 mt -76.4 133.95 39.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 16' ' ' THR . 46.4 t -67.3 135.57 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' OD2' ' HA3' ' A' ' 17' ' ' GLY . 71.7 m-20 -65.01 135.82 96.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -45.8 -51.55 8.11 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.427 2.751 . . . . 1.0 112.963 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 mp0 -60.31 -37.03 79.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.802 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -35.66 69.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -63.11 -45.5 91.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.452 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.62 -1.56 31.01 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.207 -0.52 . . . . 1.0 113.991 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' GLU . 70.1 t -96.03 -53.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 117.03 0.415 . . . . 1.0 111.711 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HE1' HD11 ' A' ' 31' ' ' ILE . 7.5 p80 -109.8 -3.66 16.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.54 64.36 4.3 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 114.872 0.709 . . . . 1.0 114.872 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 HD21 ' B' ' 20' ' ' LEU . 45.1 mt -129.78 126.17 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.163 0.482 . . . . 1.0 110.172 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' B' ' 23' ' ' ALA . . . -98.37 152.96 18.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.337 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 57' ' ' LEU . 6.9 m-20 -64.44 -38.11 89.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.982 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' B' ' 30' ' ' ARG . 15.2 mp0 -61.93 -16.78 53.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.421 -0.808 . . . . 1.0 111.826 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' B' ' 23' ' ' ALA . 28.5 t80 -86.47 -27.84 23.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -92.26 11.3 26.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.589 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.03 -45.02 28.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.0 112.571 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 7.6 p-10 -79.97 -19.75 47.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.965 0.412 . . . . 1.0 111.739 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 75' ' ' ASP . 41.6 mmtm -77.81 147.53 74.39 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.19 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 65.2 Cg_endo -73.53 178.18 7.03 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.481 . . . . 1.0 112.465 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 53' ' ' LYS . 30.6 p -102.69 -177.45 3.39 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.985 0.422 . . . . 1.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' HD22 ' A' ' 52' ' ' LEU . 71.8 t80 -68.27 -23.25 64.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.87 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -22.26 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.57 -53.85 6.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.845 0.355 . . . . 1.0 111.763 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -95.81 23.02 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.16 -53.78 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.898 0.38 . . . . 1.0 111.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -68.82 -32.52 72.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.785 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.78 -53.37 55.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.583 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -64.37 -39.33 93.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 8.6 ttm -63.86 -43.34 96.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.806 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.53 -17.42 61.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.744 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -83.03 -36.97 24.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.652 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.3 pt -100.96 -5.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' MET . 33.2 ttm105 -66.05 135.37 54.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.72 0.295 . . . . 1.0 111.622 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.03 33.23 69.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.733 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.57 167.95 20.92 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.636 -0.332 . . . . 1.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.9 tt0 -94.51 121.45 36.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.794 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 90' ' ' ILE . 83.2 mt -93.71 105.1 17.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.239 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.94 102.42 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 100' ' ' ALA . 8.4 mt -123.1 159.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.38 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -103.92 107.24 18.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.4 t30 75.07 47.18 0.11 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.455 -1.313 . . . . 1.0 107.455 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . . . -49.95 -22.51 1.57 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.199 -1.364 . . . . 1.0 113.674 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.76 65.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 1.0 110.781 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -85.54 -61.86 1.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.49 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.8 -54.37 45.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mm -59.03 -38.76 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.433 . . . . 1.0 110.385 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.42 -30.37 77.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.665 -0.698 . . . . 1.0 111.694 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -83.29 -42.03 17.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 76.1 mtp -56.89 -56.54 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -62.07 -28.45 69.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.163 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.94 -42.65 72.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.812 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.78 -36.96 85.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -62.56 -41.68 99.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.918 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -15.81 63.87 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.95 -17.89 48.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.872 0.368 . . . . 1.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.26 -28.15 53.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 62.84 40.95 9.24 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.606 0.566 . . . . 1.0 111.352 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -109.25 14.24 23.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.225 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.37 27.98 17.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.282 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 57.7 mt -70.91 124.65 91.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.94 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 118' ' ' ILE . 28.0 Cg_exo -64.52 168.94 12.01 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.691 2.261 . . . . 1.0 110.922 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 144.65 55.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 1.0 111.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 124' ' ' PHE . 8.3 m -55.14 -28.5 53.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.804 -0.635 . . . . 1.0 112.47 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.46 -10.53 55.99 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -84.6 -41.12 16.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 121' ' ' THR . 11.3 p90 -102.36 -4.36 25.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -133.64 149.13 51.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.861 0.362 . . . . 1.0 111.226 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 79.4 tttt -88.73 119.26 29.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.42 117.9 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.115 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.4 m -123.81 114.64 20.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -93.62 119.03 32.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.096 0.474 . . . . 1.0 111.068 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 p -75.93 -16.97 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.301 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.96 -41.42 78.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.2 92.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.184 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.45 -47.71 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.415 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.33 90.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.916 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -65.38 -26.95 68.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.971 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -88.06 -22.84 23.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.032 0.444 . . . . 1.0 111.132 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.2 mtp -87.82 -37.23 16.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.043 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.06 74.78 79.0 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.603 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.28 128.75 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.634 2.223 . . . . 1.0 112.409 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.98 43.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.947 -0.644 . . . . 1.0 112.889 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -138.36 168.08 20.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 142' ' ' ARG . 12.9 ttp180 -65.09 125.18 24.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -119.35 30.83 6.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.0 p -79.43 173.88 12.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.57 -43.62 93.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.44 -34.73 78.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.644 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.89 95.74 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.305 0.574 . . . . 1.0 109.722 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.959 ' HB3' HG11 ' A' ' 174' ' ' VAL . 95.9 mt -65.73 -35.56 81.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.844 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 34.8 m -63.0 -50.32 71.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.08 70.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -64.66 -53.05 53.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.441 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 178' ' ' MET . 65.5 m-85 -93.6 6.31 48.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 58.58 53.17 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.639 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 174' ' ' VAL . 66.3 mt -114.42 116.44 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.33 134.31 56.3 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -132.61 19.44 4.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.945 -1.025 . . . . 1.0 109.199 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -39.56 2.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 112.629 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -93.41 18.74 9.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.375 0.607 . . . . 1.0 110.856 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -81.76 141.94 33.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.913 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -36.67 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.58 143.36 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.503 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -133.84 175.12 9.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.434 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.23 -161.37 54.16 Favored Glycine 0 N--CA 1.446 -0.651 0 O-C-N 123.521 0.513 . . . . 1.0 112.907 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -60.5 -26.21 66.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 1.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 41.1 tp -63.43 -33.19 75.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.924 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 170' ' ' ILE . 50.6 tp -69.6 -49.47 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.07 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.668 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 65.8 m-20 -56.84 -47.39 80.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.417 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.4 90.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -62.03 -46.53 88.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 166' ' ' LEU . 44.0 mm -61.53 -50.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.441 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.4 tp -57.17 -37.83 72.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.422 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.55 64.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.65 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.01 -40.13 88.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.509 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.959 HG11 ' HB3' ' A' ' 148' ' ' LEU . 94.4 t -70.84 -43.74 76.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.639 0.257 . . . . 1.0 111.029 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -62.29 -35.88 80.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.595 0.236 . . . . 1.0 110.987 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.55 -19.96 62.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.142 0.496 . . . . 1.0 110.731 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -86.42 -44.12 12.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.39 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 68.6 mtm -63.01 -52.52 62.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.51 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.91 23.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.552 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.0 -25.47 73.61 Favored Glycine 0 C--O 1.253 1.305 0 CA-C-O 118.482 -1.176 . . . . 1.0 112.332 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.433 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.028 0.442 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -41.71 82.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.167 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -78.44 -9.92 59.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.967 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -66.57 -33.99 76.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.067 0.46 . . . . 1.0 109.768 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 t70 -75.22 -40.78 58.8 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -61.03 -45.64 93.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.728 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.06 -30.06 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.369 . . . . 1.0 111.263 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.19 -25.75 62.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.006 0.432 . . . . 1.0 110.154 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' ASP . 47.9 t -69.18 -33.17 56.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.571 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.68 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.646 HD21 HG12 ' A' ' 68' ' ' ILE . 1.8 tm? -74.04 -44.93 52.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.779 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.556 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -63.58 -39.3 94.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.079 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -9.7 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' PHE . . . -76.39 -24.16 54.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.66 -23.99 70.91 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 28' ' ' LYS . 11.1 t -71.8 -25.96 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 1.0 109.764 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.64 -42.05 22.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -64.15 -12.9 44.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.247 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.902 ' HD2' ' HB2' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -60.5 -20.76 61.15 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.986 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -64.82 -31.91 73.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.0 109.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -110.92 87.52 2.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.227 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.19 40.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.808 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.72 -16.69 53.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.242 0.544 . . . . 1.0 110.008 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 76.7 mmm -122.88 157.26 60.63 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.153 -0.93 . . . . 1.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.39 68.9 3.43 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.481 2.121 . . . . 1.0 111.975 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 p -92.33 112.39 25.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.273 0.558 . . . . 1.0 110.566 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' B' ' 38' ' ' GLU . 2.4 mt -87.04 124.73 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.445 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.902 ' HB2' ' HD2' ' B' ' 28' ' ' LYS . . . -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.951 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.572 ' HG2' HG22 ' B' ' 36' ' ' ILE . 7.3 pt-20 -67.43 -17.15 64.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.892 0.377 . . . . 1.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.82 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.762 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 37' ' ' ALA . 11.8 p -64.96 -37.94 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 41' ' ' GLU . 4.9 mm-40 -69.58 -28.1 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.745 0.307 . . . . 1.0 111.826 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtp85 -87.18 -38.77 16.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.871 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -73.03 -42.64 62.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 1.0 112.018 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 1.003 ' HB3' HD11 ' B' ' 48' ' ' LEU . 18.8 mm100 -89.48 108.69 26.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.0 -179.85 2.83 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.164 2.576 . . . . 1.0 114.456 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.83 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -66.92 -22.03 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.567 -1.197 . . . . 1.0 113.573 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -60.83 -12.88 12.25 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 1.003 HD11 ' HB3' ' B' ' 44' ' ' GLN . 2.1 pp -131.32 24.72 4.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.734 0.302 . . . . 1.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.83 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 1.1 mmp_? -59.75 -46.37 89.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.569 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -65.2 -37.67 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.104 0.478 . . . . 1.0 110.424 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -66.02 -40.89 91.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.266 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -67.24 -31.59 72.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.68 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' B' ' 56' ' ' LEU . 2.1 tpm_? -57.39 -48.91 77.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.01 -35.41 69.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.182 0.515 . . . . 1.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -37.13 73.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.432 HD22 ' NH2' ' B' ' 53' ' ' ARG . 2.3 tp -66.81 -43.17 84.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.197 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' B' ' 60' ' ' ARG . 45.8 mt -59.48 -49.36 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 1.0 111.149 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.21 71.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -86.48 -32.14 20.96 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.706 0.632 . . . . 1.0 112.706 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' B' ' 57' ' ' ILE . 12.5 ptm180 -66.69 -24.01 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.172 0.51 . . . . 1.0 110.996 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.0 -27.72 35.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.43 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.54 -29.61 68.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.976 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.1 m -71.52 -7.01 44.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.987 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.28 -43.3 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.855 ' HB2' ' HG3' ' B' ' 68' ' ' ARG . 21.2 p-10 -83.17 -29.27 28.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt 70.27 -52.14 0.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.2 m -152.2 -54.32 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.558 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.855 ' HG3' ' HB2' ' B' ' 65' ' ' ASN . 0.1 OUTLIER 53.96 44.05 29.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.729 0.643 . . . . 1.0 112.416 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' B' ' 70' ' ' PRO . 34.6 mt -59.5 -55.08 49.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.771 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' B' ' 69' ' ' LEU . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.782 0 C-N-CA 122.212 1.941 . . . . 1.0 111.549 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.668 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 1.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' GLU . 40.2 mt-30 -100.21 134.26 43.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.149 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.44 124.0 70.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.091 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 58.2 t -96.43 138.79 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -135.71 158.68 43.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 10.6 t70 -149.45 95.67 2.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -79.37 102.77 8.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.2 mm-40 -92.1 124.82 36.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 30' ' ' ILE . 22.1 p -117.79 -166.69 1.23 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.827 0.677 . . . . 1.0 112.827 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.675 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -92.82 2.54 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.592 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.27 -179.62 18.16 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -146.38 163.98 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.825 0.313 . . . . 1.0 110.526 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 96.4 m-20 -97.83 148.17 23.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.359 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -82.99 -35.73 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.114 0.483 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -122.97 159.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -132.4 18.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.286 -0.483 . . . . 1.0 112.033 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -92.23 118.09 30.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 36.1 p-80 -63.38 -15.27 57.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.143 0.794 . . . . 1.0 113.143 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.02 -0.28 23.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.258 0.466 . . . . 1.0 112.258 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.3 tt0 -69.23 116.19 9.38 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.95 66.05 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.964 -0.636 . . . . 1.0 113.533 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.68 173.41 9.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.586 -0.361 . . . . 1.0 110.419 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -146.56 151.12 36.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.706 0.289 . . . . 1.0 111.132 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 15' ' ' THR . 68.4 mt -81.52 134.04 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.437 HG21 HG23 ' A' ' 16' ' ' THR . 41.4 pt -123.29 -18.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 2.3 mt-10 -133.59 119.66 19.73 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 65.7 mt -112.63 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.467 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -130.44 115.03 1.74 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -137.17 141.66 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.867 0.365 . . . . 1.0 111.364 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 12.2 m -123.73 143.68 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.619 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -98.0 131.1 44.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 t -119.13 118.65 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.669 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.4 t -131.34 128.35 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.77 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.11 35.68 18.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.241 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 65.75 23.45 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.469 -0.787 . . . . 1.0 111.946 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -137.39 152.11 49.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -70.68 -40.23 73.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.037 0.446 . . . . 1.0 111.367 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.88 -1.35 21.39 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 69.4 4.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 1.0 109.77 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -83.31 142.23 31.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.708 -0.678 . . . . 1.0 111.473 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -124.33 118.68 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.229 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 35.4 t-80 -147.44 112.08 5.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.363 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.38 156.39 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.842 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -107.07 141.57 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 21.9 mt -122.73 141.24 52.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.089 0.471 . . . . 1.0 112.144 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.71 ' HB3' HG22 ' A' ' 78' ' ' THR . 27.8 ttpp -76.59 122.54 86.78 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.655 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -86.36 -29.59 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.817 2.345 . . . . 1.0 113.58 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.52 14.1 8.32 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.53 0.681 . . . . 1.0 111.138 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -149.83 146.53 27.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 1.0 109.448 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' NH2' ' B' ' 68' ' ' ARG . 5.7 mt -57.11 139.18 53.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 16' ' ' THR . 29.2 t -75.32 130.27 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -58.14 136.92 84.49 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.648 -0.251 . . . . 1.0 110.772 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.9 -36.01 51.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.109 2.54 . . . . 1.0 112.752 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.45 -25.51 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 1.0 111.699 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 -24.71 30.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 1.0 109.741 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HA2' ' B' ' 24' ' ' GLY . 89.7 t80 -64.71 -38.58 91.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.12 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.97 1.93 61.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 1.0 112.809 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.6 -46.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.709 -0.289 . . . . 1.0 111.281 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -136.1 9.16 3.24 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.64 48.82 78.79 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.967 0.747 . . . . 1.0 114.967 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.787 HG12 HD11 ' B' ' 20' ' ' LEU . 5.8 mt -118.66 130.63 73.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 117.11 0.455 . . . . 1.0 110.939 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . . . -108.08 -175.62 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.342 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' CG ' ' HE ' ' B' ' 68' ' ' ARG . 2.5 t70 -67.75 -57.21 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -58.42 -28.16 64.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.723 1.008 . . . . 1.0 113.723 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.07 -28.91 69.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.801 0.334 . . . . 1.0 111.313 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.07 16.26 22.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.917 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 14.1 tp -77.46 -31.96 54.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.89 -14.31 24.64 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 1.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -79.45 155.77 76.25 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.903 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 Cg_endo -74.96 171.52 18.15 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.424 2.083 . . . . 1.0 111.73 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 53' ' ' LYS . 60.5 p -98.44 178.57 4.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.311 . . . . 1.0 110.608 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 77.6 t80 -67.29 -26.84 66.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.898 0.38 . . . . 1.0 110.527 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.54 71.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.61 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -74.29 -31.55 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.916 -0.583 . . . . 1.0 112.057 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.04 14.26 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.52 82.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.069 0.461 . . . . 1.0 110.919 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.57 -31.56 72.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.939 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -75.18 -46.72 32.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 121.109 -0.236 . . . . 1.0 110.994 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HE2' ' HE3' ' A' ' 107' ' ' MET . 23.4 t80 -61.56 -44.56 96.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 1.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -63.1 -40.14 96.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.981 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -34.18 77.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.212 0.53 . . . . 1.0 110.682 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -69.93 -48.66 57.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 1.0 112.836 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.5 3.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.0 ttm180 -61.61 116.18 4.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.71 52.13 45.46 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.8 -0.636 . . . . 1.0 112.876 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.98 165.93 23.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.749 0.309 . . . . 1.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 tp10 -88.76 112.4 23.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.81 106.98 18.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 1.0 111.655 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 t -105.19 99.41 8.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.4 162.93 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.771 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -104.63 110.42 22.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.5 t30 72.7 45.71 0.31 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.48 -21.25 0.53 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.033 -1.439 . . . . 1.0 114.04 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.65 70.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.024 0.44 . . . . 1.0 110.553 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -77.35 -55.67 5.2 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.036 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.82 -57.87 10.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 1.0 112.442 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.2 mm -57.54 -37.92 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.176 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.75 -38.64 94.19 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.8 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -75.66 -40.57 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 1.0 110.308 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.454 ' HE3' ' HE2' ' A' ' 86' ' ' PHE . 90.8 mtp -59.57 -53.36 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.318 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -38.79 80.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.107 0.48 . . . . 1.0 110.428 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 5.9 t80 -63.83 -44.62 92.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG3' HD12 ' A' ' 30' ' ' ILE . 14.2 mm-40 -64.11 -34.82 78.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 1.0 110.572 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -67.04 -42.82 84.18 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.032 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -66.63 -26.02 66.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.855 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' A' ' 109' ' ' TYR . 27.0 mt -68.62 -24.95 64.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.013 0.435 . . . . 1.0 111.156 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.92 -26.32 36.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.826 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 50.61 45.13 27.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.744 -0.662 . . . . 1.0 112.032 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -106.56 31.32 5.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.435 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.2 t70 55.89 64.09 1.84 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.266 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.3 mt -115.38 126.61 27.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.989 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.52 172.4 15.29 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.599 2.199 . . . . 1.0 111.045 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.32 150.39 43.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.249 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 m -60.31 -26.82 66.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.009 0.433 . . . . 1.0 111.705 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -74.68 3.61 7.6 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -91.66 -45.65 8.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 1.0 111.528 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.82 -6.86 22.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 55.9 m -129.15 158.02 40.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.433 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -100.97 115.54 30.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.888 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.86 109.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.959 0.409 . . . . 1.0 111.35 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 m -122.02 115.4 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.993 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -89.69 128.35 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 1.0 111.581 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.8 p -81.82 -21.12 37.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.96 -42.74 80.42 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.926 0.393 . . . . 1.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.53 98.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.262 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.72 -43.39 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.375 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.95 97.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.509 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.29 -24.52 66.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.25 0.548 . . . . 1.0 110.761 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.47 -25.3 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.764 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 82.4 mtp -92.22 -43.62 9.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.559 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -117.99 86.7 26.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.701 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.65 135.87 14.88 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.492 2.128 . . . . 1.0 113.13 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.5 79.34 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.0 113.204 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -112.31 162.57 15.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.66 100.18 7.73 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -91.14 33.17 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 1.0 112.075 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.7 m -72.18 158.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.05 -54.41 45.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -58.89 -28.95 66.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.663 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.34 -42.39 54.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 1.0 109.893 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.87 -42.36 98.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.98 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 34.3 m -60.05 -39.9 87.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.364 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.5 -45.09 73.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -66.13 -35.36 80.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.478 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -90.67 0.08 57.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 58.09 42.73 21.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.824 -0.626 . . . . 1.0 112.185 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.8 mt -111.21 122.92 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.59 126.12 28.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.248 0.547 . . . . 1.0 112.093 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -125.16 14.67 8.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.487 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -49.02 3.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.636 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -89.73 51.72 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.246 0.546 . . . . 1.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -112.84 139.38 48.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.255 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -27.23 64.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.727 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 166' ' ' LEU . 80.7 mt -78.05 138.09 38.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.955 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 166' ' ' LEU . 42.7 m80 -136.97 167.2 21.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.57 -144.49 31.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.822 -0.704 . . . . 1.0 112.594 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -65.45 -31.64 72.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.412 . . . . 1.0 111.639 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 49' ' ' HIS . 15.3 tp -71.48 -23.74 61.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 1.0 110.985 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.476 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.1 tp -68.58 -60.12 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.222 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 66.3 m-20 -60.75 -37.59 82.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.289 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.47 81.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.951 0.405 . . . . 1.0 110.482 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 52.2 tp60 -63.5 -46.8 84.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.027 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 166' ' ' LEU . 47.0 mm -61.64 -46.84 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.623 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.77 -35.23 75.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.0 110.917 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.996 0.427 . . . . 1.0 109.944 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 169' ' ' GLN . 86.8 mt-10 -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.657 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.18 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -59.69 -39.74 85.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.927 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.63 -38.1 88.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.79 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.54 73.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.83 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.18 -34.92 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.269 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 p -99.28 8.44 44.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.302 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -101.04 -158.45 27.36 Favored Glycine 0 C--O 1.247 0.944 0 CA-C-O 118.37 -1.239 . . . . 1.0 111.6 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.493 0 CA-C-N 118.769 1.285 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.165 0.507 . . . . 1.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -67.47 -20.5 65.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -67.45 -47.57 69.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.051 0.453 . . . . 1.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.75 -24.71 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.084 0.469 . . . . 1.0 109.753 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 27.0 t70 -63.54 -28.65 70.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.298 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -68.33 -33.42 74.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -73.86 -25.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.461 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' B' ' 14' ' ' ASP . 6.5 m-20 -60.13 -37.21 79.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.535 0.683 . . . . 1.0 109.571 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.02 -31.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 1.0 109.619 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 19.4 t70 -65.96 -30.4 70.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.33 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 68' ' ' ILE . 27.6 tp -63.9 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.844 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.41 73.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.309 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.47 68.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.485 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.84 73.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.0 109.862 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HZ ' ' A' ' 63' ' ' PHE . . . -66.16 -29.0 74.1 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.457 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.92 -34.68 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.079 0.466 . . . . 1.0 109.959 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.68 62.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.628 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.38 -1.73 19.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 1.0 111.008 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -64.25 -11.17 28.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.038 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.64 -22.98 67.11 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' B' ' 30' ' ' ARG . 10.5 tpt180 -106.37 42.1 1.33 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -58.77 -14.25 8.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.924 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -70.42 -18.24 63.02 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -106.17 164.46 14.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.297 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.98 106.44 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.852 2.368 . . . . 1.0 112.891 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -162.58 111.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.698 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.36 110.55 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.729 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.22 -26.52 62.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.149 0.499 . . . . 1.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.53 -32.93 72.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.19 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.64 -54.63 32.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.922 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.48 -22.35 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.765 0.317 . . . . 1.0 111.66 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.484 ' HG2' ' CE2' ' B' ' 52' ' ' PHE . 1.6 tm-20 -74.8 -35.23 62.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.287 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 42' ' ' ARG . 4.1 mmm180 -87.42 -18.92 28.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -77.8 -19.97 54.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.496 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -75.76 147.7 81.46 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.689 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.42 107.17 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.777 2.318 . . . . 1.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.86 -11.42 18.13 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.552 0.575 . . . . 1.0 112.552 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -70.82 -15.03 62.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.847 0.356 . . . . 1.0 110.326 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.09 61.57 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.035 0.445 . . . . 1.0 111.454 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HG2' ' OE1' ' B' ' 44' ' ' GLN . 5.3 mtm180 -70.74 -25.97 63.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.067 0.46 . . . . 1.0 110.539 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.26 86.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.728 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -69.41 -35.61 75.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.289 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HG2' ' B' ' 41' ' ' GLU . 49.4 t80 -63.08 -41.88 99.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.047 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 54' ' ' GLU . 0.0 OUTLIER -61.85 -35.86 79.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.58 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 8.7 tm-20 -67.15 -46.02 75.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.102 0.477 . . . . 1.0 109.914 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.631 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 4.1 mmp_? -64.49 -31.77 73.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 52' ' ' PHE . 44.4 mt -62.17 -48.8 78.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.888 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.7 mt -58.4 -51.99 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.8 94.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.022 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -70.52 -44.15 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.892 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.5 ' HA ' ' OG ' ' B' ' 63' ' ' SER . 75.0 mtp180 -66.42 -26.43 67.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.237 0.541 . . . . 1.0 111.214 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.18 -27.85 63.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.892 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.83 -30.34 20.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.815 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' B' ' 60' ' ' ARG . 0.0 OUTLIER -66.11 -29.85 70.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.97 0.415 . . . . 1.0 111.677 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.41 3.39 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 1.0 110.571 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -131.39 36.68 3.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 69.6 mt -71.51 -79.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.263 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.6 m 68.44 -76.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.534 0.568 . . . . 1.0 112.534 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.617 ' NH2' ' HG ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER 62.74 90.24 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.669 0.618 . . . . 1.0 112.669 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.81 117.04 66.95 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.524 -0.762 . . . . 1.0 109.359 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.931 2.421 . . . . 1.0 112.294 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.68 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.995 0.426 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.75 132.52 56.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.18 124.31 71.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.029 0.442 . . . . 1.0 111.265 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.74 130.4 43.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.122 -1.436 . . . . 1.0 107.122 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 tp -132.93 149.17 52.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.42 0.896 . . . . 1.0 113.42 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 38.4 t70 -143.56 123.32 13.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.21 117.2 32.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 72.2 mm-40 -94.84 129.21 41.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 30' ' ' ILE . 20.4 p -119.25 -171.18 2.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.618 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -83.18 1.18 41.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.779 -0.646 . . . . 1.0 111.288 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.84 -178.94 17.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 102' ' ' PHE . 25.2 ptm -141.93 160.55 39.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 1.0 111.16 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 88.4 m-20 -93.62 147.93 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -71.73 -45.09 62.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.746 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.3 pt -127.07 169.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.679 -0.237 . . . . 1.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.23 -140.13 33.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.292 -0.723 . . . . 1.0 111.292 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -81.05 104.83 11.81 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 22.9 p-80 -62.42 -10.47 11.61 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -110.4 -1.66 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.093 0.405 . . . . 1.0 112.093 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 8.4 tp10 -65.87 115.43 5.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.862 0.363 . . . . 1.0 111.395 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 30.64 55.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.0 112.765 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.25 151.67 49.92 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 1.6 mmmp? -131.42 160.7 34.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.67 0.272 . . . . 1.0 111.618 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 15' ' ' THR . 87.8 mt -80.4 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -114.17 -37.14 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.815 0.672 . . . . 1.0 112.815 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 43.8 tt0 -135.37 129.2 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.196 0.522 . . . . 1.0 111.629 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.05 121.93 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.498 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.4 120.63 3.08 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.468 -0.872 . . . . 1.0 111.682 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.65 150.16 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.586 0.231 . . . . 1.0 110.836 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.17 144.71 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.409 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.3 128.15 42.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0 111.25 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -120.55 110.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.195 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.65 124.23 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 59.73 34.58 22.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.299 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.2 mtp85 69.42 15.28 8.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.273 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -125.72 141.75 51.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.51 120.63 23.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 1.0 110.246 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -12.76 60.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.468 . . . . 1.0 112.014 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -2.05 58.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.141 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.74 90.21 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.47 137.22 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.465 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.79 118.72 35.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.15 94.32 2.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.721 0.296 . . . . 1.0 110.803 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.37 149.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.19 143.96 37.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 61.8 mt -125.8 160.01 30.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 78' ' ' THR . 16.8 tttm -66.4 124.85 89.24 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.542 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 95.0 Cg_endo -78.68 -24.75 7.09 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.029 2.486 . . . . 1.0 113.435 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.85 -44.77 0.58 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.157 0.583 . . . . 1.0 112.077 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.8 150.69 47.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.74 146.96 51.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 16' ' ' THR . 61.3 t -69.3 145.46 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.41 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.36 131.09 94.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.896 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.32 -43.46 31.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.215 2.61 . . . . 1.0 113.289 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.32 -21.44 63.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.57 -18.98 24.28 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.155 0.502 . . . . 1.0 110.256 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.62 -45.29 87.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.87 -2.39 51.5 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.091 -0.576 . . . . 1.0 113.63 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.46 -55.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 1.0 111.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.04 -3.15 15.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.729 1.011 . . . . 1.0 113.729 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.84 64.37 4.41 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.128 -0.558 . . . . 1.0 113.689 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.436 HG23 HD21 ' B' ' 20' ' ' LEU . 88.8 mt -137.24 125.6 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -101.15 152.26 20.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.529 -0.305 . . . . 1.0 110.845 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 73' ' ' LEU . 10.6 m-20 -69.41 -29.95 67.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.73 -0.668 . . . . 1.0 112.111 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 56.2 mp0 -59.63 -20.39 55.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.016 0.436 . . . . 1.0 111.716 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 92.4 t80 -88.09 -18.77 28.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.485 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 8.9 mt -96.7 7.34 46.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.841 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.9 mt -80.45 -32.22 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 1.0 111.556 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -96.25 35.77 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.494 0.664 . . . . 1.0 110.135 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 48.2 mmtm -130.14 160.98 62.81 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 86.1 Cg_endo -80.3 176.92 8.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.762 2.308 . . . . 1.0 112.619 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 53' ' ' LYS . 31.8 p -103.26 169.05 8.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.038 0.446 . . . . 1.0 110.736 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -62.78 -31.11 72.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.84 68.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 1.0 111.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.1 -46.53 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.899 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.21 13.28 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.089 0.403 . . . . 1.0 112.089 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.3 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.747 0.647 . . . . 1.0 112.747 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.89 -35.37 79.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.864 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.01 -46.24 90.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.0 110.627 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -71.68 -37.65 70.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 52.8 ttm -62.86 -40.22 96.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.754 0.311 . . . . 1.0 111.046 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.16 -37.44 85.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 1.0 110.503 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.18 -34.36 76.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.442 -0.799 . . . . 1.0 112.727 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 95' ' ' LEU . 36.2 pt -116.66 22.21 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.65 0.611 . . . . 1.0 112.65 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 91' ' ' ARG . 33.5 ttm105 -73.31 108.33 6.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.77 54.84 10.82 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.787 -0.642 . . . . 1.0 112.824 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.37 162.94 33.81 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.717 -0.284 . . . . 1.0 110.712 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.22 116.71 18.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 90' ' ' ILE . 64.7 mt -96.75 105.79 17.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 1.0 111.229 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.81 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.581 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.14 152.86 34.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 9.8 t60 -101.54 111.94 24.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.053 -1.462 . . . . 1.0 107.053 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 98' ' ' HIS . 60.1 t30 74.98 51.79 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.82 -24.9 3.86 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.31 -1.314 . . . . 1.0 113.581 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -25.75 66.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 1.0 111.092 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 18' ' ' MET . 85.5 t80 -84.11 -62.68 1.5 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.502 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.58 -57.97 9.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.882 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 127' ' ' VAL . 41.3 mm -57.27 -37.79 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.741 0.305 . . . . 1.0 111.043 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.82 95.79 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.938 -0.648 . . . . 1.0 111.803 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 15' ' ' THR . 8.9 m-85 -76.05 -40.24 53.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.861 0.362 . . . . 1.0 110.664 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 87.6 mtp -57.77 -51.78 68.16 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.51 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -34.44 77.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.751 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.66 -45.87 88.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.843 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.7 mm-40 -65.71 -35.09 79.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 1.0 110.525 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -67.87 -36.73 80.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.693 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -29.16 63.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.829 0.347 . . . . 1.0 111.158 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.1 -18.56 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.703 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 110' ' ' GLU . 64.1 mt -81.72 -28.09 33.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.747 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 52.81 63.51 2.21 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.709 0.631 . . . . 1.0 110.581 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -126.09 32.9 5.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.405 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 60.66 28.98 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.023 0.439 . . . . 1.0 111.443 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.4 mt -84.45 126.92 67.91 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.444 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.49 -172.56 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.74 2.293 . . . . 1.0 111.121 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.5 140.3 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 1.0 110.476 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 m -58.46 -33.53 69.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.735 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.48 4.79 8.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.7 p -91.83 -32.48 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.46 6.39 14.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 74.4 m -141.89 133.09 26.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.624 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -81.68 110.66 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 104' ' ' ILE . 25.6 t -96.19 124.38 48.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.205 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 m -120.2 117.36 27.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.947 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.18 116.85 23.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 p -76.45 -16.04 59.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.77 -42.91 80.99 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.43 80.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.794 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 t -68.78 -49.51 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.917 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -64.5 -34.8 79.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.975 0.417 . . . . 1.0 110.568 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -78.22 -35.1 48.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.45 -37.0 68.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.235 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 72.8 m-85 -126.46 78.17 72.27 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.252 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.82 119.67 6.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.503 2.135 . . . . 1.0 112.635 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.68 75.11 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 1.0 112.707 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 138' ' ' PHE . 75.1 mmtt -114.23 163.65 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 147' ' ' ALA . 0.9 OUTLIER -59.1 114.35 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.51 11.95 38.15 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.756 0.65 . . . . 1.0 112.756 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.24 156.73 38.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.266 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.83 -40.07 83.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 1.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.69 -37.84 76.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.393 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . . . -67.5 -41.53 84.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.414 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 174' ' ' VAL . 88.4 mt -60.09 -39.02 84.67 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.155 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.637 ' SG ' HG21 ' A' ' 170' ' ' ILE . 30.8 m -62.26 -48.27 80.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 1.0 109.986 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.62 66.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -71.28 -51.27 25.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 3.94 46.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.892 0.377 . . . . 1.0 111.596 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 59.03 57.04 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.536 0.684 . . . . 1.0 112.09 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.69 128.88 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.43 135.74 38.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.0 111.92 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -137.47 27.49 2.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 -24.67 4.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.866 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -109.63 3.05 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.124 0.488 . . . . 1.0 111.0 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -75.09 137.46 41.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 56.13 2.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.501 . . . . 1.0 111.511 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.6 mt -139.6 156.43 46.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -144.8 143.04 30.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.596 0.236 . . . . 1.0 110.64 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.4 -149.89 39.44 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.77 -0.65 . . . . 1.0 114.15 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.624 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -54.53 -37.84 65.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.323 0.649 . . . . 1.0 112.396 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.99 -31.34 71.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 1.0 111.134 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 170' ' ' ILE . 37.5 tp -71.79 -42.28 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.624 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 77.2 m-20 -66.91 -42.9 84.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.279 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.01 82.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.094 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -61.78 -50.09 73.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.637 HG21 ' SG ' ' A' ' 149' ' ' CYS . 47.9 mm -62.89 -46.79 95.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 1.0 111.436 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.54 -36.16 73.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.996 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.13 84.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.921 0.391 . . . . 1.0 110.026 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.54 -42.52 95.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 148' ' ' LEU . 86.7 t -64.98 -42.15 93.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.139 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.62 -41.87 86.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.793 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.78 -36.55 83.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.992 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.41 65.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.58 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 83.9 mtp -64.97 -41.25 95.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.318 0.58 . . . . 1.0 110.31 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 55.7 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.89 -157.61 9.76 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-O 118.169 -1.351 . . . . 1.0 111.303 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.246 -4.47 0 CA-C-N 118.952 1.376 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.197 0.522 . . . . 1.0 110.129 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -35.37 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 1.0 111.512 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -36.87 85.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 1.0 110.658 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.8 mmm -66.43 -30.87 71.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.275 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.2 -43.22 24.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.167 0.508 . . . . 1.0 110.49 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -61.31 -41.47 97.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.586 -0.734 . . . . 1.0 112.22 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.55 -29.09 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -68.66 -45.5 71.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 1.0 109.86 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.634 HG11 HD13 ' B' ' 48' ' ' LEU . 22.0 t -67.96 -38.71 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.965 -0.562 . . . . 1.0 110.573 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.447 ' CG ' ' HD3' ' B' ' 55' ' ' ARG . 13.8 t0 -64.18 -35.83 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 68' ' ' ILE . 2.4 mt -62.42 -38.48 89.89 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.858 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.5 71.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.664 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.04 68.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.792 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -15.98 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.565 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.95 71.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.495 -0.642 . . . . 1.0 111.495 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.18 -28.13 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.198 0.523 . . . . 1.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.71 -42.29 77.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -19.65 63.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.151 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -67.92 -24.27 65.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -60.34 -42.57 95.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -84.88 64.04 8.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.537 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -73.57 60.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.244 -0.889 . . . . 1.0 111.596 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 2.31 2.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.119 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -128.08 165.68 29.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.941 -1.027 . . . . 1.0 108.84 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.84 104.87 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.287 1.992 . . . . 1.0 112.174 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.73 141.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.411 HG22 ' H ' ' B' ' 39' ' ' ALA . 11.8 mt -94.61 115.83 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.942 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.51 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -78.07 -26.65 48.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 1.0 110.577 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -70.11 -36.07 74.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.586 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.411 ' H ' HG22 ' B' ' 36' ' ' ILE . . . -56.71 -39.55 74.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.831 0.678 . . . . 1.0 112.831 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' B' ' 37' ' ' ALA . 3.3 m -66.31 -19.45 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 1.0 111.855 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.25 13.94 19.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.761 0.791 . . . . 1.0 109.625 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -119.01 -37.17 3.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.0 110.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.07 27.81 0.99 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.534 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.35 71.37 79.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.624 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.487 ' HD2' HD11 ' B' ' 48' ' ' LEU . 15.4 Cg_endo -60.41 149.85 83.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.919 1.746 . . . . 1.0 111.393 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 49' ' ' ARG . 3.7 pm0 -62.94 -16.72 60.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.506 . . . . 1.0 112.227 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.0 111.063 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.634 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 pp -150.72 28.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.218 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' B' ' 46' ' ' GLU . 0.3 OUTLIER -60.99 -30.54 70.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.814 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -40.58 96.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.792 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 61.5 t-105 -68.05 -45.47 73.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.377 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -66.46 -37.26 84.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.18 95.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.164 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -42.65 79.42 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.073 0.463 . . . . 1.0 110.055 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.447 ' HD3' ' CG ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -61.77 -29.21 69.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.616 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' B' ' 60' ' ' ARG . 38.2 tp -61.68 -22.25 65.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.582 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 mt -109.05 -45.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.154 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.03 -58.15 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 1.0 112.209 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -7.3 54.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' B' ' 60' ' ' ARG . 12.2 ttm180 -75.27 -30.71 60.52 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.255 0.55 . . . . 1.0 109.948 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.5 -18.55 56.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.426 0.631 . . . . 1.0 109.618 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.602 ' HA ' ' OD1' ' B' ' 65' ' ' ASN . . . -84.16 -4.15 58.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.076 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -85.8 -5.47 59.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.727 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.26 -27.82 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.981 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' B' ' 62' ' ' ALA . 25.0 p-10 -88.4 24.56 1.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 1.0 112.101 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.52 -24.14 66.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 32.3 0.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.711 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' B' ' 68' ' ' ARG . 0.0 OUTLIER -68.61 -21.06 64.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.0 110.889 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 53' ' ' LYS . 8.5 tp -91.96 116.23 66.09 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.006 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--O 1.237 0.46 0 C-N-CA 122.504 2.136 . . . . 1.0 112.295 -179.832 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.654 'CA ' ' OE2' ' A' ' 14' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.899 0.381 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -104.81 133.56 49.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.195 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.56 117.14 54.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.157 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.27 139.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 tp -137.41 155.15 49.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 164' ' ' ALA . 7.1 t70 -160.46 108.77 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 p -107.43 120.64 42.72 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.868 0.692 . . . . 1.0 112.868 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.677 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.7 mm-40 -88.55 136.93 32.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.788 HG22 ' HA ' ' A' ' 30' ' ' ILE . 7.2 p -126.27 -177.67 4.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.317 0.58 . . . . 1.0 112.333 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -87.91 48.54 1.66 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 1.0 109.938 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.58 -178.35 50.2 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.641 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 ptm -144.96 171.77 13.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.658 0.266 . . . . 1.0 110.603 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.709 ' HB2' ' HA ' ' A' ' 24' ' ' HIS . 99.6 m-20 -97.4 157.36 16.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.33 -29.7 18.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 1.0 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.35 167.26 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.185 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.73 -137.01 46.62 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -86.96 111.16 20.56 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 19.2 p-80 -61.59 -14.74 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 1.0 112.025 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -101.8 -3.5 27.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.895 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.4 tp10 -71.77 122.99 21.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 1.0 111.15 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.52 24.51 67.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.765 -0.731 . . . . 1.0 112.416 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -135.86 157.07 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.167 -0.308 . . . . 1.0 110.167 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 23.3 mmmt -134.09 158.11 44.44 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.607 0.242 . . . . 1.0 111.225 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HG22 ' A' ' 15' ' ' THR . 56.1 mt -84.22 133.74 28.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 pt -107.39 -34.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -139.94 137.15 34.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.027 0.441 . . . . 1.0 111.765 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.68 118.41 57.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.064 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -123.34 121.82 4.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.104 -0.798 . . . . 1.0 111.104 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . . . -139.95 147.23 40.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 1.0 110.799 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.69 141.45 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.373 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.21 132.51 41.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.923 0.392 . . . . 1.0 111.677 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.7 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.897 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.29 129.29 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 62.26 33.96 16.27 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.303 0.573 . . . . 1.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 65.85 18.78 11.21 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.133 -0.939 . . . . 1.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -137.88 151.12 47.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 1.0 110.183 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.75 116.14 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.092 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -19.04 64.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.709 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.52 -5.66 38.04 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -76.91 94.05 3.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.169 0.509 . . . . 1.0 110.002 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -109.33 128.35 55.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.988 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 16.3 t80 -102.42 114.34 28.44 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 14.9 t-80 -140.27 101.91 4.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.512 0.196 . . . . 1.0 111.168 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.15 159.06 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 72' ' ' PHE . 76.6 m-85 -117.83 147.5 42.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 79' ' ' PHE . 21.2 mt -125.0 152.54 44.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.151 0.426 . . . . 1.0 112.151 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.1 tppt? -67.95 120.67 75.64 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 73' ' ' LEU . 55.7 Cg_endo -69.72 -29.99 23.17 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.823 2.349 . . . . 1.0 113.302 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.93 -51.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.3 0.64 . . . . 1.0 110.816 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -112.13 143.74 42.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 66.8 mt -57.93 148.27 26.26 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 16' ' ' THR . 47.4 t -70.72 140.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.866 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.2 139.67 84.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -48.83 -45.1 29.6 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.67 2.913 . . . . 1.0 113.87 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 65' ' ' VAL . 41.5 tt0 -62.39 -45.79 91.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.848 0.356 . . . . 1.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.35 70.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.889 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -65.24 -41.74 94.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.24 79.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.905 -0.664 . . . . 1.0 113.279 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 61' ' ' GLU . 64.2 t -82.22 -44.41 19.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.528 0.566 . . . . 1.0 112.528 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -129.86 9.13 5.35 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 46.57 66.15 1.87 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.365 0.906 . . . . 1.0 115.365 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.63 127.97 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 117.226 0.513 . . . . 1.0 109.884 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.83 157.59 18.46 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.326 0.391 . . . . 1.0 111.608 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 57' ' ' LEU . 5.8 m-20 -63.39 -31.59 72.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.582 -0.736 . . . . 1.0 112.267 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -51.74 -35.03 41.81 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.189 0.811 . . . . 1.0 113.189 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' B' ' 19' ' ' ASP . 63.6 t80 -77.37 -14.84 59.63 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 2.6 mt -108.3 20.22 18.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.86 -46.36 15.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -75.69 -37.1 59.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 1.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 41.0 mmtm -53.18 147.86 16.81 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.182 -0.917 . . . . 1.0 111.497 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.6 Cg_endo -74.75 179.64 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.887 2.392 . . . . 1.0 112.216 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 53' ' ' LYS . 69.5 p -98.01 169.96 9.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.67 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 52' ' ' LEU . 91.5 t80 -61.33 -33.12 73.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.081 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -16.17 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.072 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -96.34 -14.79 22.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.21 6.68 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.875 0.369 . . . . 1.0 111.114 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.9 81.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.624 -0.716 . . . . 1.0 112.572 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.64 -44.67 89.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.884 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -41.3 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.028 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -70.23 -42.64 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.714 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 44.9 mtm -61.02 -50.73 72.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.544 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.77 -24.52 67.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -78.49 -39.81 37.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.9 pt -101.77 -7.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' MET . 39.9 ttm180 -55.82 118.99 5.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.383 0.512 . . . . 1.0 112.383 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.11 68.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.084 -0.579 . . . . 1.0 113.57 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.72 160.17 23.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 122.458 -0.436 . . . . 1.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.83 121.46 25.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.7 99.57 11.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.092 0.472 . . . . 1.0 111.564 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.12 98.38 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.16 164.39 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.633 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -104.25 108.62 20.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.2 t30 71.53 56.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.0 -23.21 1.9 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.456 -1.247 . . . . 1.0 113.357 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.83 65.8 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.483 . . . . 1.0 110.376 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -82.67 -65.53 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.28 -53.61 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.28 -40.0 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.948 0.404 . . . . 1.0 110.876 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.05 -35.83 92.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.762 -0.732 . . . . 1.0 111.917 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -78.49 -39.32 38.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.693 0.282 . . . . 1.0 110.658 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 61.9 mtp -58.13 -52.07 67.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.602 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -62.81 -35.0 78.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.0 111.081 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -63.06 -49.29 75.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.79 -36.94 85.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.213 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.26 -47.52 83.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.499 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 93.7 p -60.52 -31.43 70.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.2 -24.15 64.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.287 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.89 -28.45 62.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.456 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 59.81 33.86 21.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.191 0.52 . . . . 1.0 110.918 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -98.42 14.18 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.025 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 t0 59.54 55.31 4.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.091 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.0 mt -104.11 122.74 43.16 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.1 166.55 22.69 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.552 2.168 . . . . 1.0 111.606 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 94.0 mttt -56.54 148.13 20.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.16 0.43 . . . . 1.0 112.16 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 124' ' ' PHE . 6.6 m -52.81 -33.76 50.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.224 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.05 5.73 4.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.2 p -95.66 -37.12 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.484 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 121' ' ' THR . 24.4 p90 -106.7 -11.18 15.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.427 0.529 . . . . 1.0 112.427 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 90.6 m -136.64 156.89 47.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.805 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -93.32 135.35 34.62 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.02 111.37 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.12 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.0 m -119.08 120.52 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.144 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -102.11 122.72 44.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.215 0.531 . . . . 1.0 111.497 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -75.66 -21.92 57.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.161 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 50.9 tp -69.07 -41.43 77.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.56 90.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.68 -50.33 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.107 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.57 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.158 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.488 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 79.6 mtm180 -65.11 -23.97 67.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.118 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -87.19 -27.4 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.296 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.77 -46.75 12.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.577 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -123.3 79.05 53.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.02 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.69 133.17 18.28 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.464 2.109 . . . . 1.0 112.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.09 15.9 75.93 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.851 -0.69 . . . . 1.0 112.336 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.58 164.5 18.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 142' ' ' ARG . 31.9 ttp85 -71.18 110.86 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -109.95 36.06 3.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 1.0 112.246 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 p -80.85 166.82 20.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 145' ' ' LEU . 17.6 tp -59.93 -42.43 93.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.732 0.301 . . . . 1.0 110.724 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.39 -41.46 97.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.641 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -48.23 70.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.36 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.02 -37.76 86.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.224 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 156' ' ' ASN . 3.2 t -61.05 -53.54 55.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.746 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.16 88.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -60.33 -28.99 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.8 10.61 28.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 65.85 23.52 11.37 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 149' ' ' CYS . 50.0 mt -84.65 129.49 37.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 159' ' ' ARG . 0.6 OUTLIER -75.3 126.83 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.283 0.563 . . . . 1.0 111.669 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.473 ' HB3' ' SG ' ' A' ' 149' ' ' CYS . 29.2 p-10 -127.27 27.19 5.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.458 -0.792 . . . . 1.0 108.956 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.42 -44.28 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.21 -0.905 . . . . 1.0 112.57 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.77 -20.98 26.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.308 0.484 . . . . 1.0 112.308 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 155' ' ' ASP . 48.3 mmt-85 -45.0 123.59 3.95 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.279 0.362 . . . . 1.0 111.407 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.19 50.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.608 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.2 mt -129.96 137.69 50.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.519 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.406 ' ND1' HD12 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -123.24 124.64 43.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.195 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.8 19.31 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.574 -0.822 . . . . 1.0 114.64 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . . . -55.98 -38.1 69.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.842 1.053 . . . . 1.0 113.842 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . 15.9 tp -59.1 -27.47 65.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 170' ' ' ILE . 56.8 tp -70.9 -49.72 42.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.507 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.681 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.0 m-20 -63.84 -41.69 97.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.51 89.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.509 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -63.77 -47.52 80.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.232 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 166' ' ' LEU . 30.2 mm -60.26 -48.89 86.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 1.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.2 tp -58.2 -38.4 76.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.737 0.303 . . . . 1.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.03 86.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.214 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -63.64 -41.5 98.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.847 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 178' ' ' MET . 81.9 t -64.06 -46.43 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.024 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -57.85 -44.47 86.56 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.098 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.06 -41.01 97.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.569 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.03 -35.79 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.559 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 174' ' ' VAL . 62.2 mtm -71.1 -21.98 62.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.917 0.389 . . . . 1.0 111.575 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.0 p -111.21 16.46 20.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.374 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.48 -19.28 4.63 Favored Glycine 0 C--O 1.249 1.035 0 CA-C-O 118.769 -1.017 . . . . 1.0 111.695 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.245 -4.482 0 CA-C-N 118.653 1.226 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.816 0.341 . . . . 1.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.41 -35.71 73.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.825 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.31 -29.77 70.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.739 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 18.4 mmm -65.51 -38.52 89.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.465 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.45 ' O ' HG23 ' B' ' 18' ' ' VAL . 4.6 t70 -66.28 -42.23 88.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.26 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 15' ' ' LYS . 0.9 OUTLIER -61.59 -49.2 77.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.0 112.24 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.58 -27.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.128 0.49 . . . . 1.0 111.128 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -66.86 -42.52 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.166 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 14' ' ' ASP . 60.1 t -73.2 -38.28 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' PHE . 7.0 t70 -62.38 -35.3 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.557 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 72' ' ' PHE . 2.0 tm? -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.76 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -32.91 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.095 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.25 66.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.16 60.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.85 -29.22 74.35 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.168 -0.773 . . . . 1.0 111.168 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' B' ' 40' ' ' VAL . 3.4 t -70.99 -31.29 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.98 63.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -66.79 -20.79 66.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -69.54 -10.67 59.08 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.28 -38.29 76.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.457 0.646 . . . . 1.0 109.514 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 84.68 3.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.15 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -71.76 11.26 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.802 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -86.91 -4.87 59.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . . . . . . . . . 49.6 mtt -114.9 156.22 45.38 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.808 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.96 88.3 0.37 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.593 2.195 . . . . 1.0 113.011 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.39 131.42 65.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.445 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mt -89.22 109.02 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 1.0 110.8 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.58 ' O ' HG22 ' B' ' 40' ' ' VAL . . . -68.5 -36.55 79.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.75 -31.65 72.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.92 99.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.841 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' B' ' 25' ' ' VAL . 3.2 m -66.46 -17.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 1.0 111.829 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -105.82 2.92 28.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.325 0.583 . . . . 1.0 109.762 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -107.8 -41.44 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.481 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.31 24.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.528 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -124.22 73.6 58.34 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.456 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.707 ' HD2' HD11 ' B' ' 48' ' ' LEU . 48.6 Cg_exo -56.25 142.27 87.61 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.74 2.294 . . . . 1.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -26.83 62.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.752 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -57.9 -29.09 64.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.936 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.707 HD11 ' HD2' ' B' ' 45' ' ' PRO . 1.1 pp -134.76 35.83 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 1.0 110.771 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.28 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 1.0 111.679 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -42.94 97.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' B' ' 55' ' ' ARG . 71.2 t-105 -59.5 -46.37 89.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.708 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -68.61 -35.33 77.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.09 -50.48 73.09 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.97 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.99 -41.31 82.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 1.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' B' ' 51' ' ' TRP . 0.0 OUTLIER -57.85 -36.87 72.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.581 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.495 HD13 HG11 ' B' ' 25' ' ' VAL . 4.1 tp -57.63 -52.12 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.705 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.45 -47.4 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.7 71.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.784 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -82.08 -24.43 35.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.72 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 60' ' ' ARG . 4.9 mmt180 -71.13 -23.96 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.97 3.91 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.877 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 -46.23 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.887 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -21.4 62.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.128 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.04 -19.73 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.17 59.22 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.085 0.469 . . . . 1.0 110.696 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -28.32 66.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.175 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -82.77 65.37 7.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -74.81 -22.51 58.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.38 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 70' ' ' PRO . 58.6 mt -126.01 125.97 24.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.472 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 69' ' ' LEU . 25.7 Cg_exo . . . . . 0 C--O 1.235 0.368 0 C-N-CA 122.825 2.35 . . . . 1.0 111.551 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.681 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -117.07 143.39 45.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.743 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 37' ' ' GLU . 36.2 mm -124.35 121.46 61.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.85 0.357 . . . . 1.0 111.033 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 61.9 t -95.7 129.74 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 15.4 tp -131.6 157.52 43.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.897 0.703 . . . . 1.0 112.897 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 8.5 t70 -143.21 105.66 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -89.22 110.26 21.04 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.717 1.006 . . . . 1.0 113.717 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' OE2' 'CA ' ' A' ' 190' ' ' ' CA' . 81.7 mm-40 -96.33 114.93 26.65 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.558 -0.905 . . . . 1.0 108.558 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 30' ' ' ILE . 28.2 p -109.15 -174.41 2.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.531 0.567 . . . . 1.0 112.531 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.29 6.35 26.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.677 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.47 -177.9 16.52 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . 18.8 ptt? -150.39 158.14 43.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.17 0.485 . . . . 1.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -86.66 155.82 20.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.72 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.0 -31.46 18.09 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.03 0.382 . . . . 1.0 112.03 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.1 pt -116.51 145.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 1.0 111.378 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.07 -141.35 27.95 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.333 -0.707 . . . . 1.0 111.333 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -79.72 115.31 19.25 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 18' ' ' MET . 21.6 p-80 -63.31 -17.59 62.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -98.24 1.62 47.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.591 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.8 tp10 -63.45 108.8 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.252 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.93 23.87 63.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.855 -0.688 . . . . 1.0 113.392 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -127.44 155.35 43.83 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.682 -0.305 . . . . 1.0 110.393 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 29' ' ' LYS . 20.5 mmmt -135.36 160.26 38.98 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.921 0.391 . . . . 1.0 111.417 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' HA ' HG22 ' A' ' 15' ' ' THR . 69.4 mt -82.38 141.45 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.764 HD11 ' HE1' ' A' ' 66' ' ' HIS . 19.8 pt -120.43 -34.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 54.5 tt0 -130.79 133.18 45.76 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.303 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 68.1 mt -119.08 123.82 72.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.553 -0.748 . . . . 1.0 109.808 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.02 114.05 1.27 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.34 152.35 50.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.816 0.341 . . . . 1.0 111.493 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 10' ' ' VAL . 15.4 m -129.86 144.48 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.93 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 39' ' ' VAL . 45.7 tt0 -96.29 124.78 40.41 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.051 0.453 . . . . 1.0 112.175 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -112.22 110.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.516 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 37' ' ' GLU . 72.5 t -121.58 131.66 72.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 31.99 20.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.144 0.497 . . . . 1.0 110.412 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 67.15 20.9 10.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.158 -0.928 . . . . 1.0 112.816 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -138.25 149.42 45.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.23 126.83 31.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.836 0.35 . . . . 1.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -82.74 -19.97 36.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.419 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -5.59 61.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.639 -0.791 . . . . 1.0 111.183 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.98 73.59 4.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.38 0.61 . . . . 1.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -82.77 153.03 25.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 1.0 111.306 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -127.98 113.36 15.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.26 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB2' HD13 ' A' ' 165' ' ' LEU . 18.3 t-80 -139.02 109.55 6.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 1.0 111.333 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.33 166.53 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.544 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.57 148.96 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 33' ' ' ILE . 24.3 mt -126.09 154.64 42.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.19 0.519 . . . . 1.0 111.897 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' HG22 ' A' ' 78' ' ' THR . 2.8 ttpt -88.27 115.91 64.63 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.4 -15.79 11.06 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.86 2.373 . . . . 1.0 113.91 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 64.81 15.37 9.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.193 0.521 . . . . 1.0 111.536 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -154.74 168.45 26.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.4 mt -87.02 149.75 24.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.753 HG22 HG22 ' A' ' 16' ' ' THR . 33.9 t -72.2 135.74 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.594 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -64.27 133.26 95.58 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.399 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 60.3 Cg_exo -53.66 -39.15 84.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.112 2.541 . . . . 1.0 112.507 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -19.13 61.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.573 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.15 -13.0 23.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.064 0.459 . . . . 1.0 110.521 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.58 -41.75 98.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.13 -6.35 56.66 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.056 -0.592 . . . . 1.0 113.451 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.05 -42.44 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.66 0.23 . . . . 1.0 111.576 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.764 ' HE1' HD11 ' A' ' 31' ' ' ILE . 6.5 p80 -143.07 0.74 1.21 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.5 0.31 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.526 0.97 . . . . 1.0 115.526 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.32 130.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.094 0.447 . . . . 1.0 110.162 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.434 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -96.67 153.32 17.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.307 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 72' ' ' PHE . 4.4 m-20 -70.18 -33.29 71.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.223 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.74 ' HG2' ' HA ' ' B' ' 63' ' ' SER . 11.8 mp0 -74.37 30.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 70' ' ' ASP . 70.1 t80 -133.41 -24.96 1.76 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.26 19.29 17.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.202 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' B' ' 66' ' ' LEU . 91.7 mt -80.67 -40.05 26.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -78.48 -32.82 48.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.203 0.525 . . . . 1.0 110.869 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -60.74 151.54 71.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.24 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.9 169.09 22.32 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.815 2.343 . . . . 1.0 112.1 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 53' ' ' LYS . 66.7 p -88.16 173.76 8.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.304 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.24 -35.73 81.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 1.0 110.332 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.63 -12.14 61.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 1.0 112.079 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -92.14 -19.1 22.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.85 16.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 1.0 111.779 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.28 97.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.239 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.49 -40.49 93.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.23 -47.7 83.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 1.0 110.203 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -65.72 -41.8 91.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.722 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 32.3 ttm -63.78 -42.55 97.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.405 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.61 -28.81 68.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.402 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -76.15 -32.26 59.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.656 0.614 . . . . 1.0 112.656 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' HD21 ' A' ' 95' ' ' LEU . 46.8 pt -104.66 -6.77 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 91' ' ' ARG . 30.1 ttm105 -61.19 121.8 13.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.931 0.715 . . . . 1.0 112.931 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.48 89.88 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.717 -0.674 . . . . 1.0 113.855 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.86 164.27 11.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.775 0.321 . . . . 1.0 111.421 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' LYS . 36.4 tt0 -90.0 126.16 35.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.181 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 90' ' ' ILE . 80.4 mt -100.48 111.32 23.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.775 0.321 . . . . 1.0 111.38 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 128' ' ' THR . 50.1 t -104.43 114.69 44.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.499 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -132.54 174.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.55 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -107.46 107.75 18.76 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.2 t30 74.76 66.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.92 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.421 -1.263 . . . . 1.0 114.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -25.35 67.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.107 0.479 . . . . 1.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -82.21 -65.04 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 m-20 -56.19 -60.28 3.72 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 1.0 112.666 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.78 -39.94 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 1.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.72 -37.99 90.98 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 121.111 -0.566 . . . . 1.0 112.164 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.68 -39.66 36.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.844 0.354 . . . . 1.0 110.598 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.5 mtp -59.8 -51.38 70.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.72 -33.08 73.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.0 110.755 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 62.6 t80 -68.73 -49.19 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.28 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.15 -41.05 97.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.72 -35.38 79.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.312 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -77.99 -26.83 48.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.655 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 109' ' ' TYR . 92.0 mt -64.46 -20.72 66.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.197 0.522 . . . . 1.0 111.087 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.99 -17.96 56.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.21 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 54.59 39.79 31.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.486 0.491 . . . . 1.0 112.033 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -103.91 15.47 28.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.083 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.5 t70 57.88 42.17 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.467 0.651 . . . . 1.0 111.382 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.5 mt -88.12 127.0 59.02 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.564 -0.743 . . . . 1.0 109.638 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.39 167.61 21.88 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.552 2.168 . . . . 1.0 111.203 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -60.25 145.08 48.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 1.0 111.043 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m -59.03 -29.19 67.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.353 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -73.15 -0.2 13.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.7 p -94.72 -40.4 9.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.694 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -101.96 -11.04 19.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 78.3 m -124.46 157.41 35.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.862 0.363 . . . . 1.0 110.474 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 69.3 tttt -91.37 124.85 35.87 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.0 t -99.61 114.54 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 32.8 m -125.92 117.53 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.13 0.49 . . . . 1.0 110.494 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -92.69 125.54 37.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.408 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.2 p -76.39 -23.68 54.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.694 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.414 ' HG ' ' NE ' ' A' ' 135' ' ' ARG . 43.2 tp -68.67 -37.96 80.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.208 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.14 92.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.066 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t -65.03 -50.35 75.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.67 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.844 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.414 ' NE ' ' HG ' ' A' ' 131' ' ' LEU . 44.8 mtm180 -68.65 -28.84 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.05 0.452 . . . . 1.0 110.858 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -84.31 -31.43 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.019 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.9 mtp -77.48 -39.75 45.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -125.46 85.35 58.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.92 131.54 12.21 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.803 2.335 . . . . 1.0 112.602 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.1 28.6 73.8 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.065 -0.588 . . . . 1.0 112.32 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 141' ' ' LYS . 24.7 mmtt -122.05 169.96 10.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -65.3 109.53 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.02 15.76 27.1 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.98 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 161.44 31.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.019 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.8 tp -56.83 -52.97 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 1.0 110.705 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -56.57 -37.9 71.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.485 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.14 82.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.828 ' HB3' HG11 ' A' ' 174' ' ' VAL . 86.9 mt -67.43 -41.45 84.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.175 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.9 m -61.11 -52.98 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.051 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.92 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.193 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -63.98 -35.21 79.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.094 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -103.68 6.19 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.5 0.556 . . . . 1.0 112.5 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 65.39 31.14 10.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.213 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 174' ' ' VAL . 98.0 mt -91.34 118.42 36.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.17 127.89 33.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.437 0.637 . . . . 1.0 111.951 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -134.09 18.52 3.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.876 -1.056 . . . . 1.0 108.157 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.2 -36.4 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.304 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -106.8 21.19 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 1.0 111.687 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -75.72 140.01 42.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.67 0.272 . . . . 1.0 110.957 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -18.88 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.735 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.24 137.97 35.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 1.0 111.259 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -126.24 145.35 50.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.6 -162.45 30.43 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.818 -0.706 . . . . 1.0 113.409 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . . . -57.15 -31.57 65.51 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.916 0.487 . . . . 1.0 112.23 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 49' ' ' HIS . 26.4 tp -61.67 -26.46 68.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 30.4 tp -76.88 -50.26 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.657 ' OD2' 'CA ' ' A' ' 190' ' ' ' CA' . 79.1 m-20 -59.07 -41.82 88.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 1.0 111.549 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.91 89.48 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.975 0.417 . . . . 1.0 110.4 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -66.3 -43.48 86.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.178 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 174' ' ' VAL . 25.5 mm -60.42 -50.79 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.028 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.03 -37.13 78.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.64 85.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.366 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -61.7 -42.85 99.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.762 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 148' ' ' LEU . 93.1 t -67.96 -45.32 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -57.38 -47.7 80.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.559 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.1 mt -58.99 -34.2 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.66 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.01 -41.1 52.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.852 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 68.1 mtm -64.19 -39.74 94.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.762 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.6 p -91.01 21.08 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 1.0 111.442 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.52 21.76 30.83 Favored Glycine 0 C--O 1.247 0.935 0 CA-C-O 118.521 -1.155 . . . . 1.0 111.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--N 1.249 -4.288 0 CA-C-N 118.628 1.214 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.938 0.399 . . . . 1.0 110.279 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -64.26 -15.03 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.243 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.73 -33.93 73.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.402 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 22.2 mmt -71.05 -40.53 71.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.578 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.408 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -75.54 -37.5 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.049 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' B' ' 15' ' ' LYS . 39.6 mmtm -65.31 -35.63 81.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.214 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -77.86 -23.64 14.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 1.0 110.054 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -67.54 -33.97 76.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 14' ' ' ASP . 42.2 t -67.02 -42.82 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.061 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' B' ' 55' ' ' ARG . 13.3 t70 -66.88 -36.34 82.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.584 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -60.09 -43.08 95.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.798 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.53 64.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.216 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.2 58.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.431 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.869 0.366 . . . . 1.0 110.143 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.3 -25.28 71.13 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.821 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 56' ' ' LEU . 22.8 t -69.69 -24.88 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 110.048 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 63' ' ' SER . . . -81.62 -44.81 16.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.53 ' HE1' ' HG3' ' B' ' 33' ' ' MET . 3.5 t80 -68.02 -15.78 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.292 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.794 ' HA ' HG11 ' B' ' 35' ' ' VAL . 1.0 OUTLIER -59.01 -24.59 62.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.7 -25.29 67.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.489 0.662 . . . . 1.0 109.712 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -92.2 75.51 5.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.35 -5.03 2.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.347 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.07 -9.73 59.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' MET . . . . . 0.53 ' HG3' ' HE1' ' B' ' 27' ' ' PHE . 3.9 mmt -113.57 163.09 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.324 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.94 97.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.597 2.198 . . . . 1.0 111.966 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.794 HG11 ' HA ' ' B' ' 28' ' ' LYS . 3.0 m -115.18 91.74 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 1.0 111.818 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.67 101.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.28 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.09 -20.38 65.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 1.0 110.521 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.31 -21.08 59.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.822 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.9 67.45 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.864 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.48 -31.19 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.62 -0.264 . . . . 1.0 111.319 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.37 -28.09 67.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 25.49 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.28 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -130.0 -43.36 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.599 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' B' ' 45' ' ' PRO . 74.5 mm-40 -89.61 126.75 56.98 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.125 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PRO . . . . . 0.464 ' HD2' HD21 ' B' ' 48' ' ' LEU . 20.3 Cg_exo -67.74 155.52 69.63 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.281 2.654 . . . . 1.0 112.824 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' B' ' 49' ' ' ARG . 36.2 mm-40 -64.53 -23.96 67.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.778 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -19.35 65.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.063 0.764 . . . . 1.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.464 HD21 ' HD2' ' B' ' 45' ' ' PRO . 1.3 pp -120.03 33.83 5.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.8 0.333 . . . . 1.0 111.68 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' B' ' 46' ' ' GLU . 20.2 mmt180 -62.35 -32.78 73.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.434 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -71.3 -43.33 67.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.967 0.413 . . . . 1.0 110.017 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -65.43 -40.82 93.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -62.41 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.613 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 53' ' ' ARG . 0.3 OUTLIER -68.03 -38.08 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.463 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.91 -46.3 78.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.389 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.628 ' HD3' ' OD1' ' B' ' 19' ' ' ASP . 5.7 mmp_? -63.91 -29.59 70.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.421 ' HG ' HH21 ' B' ' 53' ' ' ARG . 0.2 OUTLIER -61.53 -54.37 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.345 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 mt -61.2 -46.06 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -73.91 -33.82 64.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.99 0.367 . . . . 1.0 111.99 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -65.93 -30.93 71.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.047 0.451 . . . . 1.0 110.548 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.407 ' O ' HG12 ' B' ' 64' ' ' VAL . 14.6 tp -76.67 -17.09 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.134 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.24 14.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.74 ' HA ' ' HG2' ' A' ' 71' ' ' GLU . 0.5 OUTLIER -65.41 -25.45 67.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.879 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.407 HG12 ' O ' ' B' ' 61' ' ' LEU . 3.5 p -73.6 -9.97 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.114 0.483 . . . . 1.0 111.281 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.36 57.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.295 0.48 . . . . 1.0 112.295 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . 0.505 ' H ' HD23 ' B' ' 66' ' ' LEU . 2.0 pt? -81.73 -37.7 26.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.073 0.463 . . . . 1.0 109.899 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.35 119.79 30.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -127.96 -92.69 0.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' B' ' 70' ' ' PRO . 46.4 tp -136.5 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 111.763 0.283 . . . . 1.0 111.763 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 69' ' ' LEU . 96.2 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 121.739 1.626 . . . . 1.0 111.508 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . 0.657 'CA ' ' OD2' ' A' ' 167' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_